000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1210|2572|lyfalmen|V1070|1597|00|20|0|Vistor hf|Janssen-Cilag AB|2|
000020|J07AL0201|Prevenar|stl|| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|4350|7258|lyfalmen|||02|0,5|0|Icepharma hf|Wyeth Lederle Vaccines SA||
000054|B03XA0103|NeoRecormon |stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|39361|50872|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|24|
000055|B03XA0103|NeoRecormon |sts|60000|ae/rörly|1|ml|1|rörlyk|+leysir|B03XA01|01.11.2003||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|94355|119339|lyfsjukr|||00|1|0|Icepharma hf|Roche|60|
000145|B03XA0103|NeoRecormon |stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|59042|75375|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|36|
000211|J07AL0201|Prevenar|stl|| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|4350|7258|lyfalmen|||02|0,5|0|Icepharma hf|Wyeth Lederle Vaccines SA||
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|4540|6500|lyfsjukr|||00|0,9|0|Vistor hf|Ferring|0,04|
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|5833|11282|vetalmen|||00|100|0|Vistor hf|Boehringer Ingelheim||
000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|13523|18704|lyfsjukr|||00|5|0|Vistor hf|Ferring|0,23|
000240|D07AC1301|Elocon|áburður|1|mg/g|50|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1480|2983|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50|
000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|15536|22393|lyfalmen|||00|0,36|0|Icepharma hf|N.V. Organon|1,44|
000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4126|5907|lyfsjukr|||00|3000|0|Icepharma hf|Fresenius Kabi|3|
000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|30817|41417|lyfalmen|||00|0,72|0|Icepharma hf|N.V. Organon|5,76|
000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5193|8474|lyfalmen|||00|6|0|Icepharma hf|M.S.D.|6|
000530|J07BF0301|Imovax Polio|bóluefni|| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21513|29834|lyfalmen|||02|10|0|Icepharma hf|Sanofi Pasteur MSD||
000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1503|3017|lyfalmen|||06|5|0|Vistor hf|Novartis Healthcare A/S-||
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3989|6732|lyfalmen|||23|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2|
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|3593|6155|lyfalmen|||00|60|0|Vistor hf|Janssen-Cilag AB|3|
000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1934|3672|lyfalmen|||00|8|0|Vistor hf|Novartis Healthcare A/S-||
000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5140|8400|lyfalmen|||00|24|0|Vistor hf|Novartis Healthcare A/S-||
000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|11482|16163|lyfsjukr|||00|1000|0|Icepharma hf|Fresenius Kabi|1|
000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3516|6043|lyfalmen|V0311|5942|00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2909|5153|lyfalmen|||23|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1|
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|125|0|Vistor hf|McNeil Denmark ApS|1,75|
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|144055|181216|lyfsjukr|||00|6|0|Gróco ehf|Serono Nordic|122,7907|
000891|M05BA0101|Didronate|töflur|200|mg|60|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|10698|15982|lyfalmen|||00|60|0|Sofus Consulting AB|Procter & Gamble-|30|
000957|H01AC0101|Genotropin|sts|| |5|mg|1|hgl|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|26165|34443|lyfsjukr|||02|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7,4963|
001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|4853|6948|lyfsjukr|||02|0,5|0|Icepharma hf|N.V. Organon|1|
001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1317|2735|lyfalmen|||00|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10|
001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|9086|13834|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|240|
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|18864|26536|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|800|
001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2005|3780|lyfalmen|||43|100|0|Vistor hf|AstraZeneca A/S DK|15,83|
001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|9045|13780|lyfalmen|||00|98|0|Icepharma hf|Solvay Pharmaceuticals|98|
001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|352411|440619|lyfsjukr|||02|300|0|Icepharma hf|Bayer Schering Pharma AG||
001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|3582|6139|lyfalmen|||00|56|0|Icepharma hf|Solvay Pharmaceuticals|37,333|
001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|24923|32897|lyfsjukr|||02|2,5|0|Icepharma hf|N.V. Organon|5|
001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1791|3455|lyfalmen|V0367|3440|00|98|0|Actavis Group hf|Actavis hf|261,3333|
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|5116|8366|lyfalmen|||02|15|0|Vistor hf|Novo-Nordisk|37,5|
001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|3744|6375|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|40|
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20556|27460|lyfsjukr|||00|4104|0|Icepharma hf|Fresenius Kabi||
001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|SKY|0|0|1|100|CHF|10459|15664|lyfalmen|||00|25|0|Icepharma hf|SkyPharma PLC|5|
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27858|36551|lyfsjukr|||00|6160|0|Icepharma hf|Fresenius Kabi|6,16|
001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|18903|25402|lyfsjukr|||00|5132|0|Icepharma hf|Fresenius Kabi|5,13|
001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|5309|7601|lyfsjukr|||02|50|0|Vistor hf|Octapharma AB||
001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|8478|12138|lyfsjukr|||02|100|0|Vistor hf|Octapharma AB||
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|995|1425|lyfsjukr|||02|10|0|Vistor hf|Novartis Healthcare A/S-|10|
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|2654|4766|lyfalmen|||06|15|0|K.Pétursson hf|Alcon|75|
001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|898|1929|lyfalmen|||00|7|0|Vistor hf|AstraZeneca A/S DK|4,67|
001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|66536|84705|lyfsjukr|||00|60|0|GlaxoSmithKline ehf|Glaxo Group Limited||
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|3835|6508|lyfalmen|||00|45|0|Icepharma hf|Bioglan AB|45|
001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|6908|10865|lyfalmen|V0456|10774|43|100|0|Vistor hf|LEO Pharma A/S|33,3333|
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|3376|5839|lyfalmen|V0084|5740|00|28|0|Vistor hf|AstraZeneca A/S DK|18,67|
001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|6655|10512|lyfalmen|V0086|10327|00|56|0|Vistor hf|AstraZeneca A/S DK|37,33|
002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|1184|2524|lyfalmen|||00|7|0|Vistor hf|AstraZeneca A/S DK|9,33|
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|4455|7411|lyfalmen|V0085|7280|00|28|0|Vistor hf|AstraZeneca A/S DK|37,33|
002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|4062|6838|lyfalmen|||00|100|0|Icepharma hf|Schering Oy|26,6667|
002169|B05BA1010|Kabiven Peripheral|irþ|| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|16414|22303|lyfsjukr|||00|4800|0|Icepharma hf|Fresenius Kabi|4,8|
002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|5422|8793|lyfalmen|||00|50|0|Vistor hf|AstraZeneca A/S DK|33,33|
002186|B05BA1010|Kabiven Peripheral|irþ|| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|14681|20145|lyfsjukr|||00|3840|0|Icepharma hf|Fresenius Kabi|3,84|
002194|B05BA1010|Kabiven Peripheral|irþ|| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24023|31776|lyfsjukr|||00|5760|0|Icepharma hf|Fresenius Kabi|5,76|
002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|11761|17398|lyfalmen|V0087|17084|00|100|0|Vistor hf|AstraZeneca A/S DK|66,67|
002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|7074|11097|lyfalmen|||00|50|0|Vistor hf|AstraZeneca A/S DK|66,67|
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|2997|5287|lyfalmen|||02|10|0|Vistor hf|Novo-Nordisk|25|
002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|15877|22817|lyfalmen|V0089|22421|00|100|0|Vistor hf|AstraZeneca A/S DK|133,33|
002237|D05AX0201|Daivonex|smyrsli|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3188|5565|lyfalmen|||00|60|0|Vistor hf|LEO Pharma A/S||
002263|D05AX0201|Daivonex|smyrsli|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|5213|8502|lyfalmen|||00|120|0|Vistor hf|LEO Pharma A/S||
002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|5463|8850|lyfalmen|||00|120|0|Vistor hf|LEO Pharma A/S|120|
002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3180|5553|lyfalmen|||00|60|0|Vistor hf|LEO Pharma A/S|60|
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|16093|23086|lyfalmen|||00|98|0|Icepharma hf|M.S.D.|39,2|
002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|86654|109752|lyfsjukr|||00|1|0|ZLB Behring AB|Bayer HealthCare AG-|2|
002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|43528|56060|lyfsjukr|||00|1|0|ZLB Behring AB|Bayer HealthCare AG-|1|
002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|24951|32931|lyfsjukr|||00|1|0|ZLB Behring AB|Bayer HealthCare AG-|0,5|
002391|G03AA1201|Yasmin|töflur|| |63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2327|4269|lyfalmen|V1040|4199|00|63|0|Icepharma hf|Bayer Schering Pharma AG|84|
002413|G03AA1204|Yasmin 28|töflur|| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2327|4269|lyfalmen|||00|84|0|Icepharma hf|Bayer Schering Pharma AG||
002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|152013|191124|lyfsjukr|||00|1|0|Vistor hf|Novartis Ophthalmics Europe Ltd.||
002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1096|2341|lyfalmen|||07|5|0|Icepharma hf|Santen Oy|25|
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|26631|35023|lyfsjukr|||02|1|0|Vistor hf|Allergan||
002875|G03GA0202|Menopur|sts|| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|16019|22994|lyfalmen|||00|375|0|Vistor hf|Ferring Lægemidler A/S|12,5|
002892|G03GA0202|Menopur|sts|| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|28499|38532|lyfalmen|||00|750|0|Vistor hf|Ferring Lægemidler A/S|25|
002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|55722|72424|lyfalmen|||00|1|0|Gróco ehf|Serono Nordic|14|
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|12399|18487|lyfalmen|V0193|14820|00|98|0|Icepharma hf|M.S.D.|196|
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|10316|15473|lyfalmen|||00|100|0|Vistor hf|U.C.B|12,5|
003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|213783|268027|lyfsjukr|||02|2|0|Icepharma hf|Zeneus Pharma Limited-||
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|15297|22095|lyfalmen|V1710|20987|00|100|0|Vistor hf|U.C.B|25|
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|34635|46171|lyfalmen|||00|100|0|Vistor hf|U.C.B|50|
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|7489|11675|lyfalmen|||00|1|0|Vistor hf|Pierre Fabre Pharma||
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|11172|16613|lyfalmen|||00|1|0|Vistor hf|Pierre Fabre Pharma||
003195|B03XA0201|Aranesp |stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|14399|19794|lyfsjukr|||00|1,6|0|Vistor hf|Amgen|8,89|
003208|B03XA0201|Aranesp |stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|21451|28574|lyfsjukr|||00|1,5|0|Vistor hf|Amgen|13,33|
003230|B03XA0201|Aranesp |stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|24243|32050|lyfsjukr|||00|2|0|Vistor hf|Amgen|17,78|
003252|B03XA0201|Aranesp |stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|35993|46679|lyfsjukr|||00|1,2|0|Vistor hf|Amgen|26,67|
003274|B03XA0201|Aranesp |stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|47226|60664|lyfsjukr|||00|1,6|0|Vistor hf|Amgen|35,56|
003296|B03XA0201|Aranesp |stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|58138|74249|lyfsjukr|||00|2|0|Vistor hf|Amgen|44,44|
003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|174989|219729|lyfsjukr|||02|150|0|Icepharma hf|Bayer Schering Pharma AG||
003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6972|10954|lyfalmen|V0990|10759|00|120|0|Vistor hf|AstraZeneca A/S DK|30|
003318|B03XA0201|Aranesp |stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|80064|101547|lyfsjukr|||00|1,2|0|Vistor hf|Amgen|53,33|
003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6275|9982|lyfalmen|||00|120|0|Vistor hf|AstraZeneca A/S DK|15|
003340|B03XA0201|Aranesp |stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|105783|133567|lyfsjukr|||00|1,6|0|Vistor hf|Amgen|71,11|
003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|USD|44982|59053|lyfalmen|||00|100|0|Icepharma hf|Wyeth Europe|33,33|
003362|B03XA0201|Aranesp |stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|113091|142666|lyfsjukr|||00|2|0|Vistor hf|Amgen|88,89|
003386|B03XA0201|Aranesp |stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|169337|212692|lyfsjukr|||00|1,2|0|Vistor hf|Amgen|133,33|
003395|B03XA0201|Aranesp |stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|84729|107355|lyfsjukr|||00|0,6|0|Vistor hf|Amgen|66,67|
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|30|DKK|2742|4899|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15|
003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|677|1470|lyfalmen|||00|10|0|Vistor hf|Schering-Plough|10|
003910|B03XA0102|Eprex|stl|6000|ae/spr|0,6|ml|6|spr||B03XA01|01.01.2002||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|53888|68958|lyfsjukr|||51|3,6|0|Vistor hf|Janssen-Cilag AB|36|
003932|B03XA0102|Eprex|stl|8000|ae/spr|0,8|ml|6|spr||B03XA01|01.01.2002||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|67370|85743|lyfsjukr|||51|4,8|0|Vistor hf|Janssen-Cilag AB|48|
003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|299|684|lyfalmen|||67|20|0|Vistor hf|Novartis Healthcare A/S-|10|
003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|72997|92749|lyfsjukr|||00|60|0|Vistor hf|Abbott Laboratories A/S|7,5|
003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1120|2391|lyfalmen|V0608|1913|67|100|0|Vistor hf|Novartis Healthcare A/S-|50|
004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|25743|33918|lyfsjukr|||00|50|0|Vistor hf|Novartis Healthcare A/S-|10|
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6149|9807|lyfalmen|||00|250|0|Vistor hf|Novartis Healthcare A/S-|15|
004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||00|100|0|Vistor hf|Janssen-Cilag AB|2|
004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|3442|5935|lyfalmen|||23|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|460|1019|lyfalmen|||00|7|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3,5|
004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|823|1773|lyfalmen|||10|30|0|Icepharma hf|Valeant Pharmaceuticals B.V.|15|
004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|4805|7921|lyfalmen|||00|14|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7|
004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5022|8235|lyfalmen|||23|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|6990|10979|lyfalmen|||23|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|582|1272|lyfalmen|||00|10|0|Vistor hf|Schering-Plough|10|
004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|4605|7629|lyfalmen|||00|66|0|Icepharma hf|N.V. Organon|33|
004338|B03XA0102|Eprex|stl|1000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|9346|13381|lyfsjukr|||51|3|0|Vistor hf|Janssen-Cilag AB|6|
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|21416|28530|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,5|
004364|B03XA0102|Eprex|stl|2000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|18706|25156|lyfsjukr|||51|3|0|Vistor hf|Janssen-Cilag AB|12|
004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1682|3289|lyfalmen|V1901|3239|00|30|0|Vistor hf|Schering-Plough|30|
004372|B03XA0102|Eprex|stl|4000|ae/spr|0,4|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|37015|47951|lyfsjukr|||51|2,4|0|Vistor hf|Janssen-Cilag AB|24|
004375|B03XA0102|Eprex|stl|3000|ae/spr|0,3|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|27990|36715|lyfsjukr|||51|1,8|0|Vistor hf|Janssen-Cilag AB|18|
004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|3947|6671|lyfalmen|V1902|6556|00|100|0|Vistor hf|Schering-Plough|100|
004383|B03XA0102|Eprex|stl|10000|ae/spr|1|ml|6|spr|einnotaspr|B03XA01|01.10.1994||R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|74425|94527|lyfsjukr|||51|6|0|Vistor hf|Janssen-Cilag AB|60|
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|3548|6930|vetalmen|||16|100|0|Vistor hf|Boehringer Ingelheim||
004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|2523|4567|lyfalmen|||00|56|0|Icepharma hf|Norpharma |14|
004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|488|1077|lyfalmen|||00|100|0|Vistor hf|Recip AB|8,3333|
004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2483|4506|lyfalmen|||51|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3365|5823|lyfalmen|||00|56|0|Icepharma hf|Norpharma |18,6667|
004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|25516|33635|lyfsjukr|||00|21|0|Merck AB|Merck KgaA (M)||
004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4752|7843|lyfalmen|||00|56|0|Icepharma hf|Norpharma |28|
004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6325|10052|lyfalmen|||00|56|0|Icepharma hf|Norpharma |37,3333|
004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1664|3262|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|42527|54814|lyfsjukr|||00|35|0|Merck AB|Merck KgaA (M)||
004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|51033|65404|lyfsjukr|||00|42|0|Merck AB|Merck KgaA (M)||
004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|34022|44225|lyfsjukr|||00|28|0|Merck AB|Merck KgaA (M)||
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|6108|9750|lyfalmen|||00|90|0|Vistor hf|Aventis Pharma |180|
004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|SEN|0|0|0|100|SEK|32670|42542|lyfsjukr|||00|1|0|Gróco ehf|Serono Nordic|4|
004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|1493|3002|lyfalmen|||20|25|0|Actavis Group hf|Actavis Group hf|25|
004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2156|4009|lyfalmen|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3708|6323|lyfalmen|||51|1|0|Icepharma hf|Sanofi Pasteur MSD||
004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2040|3833|lyfalmen|V0927|3833|00|28|0|Actavis Group hf|Actavis hf|56|
004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|5895|9453|lyfalmen|V0929|9453|00|56|0|Actavis Group hf|Actavis hf|112|
004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1410|2876|lyfalmen|V0923|2876|00|28|0|Actavis Group hf|Actavis hf|28|
004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|33201|43203|lyfsjukr|||00|4,69|0|Vistor hf|Amgen|7|
004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|127821|161005|lyfsjukr|||00|18,76|0|Vistor hf|Amgen|28|
004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|SEN|0|0|0|100|SEK|163353|205242|lyfsjukr|||00|5|0|Gróco ehf|Serono Nordic|20|
004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen |A10AE04|01.06.2004||R|K|2|0|0|0|0|SDE|0|0|0|100|NOK|8152|12590|lyfalmen|||00|15|0|Vistor hf|Sanofi - aventis Deutschland GmbH|37,5|
004811|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|100|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|8457|12108|lyfsjukr|||00|1000|0|Actavis Group hf|Actavis Group hf|3,3333|
004822|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|200|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|15753|21480|lyfsjukr|||00|2000|0|Actavis Group hf|Actavis Group hf|6,6667|
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|504|1110|lyfalmen|||41|24|0|Actavis Group hf|Actavis Group hf|3|
004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|53644|68654|lyfsjukr|||00|2|0|Vistor hf|Novartis Europharm Ltd|9,38|
004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|4208|6025|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1|
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|299|684|lyfalmen|||41|8|0|Actavis Group hf|Actavis Group hf|2|
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|510|1123|lyfalmen|||41|14|0|Actavis Group hf|Actavis Group hf|3,5|
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|964|2067|lyfalmen|||41|30|0|Actavis Group hf|Actavis Group hf|7,5|
005085|J07AJ5205|Boostrix|stl|| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1451|2938|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|7979|12358|lyfalmen|V0437|9967|00|90|0|Vistor hf|Yamanouchi Europe|90|
005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|20915|29089|lyfalmen|||00|360|0|Vistor hf|AstraZeneca A/S DK|90|
005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|37312|49504|lyfalmen|||00|100|0|Vistor hf|AstraZeneca UK Ltd|75|
005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|2461|4473|lyfalmen|||00|10|0|Vistor hf|AstraZeneca UK Ltd|4|
005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|875|1882|lyfalmen|||00|2,4|0|Vistor hf|LEO Pharma A/S||
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|50004|65305|lyfalmen|V0438|64060|00|1|0|Vistor hf|AstraZeneca UK Ltd|83,7209|
005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|32652|43702|lyfalmen|||00|2|0|Icepharma hf|PhotoCure ASA||
005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1154|2462|lyfalmen|||24|200|0|Vistor hf|Boehringer Ingelheim|33,33|
005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|IKR|22298|30811|lyfalmen|V0815|22874|00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|42|
005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|4126|6931|lyfalmen|||00|4|0|Icepharma hf|M.S.D.|28|
005538|G03AA0702|Microgyn|töflur|| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|903|1940|lyfalmen|||23|63|0|Icepharma hf|Bayer Schering Pharma AG|84|
005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|12079|18089|lyfalmen|V0718|16657|00|12|0|Icepharma hf|M.S.D.|84|
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|5356|8701|lyfalmen|||00|30|0|Vistor hf|Boehringer Ingelheim International |30|
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|5715|9202|lyfalmen|V0985|8921|00|30|0|Vistor hf|Boehringer Ingelheim International |30|
005606|J07AH0703|NeisVac-C|bóluefni|| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|2667|4785|lyfalmen|||00|0,5|0|Icepharma hf|Baxter||
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1241|2620|lyfalmen|||00|30|0|Icepharma hf|Servier|5,63|
005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2163|4020|lyfalmen|||00|60|0|Icepharma hf|Servier|11,25|
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|5743|9241|lyfalmen|||00|180|0|Icepharma hf|Servier|33,75|
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|3156|5518|lyfalmen|||00|90|0|Icepharma hf|Servier|16,88|
005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|4777|7880|lyfalmen|||00|180|0|Icepharma hf|Servier|90|
005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|1848|3541|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|14|
005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|3898|5581|lyfsjukr|||00|1|0|Gróco ehf|Serono Nordic||
005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|59526|75977|lyfsjukr|||00|15|0|Icepharma hf|Bayer Schering Pharma AG||
005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|30558|39912|lyfsjukr|||00|7|0|Gróco ehf|Serono Nordic||
005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|30558|39912|lyfsjukr|||00|1|0|Gróco ehf|Serono Nordic||
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|5656|9119|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|50|
005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|2515|4555|lyfalmen|V0939|4333|00|28|0|Lundbeck Export A/S|Lundbeck|28|
005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|12860|22255|vetorma|||16|5|0|Vistor hf|Merial (MSD)||
005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|4985|8183|lyfalmen|||00|56|0|Lundbeck Export A/S|Lundbeck|56|
005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|66367|84494|lyfsjukr|||00|20|0|Icepharma hf|Bayer Schering Pharma AG||
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|8831|13495|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|100|
005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|4397|7326|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|42|
005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|2440|4441|lyfalmen|||00|28|0|Vistor hf|Boehringer Ingelheim International |28|
005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|2317|4254|lyfalmen|||59|8|0|Icepharma hf|Roche|2|
005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|7986|12368|lyfalmen|||00|98|0|Vistor hf|Boehringer Ingelheim International |98|
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|16774|23934|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|150|
005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2857|5074|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|28|
005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|5375|8727|lyfalmen|V1039|8578|00|28|0|Lundbeck Export A/S|Lundbeck|56|
005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|8317|12810|lyfalmen|V1110|10349|00|98|0|Vistor hf|Novartis Healthcare A/S-|98|
005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|10921|16279|lyfalmen|||00|56|0|Lundbeck Export A/S|Lundbeck|112|
005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3643|6228|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|56|
005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|12038|18038|lyfalmen|V1111|14335|00|98|0|Vistor hf|Novartis Healthcare A/S-|196|
006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|66156|84232|lyfsjukr|||00|1,5|0|Gróco ehf|Nycomed Danmark A/S|0,75|
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|4886|8038|lyfalmen|||02|15|0|Vistor hf|Novo-Nordisk|37,5|
006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|28257|37047|lyfsjukr|||00|60|0|Icepharma hf|Mayne Pharma Plc||
006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|96280|121736|lyfsjukr|||00|1|0|Icepharma hf|M.S.D.|1,4|
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|4780|7884|lyfalmen|||02|15|0|Vistor hf|Novo-Nordisk|37,5|
006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|132404|166710|lyfsjukr|||00|3|0|Gróco ehf|Nycomed Danmark A/S|1,5|
006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|75574|95957|lyfsjukr|||00|1|0|Icepharma hf|M.S.D.|1|
006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|0|0|SDE|0|0|0|100|NOK|7574|11794|lyfalmen|||00|15|0|Vistor hf|Sanofi - aventis Deutschland GmbH|37,5|
006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|32612|42469|lyfsjukr|||00|1200|0|Vistor hf|Bayer HealthCare AG||
006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|56071|71676|lyfsjukr|||00|2400|0|Vistor hf|Bayer HealthCare AG||
006289|N02AB0302|Actiq|pinni|200|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|4610|7636|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|1|
006336|N02AB0302|Actiq|pinni|400|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|4610|7636|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|2|
006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2043|3838|lyfalmen|||43|40|0|Vistor hf|Sanofi-aventis Norge AS|13,3333|
006380|N02AB0302|Actiq|pinni|600|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|4610|7636|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|3|
006422|N02AB0302|Actiq|pinni|800|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|4610|7636|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|4|
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|6846|13212|vetalmen|||00|50|0|Vistor hf|Boehringer Ingelheim||
006466|N02AB0302|Actiq|pinni|1200|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|4610|7636|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|6|
006512|N02AB0302|Actiq|pinni|1600|mcg|3|stk|1|pakki||N02AB03|01.02.2002||R|A|3|1|0|0|0|CUL|0|0|0|100|DKK|4610|7636|lyfalmen|||00|3|0|Swedish Orphan International AB|Cephalon UK Limited (S)|8|
006579|D05AX5201|Daivobet|smyrsli|| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7268|11367|lyfalmen|V0391|11172|00|60|0|Vistor hf|LEO Pharma A/S||
006637|D05AX5201|Daivobet|smyrsli|| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|12454|18555|lyfalmen|||00|120|0|Vistor hf|LEO Pharma A/S||
006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|27220|35756|lyfsjukr|||02|50|0|Vistor hf|Novartis Healthcare A/S-|10|
006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|SEK|||lyfalmen|||23|2|0|Gróco ehf|Laboratoire HRA Pharma||
006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|12059|16881|lyfsjukr|||10|5|0|Vistor hf|Novartis Healthcare A/S-|5|
006903|L03AX1301|Copaxone|sts|20|mg/hgl|28|hgl|1|pakki|+ leysir|L03AX13|01.01.2001||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|121959|153706|lyfsjukr|||00|28|0|Vistor hf|Teva Pharmaceuticals Limited|28|
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|12399|18487|lyfalmen|||00|98|0|Icepharma hf|M.S.D.|196|
007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3333|5776|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|28|
007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|862|1854|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|1,6667|
007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|24466|33510|lyfalmen|||00|180|0|Vistor hf|Genzyme Europe B.V.|22,5|
007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|18794|35971|vetalmen|||27|20|0|Vistor hf|Boehringer Ingelheim Danmark||
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|10604|15857|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|98|
007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|2239|4135|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|8,3333|
007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4994|8196|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|56|
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|15890|22833|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|196|
007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|4997|8200|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|33,3333|
007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6630|10477|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|112|
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|23203|31938|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|392|
007223|B01AX0001|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|132222|166484|lyfsjukr|||00|1|0|Icepharma hf|Baxter||
007268|B01AX0001|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|233564|292655|lyfsjukr|||00|1|0|Icepharma hf|Baxter||
007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1637|3221|lyfalmen|||10|30|0|Vistor hf|Novartis Healthcare A/S-|15|
007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2334|4280|lyfalmen|||00|3|0|Vistor hf|Allergan|30|
007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|116051|146351|lyfsjukr|||00|1|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|20|
007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|178604|224229|lyfsjukr|||00|1|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|40|
007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|155278|195189|lyfsjukr|||00|1|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|30|
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|101323|128015|lyfsjukr|||00|3000|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5|
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|255268|319676|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15|
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|2749|4910|lyfalmen|V0988|4828|06|2,5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
007448|B05XC04|Cernevit|sts|| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|6287|9001|lyfsjukr|||02|50|0|Icepharma hf|Clintec parenteral SA||
007449|V03AB0001|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB00|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|93885|118754|lyfsjukr|||00|100|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)||
007462|N01AB0801|Sevorane|innönd.l|| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|19986|26750|lyfsjukr|||00|250|0|Vistor hf|Abbott Scandinavia AB||
007494|QP52AA0101|Droncit, vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BHC|0|0|0||DKK|1529|2646|vetorma|||16|6,67|0|Vistor hf|Bayer HealthCare AG||
007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|5345|8686|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10,5|
007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|3850|6529|lyfalmen|||00|60|0|Vistor hf|Schering-Plough Europe|30|
007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2661|4776|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|56|
007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|3850|6529|lyfalmen|||00|30|0|Vistor hf|Schering-Plough Europe|30|
007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|7066|10117|lyfsjukr|||00|1200|0|Vistor hf|Bristol-Myers Squibb|4|
007541|J07BL0101|Stamaril|bóluefni|| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|16722|23869|lyfalmen|||02|5|0|Icepharma hf|Sanofi Pasteur MSD||
007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|7503|11695|lyfalmen|||00|60|0|Vistor hf|Schering-Plough Europe|60|
007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8465|13007|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|196|
007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|1965|2813|lyfsjukr|||02|9000|0|Icepharma hf|Fresenius Kabi||
007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2027|3813|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|14|
007657|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|1|hgl||QH02AB06|01.05.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|1462|2885|vetalmen|||58|50|0|Icepharma hf|Intervet International B.V.||
007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|5950|9529|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|21|
007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|18070|25547|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|70|
007852|G02BB0101|NuvaRing|sk-hring|| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|3205|5590|lyfalmen|||00|3|0|Icepharma hf|N.V. Organon|84|
007920|S01EX0601|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EX06|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|1686|3295|lyfalmen|||00|2,5|0|K.Pétursson hf|Alcon||
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|848|1825|lyfalmen|||00|5|0|K.Pétursson hf|Alcon||
007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|XEU|||lyfalmen|||20|15|0|Vistor hf|Astellas Pharma A/S|15|
007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|17305|23412|lyfsjukr|||00|10|0|Ísaga ehf|AGA AB||
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|515|1133|lyfalmen|||00|30|0|Icepharma hf|Merck Santé s.a.s.|15|
008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|2752|4915|lyfalmen|||00|1|0|Icepharma hf|Roche Registration Limited|5|
008058|B05BA1011|Oliclinomel N4 550E|irl|| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|21395|28504|lyfsjukr|||00|6000|0|Icepharma hf|Baxter Medical AB||
008069|B05BA1011|Oliclinomel N4 550E|irl|| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|26745|35165|lyfsjukr|||00|8000|0|Icepharma hf|Baxter Medical AB||
008086|D07AC0101|Betnovat|krem|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|369|829|lyfalmen|||20|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5242|8542|lyfalmen|||00|6|0|Icepharma hf|M.S.D.|3|
008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|71819|91282|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|26,67|
008102|D07AC0101|Betnovat|krem|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1169|2493|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|144387|181629|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|53,33|
008123|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|1|hgl||J07AH07|01.05.2002||R|K|3|0|0|0|0|WAB|0|0|0|100|USD|2258|4164|lyfalmen|||00|0,5|0|Icepharma hf|Wyeth AB||
008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|104703|132223|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|42,67|
008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|154117|193743|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|64|
008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|179916|225863|lyfsjukr|||00|4|0|Vistor hf|Schering-Plough|80|
008157|B05BA1012|Oliclinomel N5 800E|irl|| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|27252|35796|lyfsjukr|||00|8000|0|Icepharma hf|Baxter Medical AB||
008182|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|10|hgl||J07AH07|01.05.2002||R|K|3|0|0|0|0|WAB|0|0|0|100|USD|22580|31162|lyfalmen|||00|5|0|Icepharma hf|Wyeth AB||
008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|XEU|||lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30|
008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1580|3134|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100|
008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|902|1938|lyfalmen|||00|120|0|Vistor hf|Schering-Plough|12|
008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|235|551|lyfalmen|||20|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|20|
008223|B05BA1013|Oliclinomel N6 900E|irl|| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|28176|36947|lyfsjukr|||00|6000|0|Icepharma hf|Baxter Medical AB||
008234|B05BA1013|Oliclinomel N6 900E|irl|| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|22000|29258|lyfsjukr|||00|6000|0|Icepharma hf|Baxter Medical AB||
008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|386|865|lyfalmen|||33|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
008245|B05BA1013|Oliclinomel N6 900E|irl|| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|27571|36193|lyfsjukr|||00|8000|0|Icepharma hf|Baxter Medical AB||
008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6869|10811|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|49|
008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1009|2160|lyfalmen|V0733|2160|00|20|0|Actavis Group hf|Actavis hf|6,67|
008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2177|4041|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|28|
008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1151|2455|lyfalmen|||33|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6929|10894|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|98|
008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|3824|6492|lyfalmen|V0734|6492|00|100|0|Actavis Group hf|Actavis hf|33,33|
008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|5869|9416|lyfalmen|V0736|9416|00|100|0|Actavis Group hf|Actavis hf|50|
008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|7728|12008|lyfalmen|V0738|12008|00|100|0|Actavis Group hf|Actavis hf|66,67|
008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|160915|202207|lyfsjukr|||02|2|0|Vistor hf|Genzyme BV||
008383|D07AC0101|Betnovat|smyrsli|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|369|829|lyfalmen|||20|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|606|1322|lyfalmen|V0431|1322|00|100|0|Actavis Group PTC ehf|Merck KgaA (A) |33,33|
008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|512|1127|lyfalmen|V0430|1127|00|100|0|Actavis Group PTC ehf|Merck KgaA (A) |66,67|
008466|D07AC0101|Betnovat|smyrsli|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1169|2493|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|3268|5655|vetorma|||00|1000|0|Icepharma hf|Chanelle Pharmaceuticals ||
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|8483|16330|vetalmen|||00|50|0|Icepharma hf|Chanelle Pharmaceuticals ||
008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|E|0|ALF|0|0|1|100|NOK|471|1042|lyfalmen|||00|10|0|Gróco ehf|Almirall-Prodesfarma S.A.|10|
008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|3884|6579|lyfalmen|||00|100|0|Gróco ehf|Almirall-Prodesfarma S.A.|100|
008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|E|0|ALF|0|0|1|100|NOK|1260|2648|lyfalmen|||00|30|0|Gróco ehf|Almirall-Prodesfarma S.A.|30|
008545|G03FB0506|NovoFem|filmhtfl|| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2244|4143|lyfalmen|||23|84|0|Vistor hf|Novo-Nordisk|84|
008565|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|lykja||J06BA01|01.08.2003||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|10725|15220|lyfsjukr|||17|10|0|Vistor hf|Octapharma AB||
008664|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|lykjur||J06BA01|01.08.2003||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|107243|135385|lyfsjukr|||17|100|0|Vistor hf|Octapharma AB||
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|102054|128925|lyfsjukr|||00|2|0|Icepharma hf|Roche Registration Limited||
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|106381|134312|lyfsjukr|||00|2|0|Icepharma hf|Roche Registration Limited|27,69|
008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|1674|2897|vetorma|||00|500|0|Icepharma hf|Chanelle Pharmaceuticals ||
008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|2390|4365|lyfalmen|||00|15|0|Vistor hf|Novartis Healthcare A/S-|15|
008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2661|4776|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|56|
008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1777|3434|lyfalmen|||20|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|4264|7132|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|30|
009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|12515|18631|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|100|
009137|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|24964|32948|lyfsjukr|||00|25|0|Icepharma hf|Mayne Pharma Plc|1,25|
009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju  |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|5705|9188|lyfalmen|||03|5|0|Vistor hf|Pfizer Limited|5|
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|10829|16156|lyfalmen|||03|10|0|Vistor hf|Pfizer Limited|10|
009275|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|10295|14685|lyfsjukr|||00|10|0|Icepharma hf|Mayne Pharma Plc|0,5|
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|47319|60780|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyflausa|||02|400|0|Icepharma hf|Fresenius Kabi||
009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|1|0|0|ASP|0|0|0|100|XEU|4549|7548|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S||
009286|M05BA0303|Pamidronatdinatrium Mayne 6 mg/ml|irþ|6|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|21724|28914|lyfsjukr|||00|10|0|Icepharma hf|Mayne Pharma Plc|1|
009297|M05BA0304|Pamidronatdinatrium Mayne 9 mg/ml|irþ|9|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|28942|37900|lyfsjukr|||00|10|0|Icepharma hf|Mayne Pharma Plc|1,5|
009340|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||00|400|0|Icepharma hf|Fresenius Kabi||
009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1057|2260|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|21|
009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1136|2424|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|28|
009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1339|2768|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|42|
009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1540|3074|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|56|
009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||04|10|0|Icepharma hf|GlaxoSmithKline CH A/S|1,6667|
009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|189017|237194|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15|
009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|1|0|0|ASP|0|0|0|100|XEU|5069|8301|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S||
009672|J05AB0102|Zovir|töflur|400|mg|55|stk|1|þpakki||J05AB01|01.09.2003||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|8361|12869|lyfalmen|||00|55|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5,5|
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GSC|0|0|0|100|DKK|54600|69844|lyfsjukr|||00|30|0|Swedish Orphan International AB|Gilead Science International (S) |30|
009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8464|13006|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|196|
009830|B03XA0103|NeoRecormon |stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|32079|41806|lyfsjukr|||00|0,6|0|Icepharma hf|Roche|20|
009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|654|1422|lyfalmen|||00|30|0|Icepharma hf|Merck Santé s.a.s.|15|
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|5115|8365|lyfalmen|||02|180|0|Vistor hf|Dentsply Limited||
009905|N01BB5402|Citanest Dental Octapressin|stl|| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|5021|8234|lyfalmen|||00|180|0|Vistor hf|Dentsply Limited||
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|5950|9529|lyfalmen|||17|180|0|Vistor hf|Dentsply Limited||
009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|426|948|lyfalmen|||00|6|0|Icepharma hf|N.V. Organon|3|
009942|N01BB5402|Citanest Dental Octapressin|stl|| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|5417|8786|lyfalmen|||00|180|0|Vistor hf|Dentsply Limited||
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|6142|9797|lyfalmen|||17|180|0|Vistor hf|Dentsply Limited||
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|4595|7615|lyfalmen|||02|180|0|Vistor hf|Dentsply Limited||
010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2387|4360|lyfalmen|V1151|2685|00|30|0|Icepharma hf|N.V. Organon|15|
010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|3212|5600|lyfalmen|V1152|3901|00|30|0|Icepharma hf|N.V. Organon|30|
010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|6859|10797|lyfalmen|||00|30|0|Icepharma hf|N.V. Organon|45|
010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|174661|219320|lyfsjukr|||00|0,6|0|Vistor hf|Amgen Europe B.V.|20|
010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|3991|6735|lyfalmen|||00|1|0|Gróco ehf|Serono Europe|1|
010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|937|2010|lyfalmen|||00|30|0|Icepharma hf|Merck Santé s.a.s.|15|
010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|41001|54096|lyfalmen|||00|10|0|Gróco ehf|Serono Europe|10|
010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|24602|33680|lyfalmen|||00|1|0|Gróco ehf|Serono Europe|6|
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|30|DKK|188471|236514|lyfsjukr|||00|60|0|Icepharma hf|Roche Registration Limited|30|
010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|325786|407471|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
010203|B03XA0201|Aranesp |stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|152323|191510|lyfsjukr|||00|1|0|Vistor hf|Amgen|111,11|
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|5842|8364|lyfsjukr|||00|1|0|Icepharma hf|M.S.D.||
010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|10645|15911|lyfalmen|V1153|11576|00|96|0|Icepharma hf|N.V. Organon|96|
010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|19735|27620|lyfalmen|||00|96|0|Icepharma hf|N.V. Organon|144|
010312|N06DX0101|Ebixa|töflur|10|mg|30|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|0|0|LUN|0|0|0|100|DKK|6667|10529|lyfalmen|||00|30|0|Lundbeck Export A/S|Lundbeck|15|
010323|N06DX0101|Ebixa|töflur|10|mg|50|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|0|0|LUN|0|0|0|100|DKK|10889|16236|lyfalmen|||00|50|0|Lundbeck Export A/S|Lundbeck|25|
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|0|0|LUN|0|0|0|100|DKK|19605|27458|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|50|
010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3016|5315|lyfalmen|||00|28|0|Vistor hf|Boehringer Ingelheim International |56|
010348|J07BB0203|Vaxigrip|bóluefni|| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|6954|10929|lyfalmen|||51|5|0|Icepharma hf|Sanofi Pasteur MSD||
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|9744|14711|lyfalmen|||00|98|0|Vistor hf|Boehringer Ingelheim International |196|
010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|10745|15245|lyfsjukr|||00|2500|0|Icepharma hf|Baxter Medical AB||
010534|B05BA0108|Vaminolac|irl|| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6490|9292|lyfsjukr|||00|1000|0|Icepharma hf|Fresenius Kabi|1|
010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1035|2214|lyfalmen|||00|5|0|Icepharma hf|Santen Oy||
010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|4159|6980|lyfalmen|||00|4|0|Vistor hf|Sanofi-aventis Norge AS|28|
010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5693|8151|lyfsjukr|||00|7500|0|Icepharma hf|Baxter Medical AB|7,5|
010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|10439|14864|lyfsjukr|||00|5000|0|Icepharma hf|Baxter Medical AB|5|
010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3973|5688|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10|
010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2277|3260|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10|
010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|6492|10285|lyfalmen|||00|9|0|Vistor hf|Allergan|90|
010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|10439|14864|lyfsjukr|||00|5000|0|Icepharma hf|Baxter Medical AB|5|
010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5730|8204|lyfsjukr|||00|7500|0|Icepharma hf|Baxter Medical AB|7,5|
010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3820|5469|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10|
010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|11389|16902|lyfalmen|V1080|16600|00|12|0|Vistor hf|Sanofi-aventis Norge AS|84|
010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2120|3035|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10|
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|378128|472637|lyfsjukr|||00|56|0|Swedish Orphan International AB|Actelion Registration Ltd. (S)|14|
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|378128|472637|lyfsjukr|||00|56|0|Swedish Orphan International AB|Actelion Registration Ltd. (S)|28|
010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|486905|608064|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|45|
010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|648018|808650|lyfsjukr|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|SEK|||lyflausa|||00|300|0|Icepharma hf|GlaxoSmithKline CH A/S|20|
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|41428|53445|lyfsjukr|||03|10|0|Icepharma hf|Baxter Medical AB||
010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|2383|3412|lyfsjukr|||03|10|0|Vistor hf|Recip AB|5|
010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|1888|3602|lyfalmen|||00|28|0|Icepharma hf|Wyeth AB|14|
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|17269|24550|lyfalmen|||00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|18,67|
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|17269|24550|lyfalmen|||00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|28|
010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|SEK|||lyflausa|||00|50|0|Icepharma hf|GlaxoSmithKline CH A/S|16,6667|
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|28901|39032|lyfalmen|V1702|36938|00|56|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|37,33|
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|28901|39032|lyfalmen|V1703|36938|00|56|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|56|
011078|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|1|plpoki|án PVC (Ecobag)|B05AA07|01.05.2002||R|A|2|0|0|0|1|BRA|0|0|0|100|XEU|1247|1785|lyfsjukr|||00|500|0|Actavis Group hf|Braun|0,5|
011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|14868|21561|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|33,33|
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|4592|7610|lyfalmen|||00|28|0|Icepharma hf|M.S.D.|28|
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|4592|7610|lyfalmen|||00|28|0|Icepharma hf|M.S.D.|42|
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|18694|26324|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|200|
011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LUN|0|1|0|100|DKK|9574|14485|lyfalmen|||02|5|0|Lundbeck Export A/S|Lundbeck|166,6667|
011409|R03AK0703|Symbicort forte Turbuhaler|innúðadu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6951|10925|lyfalmen|||00|60|0|Vistor hf|AstraZeneca A/S DK|30|
011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|9069|13812|lyfalmen|||00|12|0|Vistor hf|Bayer AG-|6|
011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|5264|8573|lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|18|
011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6649|9520|lyfsjukr|||02|10000|0|Icepharma hf|Baxter Medical AB||
011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|1343|1923|lyfsjukr|||00|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|4592|7610|lyfalmen|||00|28|0|Icepharma hf|M.S.D.|56|
011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|6922|10885|lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|36|
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1053|2078|vetalmen|||00|25|0|Icepharma hf|Chanelle Pharmaceuticals ||
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2595|3715|lyfsjukr|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1170|2495|lyfalmen|||00|64|0|Gróco ehf|Oy Leiras Finland Ab|28,8|
011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|30|DKK|82821|104980|lyfsjukr|||00|168|0|Icepharma hf|Roche Registration Limited|33,6|
011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|8022|12417|lyfalmen|||00|60|0|Vistor hf|Novartis Healthcare A/S-|60|
011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2250|4152|lyfalmen|V0935|4152|00|28|0|Actavis Group hf|Actavis hf|56|
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3411|4884|lyfsjukr|||02|20|0|Vistor hf|AstraZeneca A/S DK||
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3174|4544|lyfsjukr|||02|20|0|Vistor hf|AstraZeneca A/S DK||
011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3478|5988|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|56|
011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|11974|17682|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|196|
012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|37108|48067|lyfsjukr|||00|30|0|Icepharma hf|M.S.D.|30|
012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|9393|14243|lyfalmen|||00|90|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|90|
012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|3697|6398|vetorma|||00|20|0|Icepharma hf|Icepharma hf||
012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|693|1503|lyfalmen|||00|30|0|Vistor hf|Aventis Pharma |15|
012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8676|13288|lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|54|
012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|17377|30072|vetorma|||00|100|0|Icepharma hf|Icepharma hf||
012677|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|21383|29672|lyfalmen|V0126|26087|00|28|0|Actavis Group hf|Alpharma ApS|3,5|
012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|USD|341115|426556|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe||
012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|3234|5632|lyfalmen|||00|4|0|Vistor hf|Bayer AG-|2|
012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|3578|6133|lyfalmen|||00|4|0|Vistor hf|Bayer AG-|4|
012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|10540|15771|lyfalmen|||00|12|0|Vistor hf|Bayer AG-|12|
012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4435|7382|lyfalmen|||00|4|0|Vistor hf|Bayer AG-|8|
012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|12825|19017|lyfalmen|||00|12|0|Vistor hf|Bayer AG-|24|
012921|G03AA1301|Evra|forðapl|| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|3508|6031|lyfalmen|||00|9|0|Vistor hf|Janssen-Cilag International N.V.||
012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|0|0|LBI|0|0|0|100|SEK|5311|8638|lyfalmen|||00|30|0|Icepharma hf|Laboratoires Besins International|30|
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|4805|7921|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|20|
013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|5269|10208|vetalmen|||00|100|0|Icepharma hf|Pfizer Animal Health||
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|7947|12314|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|40|
013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|1366|2696|vetalmen|||00|20|0|Icepharma hf|Pfizer Animal Health||
013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|863|1857|lyfalmen|||00|14|0|Icepharma hf|Wyeth AB|7|
013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|17305|23412|lyfsjukr|||00|2|0|Ísaga ehf|AGA AB||
013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|7771|11126|lyfsjukr|||17|2|0|Icepharma hf|ZLB GmbH||
013259|B02BD0402|BeneFIX|sts|| |250|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|22549|29941|lyfsjukr|||00|250|0|Icepharma hf|Wyeth Europe|0,83|
013270|B02BD0402|BeneFIX|sts|| |500|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|45102|58019|lyfsjukr|||00|500|0|Icepharma hf|Wyeth Europe|1,43|
013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|3461|6764|vetalmen|||00|100|0|Icepharma hf|Pfizer Animal Health||
013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|8317|16014|vetalmen|||00|100|0|Icepharma hf|Pfizer Animal Health||
013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PFA|0|0|0|100|DKK|873|1723|vetalmen|||00|20|0|Icepharma hf|Pfizer Animal Health||
013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|159406|200328|lyfsjukr|||00|1|0|Lyfjaver ehf|Baxter Medical AB (L)|3|
013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|26567|34943|lyfsjukr|||00|1|0|Lyfjaver ehf|Baxter AG (L)|0,5|
013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|106270|134174|lyfsjukr|||00|1|0|Lyfjaver ehf|Baxter AG (L)|2|
013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|51752|66299|lyfsjukr|||00|1|0|Lyfjaver ehf|Baxter AG (L)|2|
013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|16976|24185|lyfalmen|||00|98|0|Icepharma hf|M.S.D.|98|
013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|158336|198996|lyfsjukr|||00|1,6|0|Vistor hf|Abbott|27,59|
013660|A10AD0116|Mixtard 30 InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar sprautur|A10AD01|01.03.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5417|8786|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5|
013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1069|2285|lyfalmen|||00|40|0|Vistor hf|Sanofi-aventis Norge AS|5,3333|
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|405|904|lyfalmen|||00|30|0|Vistor hf|AstraZeneca A/S DK||
013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|35648|46249|lyfsjukr|||00|5|0|Vistor hf|Novartis Europharm Ltd|1|
013720|A10AD0118|Mixtard 30|stl|100|ae/ml|10|ml|1|hgl||A10AD01|01.10.1985||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2055|3856|lyfalmen|||50|10|0|Vistor hf|Novo-Nordisk|25|
013756|C09DA0304|Diovan Comp 160/25 mg|filmhtfl|| |28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|3658|6250|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|56|
013767|C09DA0304|Diovan Comp 160/25 mg|filmhtfl|| |98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|12579|18711|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|196|
013804|A10AC0105|Insulatard Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AC01|01.07.1993||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3583|6140|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5|
013879|A10AD0120|Mixtard 40 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4091|6880|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5|
013890|A10AD0119|Mixtard 50 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4201|7041|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5|
013901|A10AC0108|Insulatard InnoLet |stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5417|8786|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5|
013909|A10AD0117|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4208|7051|lyfalmen|||51|15|0|Vistor hf|Novo-Nordisk|37,5|
013913|A10AD0121|Mixtard 30 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3868|6556|lyfalmen|||50|15|0|Vistor hf|Novo-Nordisk|37,5|
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2062|3867|lyfalmen|||51|10|0|Vistor hf|Novo-Nordisk|25|
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3877|6569|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5|
013958|A10AB0103|Actrapid Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AB01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|3554|6098|lyfalmen|||51|15|0|Vistor hf|Novo-Nordisk|37,5|
013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|171540|215435|lyfsjukr|||00|60|0|Vistor hf|Novartis Europharm Ltd||
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|303305|379482|lyfsjukr|||00|30|0|Vistor hf|Novartis Europharm Ltd||
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2044|3839|lyfalmen|||71|10|0|Vistor hf|Novo-Nordisk|25|
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|30|SEK|11112|15702|lyfsjukr|||00|50|0|Vistor hf|AstraZeneca A/S DK|13,33|
014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|18271|25798|lyfalmen|||00|300|0|Vistor hf|U.C.B|20|
014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27998|36725|lyfsjukr|||00|5908|0|Icepharma hf|Fresenius Kabi||
014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1122|2395|lyfalmen|||00|30|0|Icepharma hf|Intendis GmbH Berlin|30|
014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|17247|23340|lyfsjukr|||00|3940|0|Icepharma hf|Fresenius Kabi||
014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||29|4|0|Vistor hf|Janssen-Cilag AB||
014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|18991|25511|lyfsjukr|||00|3944|0|Icepharma hf|Fresenius Kabi||
014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24854|32811|lyfsjukr|||00|5908|0|Icepharma hf|Fresenius Kabi||
014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|17247|23340|lyfsjukr|||00|3940|0|Icepharma hf|Fresenius Kabi||
014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|13493|19849|lyfalmen|||23|1|0|Icepharma hf|Schering Oy|1825|
014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|4445|8638|vetalmen|||16|24|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|227973|285694|lyfsjukr|||00|60|0|Icepharma hf|Roche Registration Limited||
014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|1878|3587|lyfalmen|||10|28|0|Icepharma hf|Norpharma |1,86|
014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3687|6292|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|112|
014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|12815|19005|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|392|
014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|58764|75029|lyfsjukr|||00|2,5|0|Vistor hf|Amgen Europe B.V.|4,29|
014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|90968|115123|lyfsjukr|||00|2,5|0|Vistor hf|Amgen Europe B.V.|6,86|
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|17804|25216|lyfalmen|||00|60|0|Icepharma hf|Novartis Healthcare A/S|10|
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|53412|69548|lyfalmen|||00|60|0|Icepharma hf|Novartis Healthcare A/S|30|
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|35609|47383|lyfalmen|||00|60|0|Icepharma hf|Novartis Healthcare A/S|20|
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2|0|0|0|0|NON|0|0|0|100|DKK|8224|12686|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5|
015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|849|1827|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|14|
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2|0|0|0|0|NON|0|0|0|100|DKK|8252|12723|lyfalmen|||00|15|0|Vistor hf|Novo-Nordisk|37,5|
015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|2|0|1|0|1|PAM|0|0|0|100|DKK|269333|337187|lyfsjukr|||00|1|0|Lyfjaver ehf|Pharma Mar S.A.||
015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|2|0|1|0|1|PAM|0|0|0|100|DKK|71587|90993|lyfsjukr|||00|1|0|Lyfjaver ehf|Pharma Mar S.A.||
015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|4776|7878|lyfalmen|||00|30|0|Vistor hf|Orion Corporation|3,33|
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15851|22785|lyfalmen|V1732|22425|00|100|0|Vistor hf|Orion Corporation|11,11|
015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|4776|7878|lyfalmen|||00|30|0|Vistor hf|Orion Corporation|10|
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15851|22785|lyfalmen|V1731|22425|00|100|0|Vistor hf|Orion Corporation|33,33|
015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|28509|38544|lyfalmen|||00|1000|0|Vistor hf|Sanofi-aventis Norge AS|1000|
015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|62307|79440|lyfsjukr|||43|60|0|Vistor hf|Bristol-Myers Squibb||
015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|62307|79440|lyfsjukr|||43|60|0|Vistor hf|Bristol-Myers Squibb||
015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|62307|79440|lyfsjukr|||43|60|0|Vistor hf|Bristol-Myers Squibb||
015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|4776|7878|lyfalmen|||00|30|0|Vistor hf|Orion Corporation|6,67|
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14063|20559|lyfalmen|V1730|20241|00|100|0|Vistor hf|Orion Corporation|22,22|
015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|62307|79440|lyfsjukr|||43|60|0|Vistor hf|Bristol-Myers Squibb||
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|21635|29986|lyfalmen|||00|120|0|Vistor hf|Novartis Healthcare A/S-|10|
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|37627|49896|lyfalmen|||00|120|0|Vistor hf|Novartis Healthcare A/S-|21,6|
015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|632|1376|lyfalmen|||06|15|0|K.Pétursson hf|Alcon||
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|2484|4299|vetorma|||16|2,4|0|Vistor hf|Bayer HealthCare AG||
015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3490|6040|vetorma|||16|12|0|Vistor hf|Bayer HealthCare AG||
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|2216|3835|vetorma|||16|1,2|0|Vistor hf|Bayer HealthCare AG||
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|2778|4807|vetorma|||16|3|0|Vistor hf|Bayer HealthCare AG||
015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|3540|6078|lyfalmen|||10|50|0|Swedish Orphan International AB|Sandoz GmbH (S)|25|
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3112|5385|vetorma|||16|7,5|0|Vistor hf|Bayer HealthCare AG||
015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|1|0|0|ASP|0|0|0|100|XEU|1814|3490|lyfalmen|||00|10|0|Vistor hf|Astellas Pharma A/S||
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1281|2680|lyfalmen|||02|10|0|Icepharma hf|Martindale Pharmaceuticals|3,33|
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|2484|4299|vetorma|||16|1,2|0|Vistor hf|Bayer HealthCare AG||
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|30|GBP|1232|2606|lyfalmen|||00|28|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|14|
015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|12073|18081|lyfalmen|||00|90|0|Icepharma hf|Servier|180|
016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|3860|6544|lyfalmen|||00|6|0|Gróco ehf|Laboratorios Almirall S.A.|6|
016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|4061|6837|lyfalmen|||00|30|0|Icepharma hf|Servier|60|
016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|5466|8854|lyfalmen|||00|9|0|Gróco ehf|Laboratorios Almirall S.A.|9|
016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|10828|16155|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|100|
016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|951|2040|lyfalmen|||02|10|0|Icepharma hf|Martindale Pharmaceuticals|1,25|
016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|16223|23248|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|200|
016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1008|2158|lyfalmen|||02|20|0|Icepharma hf|Martindale Pharmaceuticals|2,5|
016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|1993|3762|lyfalmen|||00|3|0|Gróco ehf|Laboratorios Almirall S.A.|3|
016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|NOK|||lyfalmen|||00|60|0|Vistor hf|Sanofi-aventis Norge AS||
016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6662|10522|lyfalmen|||00|112|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|56|
016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|6476|10263|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag AB|11,2|
016228|A10BD0301|Avandamet|filmhtfl|501|mg|56|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|1905|3628|lyfalmen|||00|56|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|28|
016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|3710|6325|lyfalmen|||00|112|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|56|
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2562|4626|lyfalmen|||00|14|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7|
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|5442|8821|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|14|
016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|4028|6789|lyfalmen|||00|0,5|0|Gróco ehf|Serono Europe|1|
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8284|12766|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|28|
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|1721|3349|lyfalmen|||00|14|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3,5|
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12150|18177|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56|
016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|8700|13320|lyfalmen|||10|100|0|Vistor hf|Novartis Healthcare A/S-|100|
016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|3648|6235|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag AB|5,6|
016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|3615|5176|lyfsjukr|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|4576|6552|lyfsjukr|||00|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|13289|18412|lyfsjukr|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|109574|138287|lyfsjukr|||00|70|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7|
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|6646|9515|lyfsjukr|||00|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2560|4623|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5,42|
016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|6145|8798|lyfsjukr|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|20831|27802|lyfsjukr|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|2|
016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|4|
016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|174935|219662|lyfsjukr|||00|225|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|Vistor hf|McNeil Denmark ApS|28|
016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|61352|78251|lyfsjukr|||00|75|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf|McNeil Denmark ApS|7|
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|McNeil Denmark ApS|14|
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|4|
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|2|
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|17269|24550|lyfalmen|V1701|24119|00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|6,2|
016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf|McNeil Denmark ApS|14|
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|McNeil Denmark ApS|28|
016622|A06AG1101|Microlax|innhl|| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|3521|6050|lyfalmen|||56|250|0|Vistor hf|McNeil Denmark ApS|50|
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34477|45974|lyfalmen|||00|56|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|12,4|
016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1115|2381|lyfalmen|V0466|2378|00|12|0|Actavis Group hf|LEK Pharmaceuticals d.d.|12|
016640|B03XA0103|NeoRecormon |stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|187269|235017|lyfsjukr|||00|2,4|0|Icepharma hf|Roche|180|
016671|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.09.2003||R|A|2|0|0|*|0|LVR|0|1|0|100|IKR|3911|6618|lyfalmen|V0809|6429|00|28|0|Lyfjaver ehf|Lyfjaver ehf|7|
016680|N07BA0112|Nicorette Orange|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|Vistor hf|McNeil Denmark ApS|28|
016682|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|5412|8779|lyfalmen|V0810|8726|00|28|0|Lyfjaver ehf|Lyfjaver ehf|14|
016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|163716|205694|lyfsjukr|||00|6|0|Icepharma hf|Ipsen Ltd.||
016688|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|10|mg|56|stk|1|glas||N05AH03|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|20990|29183|lyfalmen|V0812|29001|00|56|0|Lyfjaver ehf|Lyfjaver ehf|56|
016693|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|16502|23595|lyfalmen|V0811|23452|00|56|0|Lyfjaver ehf|Lyfjaver ehf|42|
016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003||R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|2337|4284|lyfalmen|||00|400|0|Lyfjaver ehf|Lyfjaver ehf|100|
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6403|10161|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|30|
016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|54572|69810|lyfsjukr|||00|2|0|Icepharma hf|Ipsen Ltd.||
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|2907|5150|lyfalmen|V0789|5150|10|200|0|Lyfjaver ehf|Lyfjaver ehf|40|
016739|N07BA0112|Nicorette Orange|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|2|
016761|N07BA0112|Nicorette Orange|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|Vistor hf|McNeil Denmark ApS|14|
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|5300|8623|lyfalmen|V0713|8623|10|200|0|Lyfjaver ehf|Lyfjaver ehf|80|
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|50292|65664|lyfalmen|||00|28|0|Vistor hf|Amgen Europe B.V.|28|
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|74339|95602|lyfalmen|||00|28|0|Vistor hf|Amgen Europe B.V.|42|
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|27641|37463|lyfalmen|||00|28|0|Vistor hf|Amgen Europe B.V.||
016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|46008|60330|lyfalmen|||00|1,5|0|Gróco ehf|Serono Europe|12|
016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|17598|24960|lyfalmen|||00|0,5|0|Gróco ehf|Serono Europe|4|
016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|26395|35912|lyfalmen|||00|0,75|0|Gróco ehf|Serono Europe|6|
016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|1599|3163|lyfalmen|||00|14|0|Icepharma hf|Wyeth AB|14|
016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|3104|5443|lyfalmen|||00|28|0|Icepharma hf|Wyeth AB|28|
016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|6045|9662|lyfalmen|||00|98|0|Icepharma hf|Wyeth AB|49|
016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|6090|9724|lyfalmen|||00|56|0|Icepharma hf|Wyeth AB|56|
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GSC|0|0|0|100|XEU|31486|41068|lyfsjukr|||00|30|0|Swedish Orphan International AB|Gilead Science International (S) |30|
016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|10669|15943|lyfalmen|||00|98|0|Icepharma hf|Wyeth AB|98|
016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|2713|4855|lyfalmen|||00|4|0|Icepharma hf|Norpharma |16,67|
016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|14693|28159|vetalmen|||16|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25421|33517|lyfsjukr|||00|4824|0|Icepharma hf|Fresenius Kabi||
017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1196|2549|lyfalmen|||03|3|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|21,4286|
017111|A09AA0201|Combizym|töflur|| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1212|2575|lyfalmen|||10|100|0|Icepharma hf|Daiichi Sankyo Europe GmbH|25|
017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|225180|282217|lyfsjukr|||00|5|0|Icepharma hf|SkyPharma PLC||
017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|5421|8792|lyfalmen|||10|60|0|Vistor hf|Ferrosan A/S|45|
017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|159863|200897|lyfsjukr|||00|1|0|Vistor hf|Janssen-Cilag International N.V.||
017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|35501|46066|lyfsjukr|||00|6|0|Icepharma hf|Roche|1|
017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26275|34580|lyfsjukr|||00|5712|0|Icepharma hf|Fresenius Kabi||
017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1127|2405|lyfalmen|V0221|2405|00|100|0|Gróco ehf|Nycomed Danmark A/S|33,3333|
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|1,5|0|1|0|1|BIF|0|0|0|100|XEU|117781|148505|lyfsjukr|||00|2|0|Icepharma hf|Biogen Frances S.A.|27,91|
017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|39619|52376|lyfalmen|||00|28|0|Icepharma hf|Roche||
017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|118256|150279|lyfalmen|||00|84|0|Icepharma hf|Roche||
017260|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.04.2007||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|8106|11606|lyfsjukr|||00|2|0|Icepharma hf|Mayne Pharma Plc||
017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|4802|7916|lyfalmen|||00|4|0|Icepharma hf|Norpharma |33,33|
017271|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2007||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|19201|25773|lyfsjukr|||00|5|0|Icepharma hf|Mayne Pharma Plc||
017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5040|8260|lyfalmen|V0714|8260|00|100|0|Actavis Group PTC ehf|Merck NM AB|16,6667|
017305|N03AX1202|Gabapentin NM Pharma|hylki|400|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|6881|10827|lyfalmen|V0715|10827|00|100|0|Actavis Group PTC ehf|Merck NM AB|22,22|
017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|8967|13676|lyfalmen|||00|4|0|Icepharma hf|Norpharma |66,66|
017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2110|3939|lyfalmen|||00|100|0|Gróco ehf|Nycomed Danmark A/S|66,6667|
017331|A04AD1201|Emend|hylki|| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|8939|12798|lyfsjukr|||00|3|0|Icepharma hf|M.S.D.||
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|2508|4544|lyfalmen|||00|30|0|Vistor hf|Recip AB|150|
017422|N06BA0404|Equasym|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.05.2004||R|A|3|1|0|0|0|UCB|0|0|0|100|DKK|627|1366|lyfalmen|||00|30|0|Vistor hf|U.C.B|5|
017499|N06BA0404|Equasym|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.05.2004||R|A|3|1|0|0|0|UCB|0|0|0|100|DKK|939|2015|lyfalmen|V0953|2002|00|30|0|Vistor hf|U.C.B|10|
017510|N06BA0404|Equasym|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.05.2004||R|A|3|1|0|0|0|UCB|0|0|0|100|DKK|1878|3587|lyfalmen|||00|30|0|Vistor hf|U.C.B|20|
017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|5658|9122|lyfalmen|||00|100|0|Medico ehf|Solvay Duphar |66,6667|
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|5244|10160|vetalmen|||00|100|0|Vistor hf|Boehringer Ingelheim||
017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|31069|41731|lyfalmen|V1371|41731|00|84|0|Vistor hf|Janssen-Cilag AB|84|
017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|10097|15181|lyfalmen|V1370|15181|00|28|0|Vistor hf|Janssen-Cilag AB|14|
017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8775|13420|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|38819|51380|lyfalmen|||00|84|0|Vistor hf|Janssen-Cilag AB|126|
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8775|13420|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15|
018268|G03FA1701|Angemin|töflur|| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|5240|8539|lyfalmen|||00|84|0|Icepharma hf|Bayer Schering Pharma AG|84|
018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|2115|3947|lyfalmen|||00|28|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|14|
018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3124|5472|lyfalmen|||00|28|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|56|
018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|52627|67388|lyfsjukr|||00|5|0|Vistor hf|AstraZeneca UK Ltd||
018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|9783|14763|lyfalmen|||00|98|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|196|
018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|6872|10815|lyfalmen|||00|98|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|49|
018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|1963|3716|lyfalmen|||02|0,25|0|Icepharma hf|Baxter AG||
018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|2127|3965|lyfalmen|||02|0,5|0|Icepharma hf|Baxter AG||
018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|8070|12481|lyfalmen|||00|98|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|98|
018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|14253|19612|lyfsjukr|||00|5|0|Icepharma hf|Mayne Pharma Plc||
018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|70475|89609|lyfsjukr|||00|25|0|Icepharma hf|Mayne Pharma Plc||
018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|2627|4725|lyfalmen|||00|28|0|Gróco ehf|Daiichi Sankyo Europe GmbH-|28|
018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|47611|61143|lyfsjukr|||00|16,7|0|Icepharma hf|Mayne Pharma Plc||
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|6482|10271|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S|60|
018617|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|140688|177024|lyfsjukr|||00|50|0|Icepharma hf|Mayne Pharma Plc||
018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|10709|15200|lyfsjukr|||03|5|0|Icepharma hf|Roche|2,5|
018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1143|2439|lyfalmen|||00|14|0|Vistor hf|Novartis Healthcare A/S-|7|
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|19089|26816|lyfalmen|||00|90|0|Vistor hf|Astellas Pharma A/S|180|
018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2286|4207|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|14|
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MAC|0|0|1|100|XEU|870|1871|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck KgaA (A) |50|
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5188|8467|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S|30|
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|15272|22064|lyfalmen|||00|90|0|Vistor hf|Astellas Pharma A/S|90|
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|29254|39471|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100|
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|117602|148282|lyfsjukr|||00|28|0|Vistor hf|Teva Pharmaceuticals Limited||
018803|C10AA0502|Lipitor (Lyfjaver)|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|15880|22821|lyfalmen|V0338|11380|00|100|0|Lyfjaver ehf|Lyfjaver ehf|200|
018814|C10AA0502|Lipitor (Lyfjaver)|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|18659|26281|lyfalmen|V0339|14060|00|100|0|Lyfjaver ehf|Lyfjaver ehf|400|
018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|37531|49776|lyfalmen|V0375|49776|00|98|0|Lyfjaver ehf|Lyfjaver ehf|65,33|
018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|40741|53773|lyfalmen|V0376|53772|00|98|0|Lyfjaver ehf|Lyfjaver ehf|130,67|
018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|XEU|11205|16657|lyfalmen|V0718|16657|00|12|0|Lyfjaver ehf|Lyfjaver ehf|84|
018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|2437|4436|lyfalmen|||00|30|0|Gróco ehf|Almirall-Prodesfarma S.A.|60|
018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|7539|11745|lyfalmen|||00|100|0|Gróco ehf|Almirall-Prodesfarma S.A.|200|
018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|49036|62917|lyfsjukr|||43|60|0|GlaxoSmithKline ehf|Glaxo Group Limited|30|
018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|466|1031|lyfalmen|||00|100|0|Gróco ehf|Nycomed Danmark A/S|50|
018979|C10AA0502|Lipitor (Lyfjaver)|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.01.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|10990|16371|lyfalmen|V0337|8383|00|100|0|Lyfjaver ehf|Lyfjaver ehf|100|
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|975|1924|vetalmen|||27|100|0|Icepharma hf|Kela Laboratoria NV||
018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|11491|17038|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|62,5|
019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|0|0|LVR|0|0|0|100|DKK|11506|17058|lyfalmen|||00|56|0|Lyfjaver ehf|Lyfjaver ehf|37,33|
019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|0|0|LVR|0|0|0|100|DKK|11506|17058|lyfalmen|||00|56|0|Lyfjaver ehf|Lyfjaver ehf|28|
019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|0|0|LVR|0|0|0|100|DKK|11280|16757|lyfalmen|||00|56|0|Lyfjaver ehf|Lyfjaver ehf|18,67|
019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|7454|11626|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|41,6667|
019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|0|0|LVR|0|0|0|100|DKK|5753|9255|lyfalmen|||00|28|0|Lyfjaver ehf|Lyfjaver ehf|4,6667|
019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4029|6790|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|20,8333|
019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|12881|19087|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|83,3333|
019293|B02BC0001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC00|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|44543|57324|lyfsjukr|||00|1|0|Gróco ehf|Nycomed Danmark A/S||
019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|581765|726165|lyfsjukr|||00|10|0|Gróco ehf|Nycomed Danmark A/S||
019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|50522|64767|lyfsjukr|||AC|4|0|Icepharma hf|Roche Registration Limited||
019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|468|1035|lyfalmen|||00|100|0|Gróco ehf|Nycomed Danmark A/S|100|
019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3124|5472|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|28|
019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|10907|16260|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|98|
019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|4452|7406|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|56|
019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|14864|21556|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|196|
019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3124|5472|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|28|
019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|10907|16260|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|98|
019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|4452|7406|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|56|
019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|14864|21556|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|196|
019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|490|1081|lyfalmen|||00|250|0|Gróco ehf|Nycomed Danmark A/S|250|
019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|184860|232018|lyfsjukr|||AC|16|0|Icepharma hf|Roche Registration Limited||
019786|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|816|1759|lyfalmen|||10|20|0|Actavis Group PTC ehf|Merck NM AB|10|
019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|46713|61208|lyfalmen|||00|1,08|0|Icepharma hf|N.V. Organon|12|
019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|A|2|0|1|0|1|AEU|0|0|0|100|DKK|614145|766478|lyfsjukr|||02|6|0|Vistor hf|Amgen Europe B.V.|8,93|
019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|324|736|lyfalmen|||00|12|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,5|
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|55566|71047|lyfsjukr|||00|30|0|GlaxoSmithKline ehf|Glaxo Group Limited||
019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1222|2591|lyfalmen|||10|30|0|Actavis Group PTC ehf|Merck NM AB|15|
020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|AZD|0|0|1|100|SEK|306|698|lyfalmen|||43|100|0|Vistor hf|AstraZeneca A/S DK|50|
020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|3489|6004|lyfalmen|||00|30|0|Vistor hf|Astellas Pharma A/S|30|
020244|J07CA0204|Boostrix Polio|stl|| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|21665|30023|lyfalmen|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
020261|A10BD0301|Avandamet|filmhtfl|1002|mg|56|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|3637|6219|lyfalmen|||00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
020272|A10BD0301|Avandamet|filmhtfl|1004|mg|56|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|6532|10341|lyfalmen|||00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2073|3883|lyfalmen|||04|50|0|Lyfjaver ehf|Lyfjaver ehf|50|
020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|552|1210|lyfalmen|||00|7|0|Icepharma hf|Wyeth AB|2,63|
020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|7670|11928|lyfalmen|||00|90|0|Vistor hf|Astellas Pharma A/S|90|
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|54472|70868|lyfalmen|||02|2|0|Vistor hf|Astellas Pharma A/S||
020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|3408|5886|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|7|
020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LUN|0|1|0|30|DKK|2835|5041|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|28|
020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|9853|14856|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|28|
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|19278|27051|lyfalmen|||02|2|0|Vistor hf|Astellas Pharma A/S||
020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|568|1243|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30|
020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|5407|8772|lyfalmen|||00|28|0|Icepharma hf|Servier|28|
020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1655|3248|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100|
020472|C09CA0103|Cozaar (Lyfjaver)|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.09.2004||R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|8556|13128|lyfalmen|V0197|7507|00|98|0|Lyfjaver ehf|Lyfjaver ehf|98|
020483|C09DA0103|Cozaar Comp (Lyfjaver)|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.08.2004||R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|8569|13146|lyfalmen|V0198|9510|00|98|0|Lyfjaver ehf|Lyfjaver ehf|98|
020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|3778|6425|lyfalmen|V0709|6425|00|60|0|Lyfjaver ehf|Lyfjaver ehf|5|
020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|5506|8910|lyfalmen|V0710|8910|00|60|0|Lyfjaver ehf|Lyfjaver ehf|10|
020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|10975|16351|lyfalmen|V0711|15857|00|60|0|Lyfjaver ehf|Lyfjaver ehf|20|
020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|2466|4480|lyfalmen|V0939|4333|00|28|0|D.A.C. ehf|D.A.C. ehf|28|
020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|15863|22800|lyfalmen|||00|84|0|Icepharma hf|Servier|84|
020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki|+stjaka|G03CA03|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|1571|3121|lyfalmen|V0418|3121|05|15|0|D.A.C. ehf|D.A.C. ehf|15|
020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|DKK|802|1730|lyfalmen|||00|10|0|Gróco ehf|Almirall-Prodesfarma S.A.|20|
020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|3352|5804|lyfalmen|||10|50|0|D.A.C. ehf|D.A.C. ehf|8,34|
020700|L04AA2101|Raptiva|sts|100|mg/ml|125|mg|4|hgl|+ leysir|L04AA21|01.05.2005||R|K|3|0|1|0|1|SEE|0|0|0|100|SEK|164397|206542|lyfsjukr|||00|500|0|Gróco ehf|Serono Europe|50|
020763|R03AK0704|Symbicort Turbuhaler (D.A.C.)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.08.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|6832|10759|lyfalmen|V0990|10759|00|120|0|D.A.C. ehf|D.A.C. ehf|30|
020770|QP54AA5101|Eqvalan Duo|pasta|| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|1739|3009|vetorma|||16|7,74|0|Vistor hf|Merial SAS||
020774|L04AB0101|Enbrel|sts|| |50|mg|4|hgl|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|139149|175108|lyfsjukr|||00|200|0|Icepharma hf|Wyeth Europe|28,57|
020796|R03AK0604|Seretide Diskus (D.A.C.)|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.09.2007||R|A|1,5|0|0|B|0|DAC|0|0|0|100|DKK|5581|9015|lyfalmen|V0992|7893|23|60|0|D.A.C. ehf|D.A.C. ehf|30|
020826|N06AX1601|Efexor|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.10.1996||R|A|3|0|0|B|0|WLN|0|1|0|100|USD|1647|3236|lyfalmen|V0951|3236|00|28|0|Icepharma hf|Wyeth Lederle Nordiska|10,5|
020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2152|4003|lyfalmen|V0429|4003|00|3|0|D.A.C. ehf|D.A.C. ehf|5|
021031|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl|innöndunarvökvi|R05CB01|01.11.2006||R|K|3|0|0|E|0|AZD|0|0|0|100|SEK|4880|8030|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK||
021046|L02AE0303|Zoladex Trimestral (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.11.2004||R|A|3|0|1|*|0|DAC|0|0|0|100|SEK|49004|64060|lyfalmen|V0438|64060|00|1|0|D.A.C. ehf|D.A.C. ehf|10,6|
021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|4721|7798|lyfalmen|||63|28|0|Icepharma hf|M.S.D.|28|
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|1878|3587|lyfalmen|||00|60|0|Icepharma hf|Galderma Nordic AB|60|
021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|2695|4828|lyfalmen|V0988|4828|06|2,5|0|D.A.C. ehf|D.A.C. ehf||
021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|SEK|8015|12408|lyfalmen|||00|60|0|D.A.C. ehf|D.A.C. ehf|15|
021120|N03AX1103|Topamax (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|SEK|10604|15857|lyfalmen|V0711|15857|00|60|0|D.A.C. ehf|D.A.C. ehf|20|
021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1114|2378|lyfalmen|V0466|2378|00|12|0|D.A.C. ehf|D.A.C. ehf|12|
021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|796|1717|lyfalmen|||00|10|0|Actavis Group hf|Gerhard Mann||
021213|N03AX0902|Lamictal (D.A.C.)|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|IKR|4520|7505|lyfalmen|V0705|6296|00|56|0|D.A.C. ehf|D.A.C. ehf|18,6667|
021221|R03AC0303|Terbasmin Turbuhaler (D.A.C.)|innönddu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|1|100|SEK|1510|3028|lyfalmen|V0987|3028|23|200|0|D.A.C. ehf|D.A.C. ehf|50|
021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|3031|5336|lyfalmen|V0931|2732|00|28|0|D.A.C. ehf|D.A.C. ehf|28|
021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|4730|7811|lyfalmen|V0935|4152|00|28|0|D.A.C. ehf|D.A.C. ehf|56|
021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|15128|21885|lyfalmen|||02|4|0|Icepharma hf|Bayer Schering Pharma AG|55,56|
021267|J05AB1102|Valtrex (D.A.C.)|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|1|30|GBP|10099|15184|lyfalmen|V0508|13898|00|42|0|D.A.C. ehf|D.A.C. ehf|7|
021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|5514|8921|lyfalmen|V0985|8921|00|30|0|D.A.C. ehf|D.A.C. ehf|30|
021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.07.2005||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|6469|10253|lyfalmen|V0993|10253|23|60|0|Lyfjaver ehf|Lyfjaver ehf|30|
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|15472|22313|lyfalmen|||63|98|0|Icepharma hf|M.S.D.|98|
021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.07.2005||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|4786|7893|lyfalmen|V0992|7893|23|60|0|Lyfjaver ehf|Lyfjaver ehf|30|
021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|4365|7280|lyfalmen|V0085|7280|00|28|0|D.A.C. ehf|D.A.C. ehf|37,33|
021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004||R|A|5|0|0|*|0|DAC|0|0|0|100|SEK|16259|23293|lyfalmen|V0560|19083|00|30|0|D.A.C. ehf|D.A.C. ehf|30|
021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|1219|2586|lyfalmen|V0965|2586|24|120|0|D.A.C. ehf|D.A.C. ehf|38,4|
021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|11210|16664|lyfalmen|V0729|16664|00|100|0|D.A.C. ehf|D.A.C. ehf|20|
021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|DKK|352|794|lyfalmen|||04|6|0|Vistor hf|Boehringer Ingelheim|6|
021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|9695|14646|lyfalmen|V0728|14646|00|84|0|D.A.C. ehf|D.A.C. ehf|28|
021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|17671|25051|lyfalmen|||63|98|0|Icepharma hf|M.S.D.|49|
021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2629|3764|lyfsjukr|||02|100|0|Icepharma hf|Fresenius Kabi||
021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|2530|4577|lyfalmen|||23|100|0|D.A.C. ehf|D.A.C. ehf|25|
021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|4141|6953|lyfalmen|||23|100|0|D.A.C. ehf|D.A.C. ehf|50|
021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|3629|6207|lyfalmen|||00|30|0|Vistor hf|Ferring Lægemidler A/S|4,5|
021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|11468|17008|lyfalmen|||00|100|0|Vistor hf|Ferring Lægemidler A/S|15|
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|10605|15858|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|49|
021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|6763|10663|lyfalmen|||00|30|0|Vistor hf|Ferring AB, Svíþjóð|9|
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|26096|34357|lyfsjukr|||02|1000|0|Icepharma hf|Fresenius Kabi||
021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|19523|27356|lyfalmen|||00|100|0|Vistor hf|Ferring Lægemidler A/S|30|
021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|28474|37318|lyfsjukr|||02|500|0|Icepharma hf|Fresenius Kabi||
021659|V01AA0304|Alutard SQ, derm. pter.|stl|| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|18999|26704|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S||
021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3333|5776|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|14|
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|13400|18550|lyfsjukr|||02|500|0|Icepharma hf|Fresenius Kabi||
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|3582|5129|lyfsjukr|||02|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2,5|
021698|A08AB0102|Xenical (D.A.C.)|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.11.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|DKK|7088|11116|lyfalmen|V0133|11116|00|84|0|D.A.C. ehf|D.A.C. ehf|28|
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|15211|21988|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|IKR|2942|5203|lyfalmen|V1951|4295|00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|14|
021771|J05AB1102|Valtrex (D.A.C.)|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.05.2005||R|A|3|0|0|E|0|DAC|0|0|1|30|GBP|2297|4223|lyfalmen|V0507|3912|00|10|0|D.A.C. ehf|D.A.C. ehf|1,67|
021829|H01BA0203|Minirin (D.A.C.)|töflur|0,2|mg|30|stk|1|plglas||H01BA02|01.08.2006||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|6975|10958|lyfalmen|||00|30|0|D.A.C. ehf|D.A.C. ehf|15|
021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|4365|7280|lyfalmen|V0085|7280|00|28|0|D.A.C. ehf|D.A.C. ehf|37,33|
021950|B05AA0705|HyperHAES|irl|| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|19965|26724|lyfsjukr|||00|2500|0|Icepharma hf|Fresenius Kabi|2,5|
022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|15211|21988|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|70890|90126|lyfsjukr|||00|30|0|Icepharma hf|Roche Registration Limited||
022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|491|969|vetalmen|||16|20|0|Vistor hf|LEO Animal Health A/S||
022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|22816|31456|lyfalmen|||00|98|0|Icepharma hf|M.S.D.|130,67|
022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|26674|36259|lyfalmen|||00|98|0|Icepharma hf|M.S.D.|261,33|
022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|28194|38152|lyfalmen|||00|98|0|Icepharma hf|M.S.D.|522,67|
022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|245195|307135|lyfsjukr|||00|30|0|Icepharma hf|Roche Registration Limited||
022204|N06AX1603|Efexor XR (D.A.C.)|forðahlk|150|mg|30|stk|1|þpakki||N06AX16|01.05.2005||R|A|2|0|0|B|0|DAC|0|1|0|100|USD|5922|9490|lyfalmen|V0954|9490|00|30|0|D.A.C. ehf|D.A.C. ehf|45|
022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|291899|365282|lyfsjukr|||00|30|0|Icepharma hf|Roche Registration Limited||
022218|QP52AA5102|Drontal Comp.vet.|töflur|| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BHC|0|0|0|100|DKK|8015|13870|vetorma|||00|24|0|Vistor hf|Bayer HealthCare AG||
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|21096|29315|lyfalmen|||02|1|0|Vistor hf|Allergan||
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1772|3067|vetorma|||00|2,24|0|Vistor hf|Bayer HealthCare AG||
022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|2277|4193|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
022281|QP52AA5102|Drontal Comp.vet.|töflur|| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BHC|0|0|0|100|DKK|854|1478|vetorma|||00|2|0|Vistor hf|Bayer HealthCare AG||
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|5314|8642|lyfalmen|V0308|3634|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100|
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|8243|12711|lyfalmen|V0310|5453|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|200|
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1679|2906|vetorma|||00|1,4|0|Vistor hf|Bayer HealthCare AG||
022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|581|1270|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30|
022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1690|3301|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100|
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1087|1881|vetorma|||00|0,7|0|Vistor hf|Bayer HealthCare AG||
022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|| |28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3657|6248|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|56|
022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|USD|936|2008|lyfalmen|||00|50|0|D.A.C. ehf|D.A.C. ehf|50|
022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|3067|5389|lyfalmen|||10|60|0|D.A.C. ehf|D.A.C. ehf|20|
022620|R01AD0802|Flixonase (D.A.C.)|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.2007||R|A|2|0|0|E|0|DAC|0|0|1|100|GBP|1115|2381|lyfalmen|V0967|2381|24|16|0|D.A.C. ehf|D.A.C. ehf|30|
022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|| |98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|12071|18079|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|196|
022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|199666|250452|lyfsjukr|||00|3|0|Icepharma hf|Genzyme Europe B.V. (I)||
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|1061|2268|lyfalmen|||00|15|0|Icepharma hf|Santen Oy||
022952|C08CA0103|Norvas (D.A.C.)|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.08.2006||R|A|4|0|0|B|0|DAC|0|0|0|100|DKK|3447|5942|lyfalmen|V0311|5942|00|30|0|D.A.C. ehf|D.A.C. ehf|60|
022962|V01AA1104|Alutard SQ, hrossaværur|stl|| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|18999|26704|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S||
022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|15211|21988|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|3075|5400|lyfalmen|||19|100|0|Vistor hf|Boehringer Ingelheim|33,3333|
023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|4422|7363|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd|28|
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GSI|0|0|0|100|DKK|93981|118874|lyfsjukr|||00|30|0|Lyfjaver ehf|Gilead Science International (L)||
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|23499|32307|lyfalmen|||00|90|0|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|20|
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|31393|42135|lyfalmen|||00|90|0|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|30|
023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|15897|22842|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd||
023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|4466|7427|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd|56|
023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|16059|23044|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd||
023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|16300|22161|lyfsjukr|||02|25|0|Icepharma hf|Roche||
023329|N03AX1204|Gabapentin Merck NM|hylki|300|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5040|8260|lyfalmen|V0714|8260|00|100|0|Actavis Group PTC ehf|Merck NM AB|16,6667|
023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|6881|10827|lyfalmen|V0715|10827|00|100|0|Actavis Group PTC ehf|Merck NM AB|22,22|
023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|0|100|XEU|12920|19136|lyfalmen|||00|34|0|Vistor hf|Dentsply DeTrey GmbH||
023414|B03XA0201|Aranesp |stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|6719|9620|lyfsjukr|||00|0,5|0|Vistor hf|Amgen|4,44|
023419|B03XA0201|Aranesp |stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|26447|34794|lyfsjukr|||00|0,4|0|Vistor hf|Amgen|17,78|
023425|B03XA0201|Aranesp |stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|20016|26787|lyfsjukr|||00|0,3|0|Vistor hf|Amgen|13,33|
023441|B03XA0201|Aranesp |stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|47650|61192|lyfsjukr|||00|0,3|0|Vistor hf|Amgen|33,33|
023447|B03XA0201|Aranesp |stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|31813|41475|lyfsjukr|||00|0,5|0|Vistor hf|Amgen|22,22|
023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|6999|10021|lyfsjukr|||00|10|0|Icepharma hf|Baxter AG||
023452|B03XA0201|Aranesp |stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|95239|120440|lyfsjukr|||00|0,6|0|Vistor hf|Amgen|66,67|
023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|17498|23653|lyfsjukr|||00|25|0|Icepharma hf|Baxter AG||
023463|B03XA0201|Aranesp |stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|13083|18156|lyfsjukr|||00|0,4|0|Vistor hf|Amgen|8,89|
023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|10658|15929|lyfalmen|||00|10|0|GlaxoSmithKline ehf|Glaxo Group Limited|20|
023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|34993|45434|lyfsjukr|||00|50|0|Icepharma hf|Baxter AG||
023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|69984|88998|lyfsjukr|||00|100|0|Icepharma hf|Baxter AG||
023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|7461|11636|lyfalmen|||00|2,8|0|GlaxoSmithKline ehf|Glaxo Group Limited|14|
023480|B03XA0201|Aranesp |stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|152323|191510|lyfsjukr|||00|1|0|Vistor hf|Amgen|111,11|
023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|139966|176125|lyfsjukr|||00|200|0|Icepharma hf|Baxter AG||
023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|14921|21627|lyfalmen|||00|5,6|0|GlaxoSmithKline ehf|Glaxo Group Limited|28|
023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|11191|16639|lyfalmen|||00|4,2|0|GlaxoSmithKline ehf|Glaxo Group Limited|21|
023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|108987|137556|lyfsjukr|||00|120|0|Vistor hf|Boehringer Ingelheim International |30|
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|20841|28997|lyfalmen|||00|100|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|100|
023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|3632|6212|lyfalmen|||00|3,5|0|GlaxoSmithKline ehf|Glaxo Group Limited|7|
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|2823|5022|lyfalmen|||00|12|0|Icepharma hf|Santen Oy|60|
023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|50876|65208|lyfsjukr|||00|120|0|Icepharma hf|Roche|100|
023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|0|0|SDE|0|0|0|100|NOK|8148|12585|lyfalmen|||00|15|0|Vistor hf|Sanofi - aventis Deutschland GmbH|37,5|
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|86082|110222|lyfalmen|||00|90|0|Vistor hf|Pfizer Limited|36|
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|2987|5272|lyfalmen|||00|100|0|Icepharma hf|M.S.D.|16,6667|
024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|USD|59312|75711|lyfsjukr|||00|10|0|Icepharma hf|Wyeth Europe|5|
024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|3478|5988|lyfalmen|||00|5|0|Vistor hf|Janssen-Cilag AB|9,99|
024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|15448|22283|lyfalmen|||00|30|0|Lundbeck Export A/S|Teva Pharma GmbH|30|
024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|1819|2604|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10|
024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|7472|11652|lyfalmen|||00|112|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|13064|19315|lyfalmen|||00|112|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|51494|67160|lyfalmen|||00|100|0|Lundbeck Export A/S|Teva Pharma GmbH|100|
024307|V01AA1105|Alutard SQ, hundahar|stl|| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|18999|26704|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S||
024478|V04CL0024|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5981|9572|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|325|738|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|2|
024482|V04CL0025|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5981|9572|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024504|V04CL0011|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|10078|15156|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024510|V04CL0012|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|10078|15156|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024526|V04CL0014|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|10095|15179|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024530|N05AH0304|Zyprexa (D.A.C.)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.08.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|16846|24024|lyfalmen|V0811|23452|00|56|0|D.A.C. ehf|D.A.C. ehf|42|
024532|V04CL0015|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|10078|15156|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024559|V04CL0016|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|10078|15156|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024565|V04CL0017|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|10198|15316|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024576|V04CL0018|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|10078|15156|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024583|V04CL0019|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5981|9572|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024589|V04CL0020|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|10078|15156|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|E|0|NOE|0|0|0|100|DKK|56930|73928|lyfalmen|||00|100|0|Vistor hf|Novartis Europharm Ltd|125|
024600|V04CL0021|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|10198|15316|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024603|V04CL0009|Soluprick  Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1228|2600|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024622|V04CL0013|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5981|9572|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024644|V04CL0023|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5981|9572|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024670|V04CL0022|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5981|9572|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
024681|V04CL0010|Soluprick  Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1228|2600|lyfalmen|||02|2|0|Vistor hf|ALK-Abello A/S||
025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|876|1884|lyfalmen|V0143|1884|70|30|0|D.A.C. ehf|D.A.C. ehf|30|
025126|M05BB0301|Fosavance|töflur|| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|4313|7204|lyfalmen|||00|4|0|Icepharma hf|M.S.D.||
025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|718|1555|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30|
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|15211|21988|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2055|3856|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100|
025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|15211|21988|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
025306|M05BB0301|Fosavance|töflur|| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|12745|18918|lyfalmen|||00|12|0|Icepharma hf|M.S.D.||
025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|78240|99276|lyfsjukr|||00|30|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |60|
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|77350|98168|lyfsjukr|||00|30|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |30|
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7537|14528|vetalmen|||00|20|0|Vistor hf|Boehringer Ingelheim||
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|13963|20434|lyfalmen|||00|30|0|Vistor hf|ALK-Abello A/S||
025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|16982|24193|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|392|
025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4953|8136|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|112|
025471|N06AB1002|Cipralex (D.A.C.)|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.12.2006||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|5268|8578|lyfalmen|V1039|8578|00|28|0|D.A.C. ehf|D.A.C. ehf|56|
025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|0|0|JAS|0|1|0|100|SEK|25588|34907|lyfalmen|||00|1|0|Vistor hf|Janssen-Cilag AB|27,78|
025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|1474|2973|lyfalmen|V1090|2973|06|5|0|D.A.C. ehf|D.A.C. ehf|16,6667|
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|4127|6933|lyfalmen|||00|1|0|Icepharma hf|Roche Registration Limited|30|
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|12036|18035|lyfalmen|||00|3|0|Icepharma hf|Roche Registration Limited|90|
025608|N06AX1203|Zyban (D.A.C.)|forðatfl|150|mg|60|stk|1|þpakki||N06AX12|01.12.2006||R|A|2|0|0|0|0|DAC|0|1|1|100|GBP|6110|9752|lyfalmen|V1155|9752|00|60|0|D.A.C. ehf|D.A.C. ehf|30|
025677|S01ED5109|Cosopt (D.A.C.)|augndr|5|mg/ml|5|ml|1|glas||S01ED51|01.04.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2111|3941|lyfalmen|V0989|3941|06|5|0|D.A.C. ehf|D.A.C. ehf||
025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|0|0|JAS|0|1|0|100|SEK|13661|20058|lyfalmen|||00|1|0|Vistor hf|Janssen-Cilag AB|13,89|
025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|0|0|JAS|0|1|0|100|SEK|19758|27649|lyfalmen|||00|1|0|Vistor hf|Janssen-Cilag AB|20,83|
025725|R01AD0505|Rhinocort Turbuhaler (D.A.C.)|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.2007||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|3208|5594|lyfalmen|V0966|5594|23|200|0|D.A.C. ehf|D.A.C. ehf|100|
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|43591|57321|lyfalmen|||00|100|0|Vistor hf|ALK-Abello A/S||
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4673|6691|lyfsjukr|||02|25|0|Vistor hf|AstraZeneca A/S DK|0,1667|
025841|V01AA1106|Alutard SQ, kattahar|stl|| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|18999|26704|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S||
025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|741|1603|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|50|
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|2750|4759|vetorma|||16|1|0|Vistor hf|Merial (MSD)||
025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|764|1651|lyfalmen|||00|50|0|Actavis Group PTC ehf|Merck NM AB|50|
025994|M01AE0215|Naproxen Merck NM|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1362|2803|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|100|
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|6225|10773|vetorma|||16|2,5|0|Vistor hf|Merial (MSD)||
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|15211|21988|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1529|3057|lyfalmen|||00|100|0|Vistor hf|Recip AB|25|
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|318|723|lyfalmen|||00|50|0|Vistor hf|Recip AB|1,25|
027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2124|3961|lyfalmen|||10|50|0|Swedish Orphan International AB|Sandoz GmbH (S)|15|
027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|6115|9759|lyfalmen|||00|50|0|Actavis Group PTC ehf|Merck NM AB|25|
027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1554|3095|lyfalmen|||00|14|0|Vistor hf|Eisai Ltd|1,75|
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|6217|9902|lyfalmen|||00|56|0|Vistor hf|Eisai Ltd|7|
027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|8322|12817|lyfalmen|||00|56|0|Vistor hf|Eisai Ltd|14|
027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|10992|16374|lyfalmen|||00|56|0|Vistor hf|Eisai Ltd|28|
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|693|1503|lyfalmen|V0431|1322|00|100|0|Gróco ehf|Nycomed Danmark A/S|33,33|
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|660|1434|lyfalmen|V0430|1127|00|100|0|Gróco ehf|Nycomed Danmark A/S|66,6667|
027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SPP|0|0|0|100|DKK|96861|122459|lyfsjukr|||00|105|0|Icepharma hf|SP Europe|0,75|
027938|C07AA0701|Sotacor|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1992||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|999|2139|lyfalmen|V0272|1882|00|100|0|Vistor hf|Bristol-Myers Squibb|50|
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|18643|26261|lyfalmen|||00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|18,67|
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|18643|26261|lyfalmen|||00|28|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|28|
028150|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|80|ml|1|glas||J01CA04|01.12.2006||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|848|1825|lyfalmen|||08|80|0|D.A.C. ehf|D.A.C. ehf||
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|1992|3760|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
028351|J07BL0101|Stamaril|sts|| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|16722|23869|lyfalmen|||02|5|0|Icepharma hf|Sanofi Pasteur MSD||
028360|J07BG0101|Rabies - Imovax|bóluefni|| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|6399|10155|lyfalmen|||02|1|0|Icepharma hf|Aventis Pasteur MSD A/S||
028405|M01AE0216|Naproxen-E Merck NM |sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1563|3109|lyfalmen|||10|50|0|Actavis Group PTC ehf|Merck NM AB|50|
028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2584|4659|lyfalmen|V0351|4454|10|60|0|Vistor hf|Ferrosan A/S|30|
028597|D07BB0401|Locoidol|krem|| |30|g|1|túpa||D07BB04|01.01.1990||R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|711|1541|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30|
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|6255|12086|vetalmen|||27|10|0|Icepharma hf|Orion Corporation (I)||
028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|772|1667|lyfalmen|||02|24|0|Vistor hf|Sanofi-aventis Norge AS|4|
028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|10366|14773|lyfsjukr|||00|10|0|Icepharma hf|Roche as|5|
029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|1770|3423|lyfalmen|||20|50|0|Vistor hf|Sanofi-aventis Norge AS|50|
029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1138|2428|lyfalmen|V0967|2381|24|16|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|817|1761|lyfalmen|||00|40|0|Vistor hf|Sanofi-aventis Norge AS|13,3333|
029298|D07AB0101|Emovat|krem|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|401|896|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|IKR|5958|9540|lyfalmen|V0297|9540|00|7|0|D.A.C. ehf|D.A.C. ehf||
029334|J05AG0302|Stocrin (Lyfjaver)|töflur|600|mg|30|stk|1|glas||J05AG03|01.09.2005||R|A|2|0|1|0|1|LVR|0|0|0|100|XEU|37506|48562|lyfsjukr|||00|30|0|Lyfjaver ehf|Lyfjaver ehf|30|
029343|L03AB0802|Betaferon (Lyfjaver)|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.09.2005||R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|124612|157009|lyfsjukr|||00|15|0|Lyfjaver ehf|Lyfjaver ehf|30|
029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|6589|10420|lyfalmen|V0358|2046|00|98|0|Lyfjaver ehf|Lyfjaver ehf|65,3333|
029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|5963|9547|lyfalmen|V0365|2462|00|98|0|Lyfjaver ehf|Lyfjaver ehf|130,6667|
029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|9371|14214|lyfalmen|V0367|3440|00|98|0|Lyfjaver ehf|Lyfjaver ehf|261,3333|
029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|13177|19456|lyfalmen|||00|98|0|Lyfjaver ehf|Lyfjaver ehf|522,6667|
029769|D07AB0101|Emovat|krem|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1579|3133|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|2|
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf|McNeil Denmark ApS|7|
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|McNeil Denmark ApS|14|
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|4|
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf|McNeil Denmark ApS|14|
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|McNeil Denmark ApS|28|
030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|19226|26987|lyfalmen|||00|98|0|Vistor hf|Eisai Ltd|49|
030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|401|896|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1579|3133|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|8245|12714|lyfalmen|V1400|12061|00|100|0|Vistor hf|Novartis Healthcare A/S-|33,3333|
030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|2784|4963|lyfalmen|V1401|4717|00|100|0|Vistor hf|Novartis Healthcare A/S-|8,3333|
030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|732|1584|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|33,3333|
031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|1068|2283|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|66,6667|
031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|656|1426|lyfalmen|||23|2|0|Artasan ehf|Novartis Healthcare A/S-A|2|
031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|3932|6649|lyfalmen|||02|15|0|Vistor hf|Sanofi - Aventis|37,5|
031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|1531|3060|lyfalmen|||00|100|0|Vistor hf|Recip AB|33,3333|
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|4943|8122|lyfalmen|||02|15|0|Vistor hf|Novo-Nordisk|37,5|
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|29106|38104|lyfsjukr|||00|5|0|Vistor hf|Ferring Lægemidler A/S|0,42|
031971|C07AA0704|Sotalol Merck NM|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1496|3007|lyfalmen|V0274|3007|00|100|0|Actavis Group PTC ehf|Merck NM AB|100|
031997|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA07|01.03.2000||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|875|1882|lyfalmen|V0272|1882|00|100|0|Actavis Group PTC ehf|Merck NM AB|50|
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|19359|27152|lyfalmen|||00|150|0|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|10|
032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|2999|5190|vetorma|||27|50|0|Vistor hf|Merial (MSD)||
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|10666|18458|vetorma|||27|200|0|Vistor hf|Merial (MSD)||
033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983||R|A|3|0|0|E|0|ALC|0|0|0|100|USD|306|698|lyfalmen|||06|5|0|K.Pétursson hf|Alcon||
033251|S01CA0102|Tobradex|augndr|| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|819|1765|lyfalmen|||00|5|0|K.Pétursson hf|Alcon||
034157|J07AM5104|Diftavax|bóluefni|| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|590|1289|lyfalmen|||AC|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|1749|3391|lyfalmen|||00|300|0|Vistor hf|Astra|10|
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1445|2929|lyfalmen|||00|6|0|Vistor hf|Novartis Healthcare A/S-||
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|2478|4498|lyfalmen|||00|12|0|Vistor hf|Novartis Healthcare A/S-||
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|6989|10007|lyfsjukr|||02|25|0|Vistor hf|LEO Pharma A/S||
035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|13692|20097|lyfalmen|||10|300|0|Vistor hf|Ferring|100|
035333|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.05.2006||R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|78913|100114|lyfsjukr|||00|20|0|Lyfjaver ehf|Lyfjaver ehf||
035342|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.05.2006||R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|59070|75410|lyfsjukr|||00|15|0|Lyfjaver ehf|Lyfjaver ehf||
035351|L01BB0502|Fludara (Lyfjaver)|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.05.2006||R|A|3|0|1|0|1|LVR|0|0|0|100|SEK|120702|152141|lyfsjukr|||00|250|0|Lyfjaver ehf|Lyfjaver ehf||
035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3690|6296|lyfalmen|V0705|6296|00|56|0|Actavis Group hf|Actavis hf|18,67|
035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|94971|120106|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35574|46157|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6|
035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|793|1711|lyfalmen|||00|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|12|
035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|423|942|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|ROC|0|0|1|100|DKK|4213|7058|lyfalmen|||00|60|0|Icepharma hf|Roche|60|
036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|172579|216728|lyfsjukr|||00|30|0|Vistor hf|Pfizer Limited||
036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|344636|430939|lyfsjukr|||00|30|0|Vistor hf|Pfizer Limited||
036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|687809|858190|lyfsjukr|||00|30|0|Vistor hf|Pfizer Limited||
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|668|1451|lyfalmen|||00|20|0|Vistor hf|Recip AB|8|
036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1067|2281|lyfalmen|||08|60|0|Vistor hf|Recip AB|3|
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2106|3933|lyfalmen|||08|125|0|Vistor hf|Recip AB|6,25|
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|638|1389|lyfalmen|||00|30|0|Vistor hf|Recip AB|12|
037061|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MNA|0|0|0|100|SEK|6264|9967|lyfalmen|V0437|9967|00|90|0|Actavis Group PTC ehf|Merck NM AB|90|
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2909|5153|lyfalmen|||00|100|0|Icepharma hf|Roche|16,6667|
037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|531|1166|lyfalmen|||00|30|0|Vistor hf|Hexal A/S|7,5|
037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|734|1588|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|25|
037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|1554|3095|lyfalmen|||10|250|0|Vistor hf|LEO Pharma A/S|62,5|
037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|1427|2902|lyfalmen|||00|100|0|Vistor hf|Hexal A/S|25|
038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|822|1771|lyfalmen|||00|50|0|Icepharma hf|Smith & Nephew|50|
038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|168198|211274|lyfsjukr|||00|0,6|0|Vistor hf|Amgen Europe B.V.||
038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|7857|12188|lyfalmen|||00|90|0|Icepharma hf|Servier|90|
038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|3461|5963|lyfalmen|||00|100|0|Medico ehf|Solvay Duphar |33,3333|
038915|J01FA1004|Zitromax UNO|forðakyr|| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2339|4287|lyfalmen|||00|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|6,67|
039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|32449|42267|lyfsjukr|||00|10|0|Vistor hf|Sanofi-aventis Norge AS||
039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|56462|72163|lyfsjukr|||00|20|0|Vistor hf|Sanofi-aventis Norge AS||
039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5037|8256|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|62,5|
039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1159|2472|lyfalmen|||00|15|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2|
039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1779|3437|lyfalmen|||00|22,5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3|
039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|249|357|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB||
039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|561|803|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB||
040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|946|1354|lyfsjukr|||02|1|0|Icepharma hf|Baxter Medical AB||
040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|2949|5214|lyfalmen|||00|200|0|Vistor hf|Novartis Healthcare A/S-|40|
041005|L04AB0102|Enbrel (Lyjaver)|sts|| |25|mg|4|hgl|+ leysir|L04AB01|01.05.2006||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|74211|94260|lyfsjukr|||00|100|0|Lyfjaver ehf|Lyfjaver ehf|14,29|
041059|J07BH0101|Rotarix|mixtduft|| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|7337|11463|lyfalmen|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA||
041423|G03AA1203|Yasminelle|töflur|| |63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2463|4476|lyfalmen|||00|63|0|Icepharma hf|Bayer Schering Pharma AG||
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|3455|5979|vetorma|||AA|100|0|Icepharma hf|Intervet International B.V.||
041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|SAG|0|0|0|100|SEK|151270|191381|lyfalmen|||02|100|0|Icepharma hf|Schering AG||
042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1133|2418|lyfalmen|||02|25|0|Vistor hf|AstraZeneca A/S DK|0,1667|
042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|8497|12166|lyfsjukr|||00|500|0|Vistor hf|AstraZeneca A/S DK||
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2864|4101|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi||
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3612|5171|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi||
042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3414|4888|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi||
042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5176|7411|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi||
042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5942|8507|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi||
042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6499|9305|lyfsjukr|||00|4000|0|Icepharma hf|Fresenius Kabi|4|
042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3451|4941|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi||
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2532|3625|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi||
042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2183|3126|lyfsjukr|||02|10000|0|Icepharma hf|Fresenius Kabi||
042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7628|10921|lyfsjukr|||00|2000|0|Icepharma hf|Fresenius Kabi||
042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|3088|4421|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi||
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|1722|2465|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi||
042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5693|8151|lyfsjukr|||00|4000|0|Icepharma hf|Fresenius Kabi|4|
042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1931|2765|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi||
042549|J07BF0301|Imovax Polio|bóluefni|| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|609|1328|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
042556|J07BF0301|Imovax Polio|bóluefni|| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|11633|17227|lyfalmen|||02|10|0|Icepharma hf|Sanofi Pasteur MSD||
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2683|3841|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi||
043232|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|280|644|lyfalmen|||00|30|0|Actavis Group PTC ehf|Merck NM AB|30|
043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|2652|3797|lyfsjukr|||00|100|0|Vistor hf|AstraZeneca A/S DK||
043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3147|5505|lyfalmen|||24|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4875|6980|lyfsjukr|||00|100|0|Vistor hf|AstraZeneca A/S DK||
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|443|983|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15|
043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|947|2031|lyfalmen|||10|30|0|Icepharma hf|N.V. Organon|30|
043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyflausa|||02|200|0|Icepharma hf|Fresenius Kabi||
043935|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||00|200|0|Icepharma hf|Fresenius Kabi||
044114|J01DH0202|Meronem (Lyfjaver)|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.02.2008||R|A|4|0|0|0|1|LVR|0|0|0|100|NOK|22428|29790|lyfsjukr|||00|5000|0|Lyfjaver ehf|Lyfjaver ehf|2,5|
044124|J01DH0202|Meronem (Lyfjaver)|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.02.2008||R|A|4|0|0|0|1|LVR|0|0|0|100|NOK|42957|55349|lyfsjukr|||00|10|0|Lyfjaver ehf|Lyfjaver ehf|5|
044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|11104|16523|lyfalmen|||00|25|0|Lyfjaver ehf|Lyfjaver ehf|5|
044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|4358|7269|lyfalmen|V1300|7269|00|4|0|D.A.C. ehf|D.A.C. ehf|8|
045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|29768|38929|lyfsjukr|||00|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1113|2376|lyfalmen|||10|50|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|8,3333|
045385|J07BF0301|Imovax Polio|bóluefni|| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5815|9341|lyfalmen|||02|5|0|Icepharma hf|Sanofi Pasteur MSD||
046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|16620|31830|vetalmen|||27|10|0|Icepharma hf|Pfizer vet.||
047042|L04AB0101|Enbrel|stl|| |25|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|72281|91857|lyfsjukr|||00|100|0|Icepharma hf|Wyeth Europe|14,29|
047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|755|1632|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|25|
047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|869|1869|lyfalmen|||23|14|0|Vistor hf|Astellas Pharma A/S|7|
047560|L04AB0101|Enbrel|stl|| |50|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|143871|180987|lyfsjukr|||00|200|0|Icepharma hf|Wyeth Europe|28,58|
047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|7692|11958|lyfalmen|||00|98|0|Vistor hf|AstraZeneca UK Ltd|49|
048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3925|5620|lyfsjukr|||02|250|0|Icepharma hf|Baxter Medical AB||
048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6195|8870|lyfsjukr|||02|100|0|Icepharma hf|Baxter Medical AB||
048199|A03CA0201|Librax|töflur|| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|VAL|0|0|0|100|DKK|1735|3370|lyfalmen|||00|100|0|Icepharma hf|Valeant Pharmaceuticals B.V.||
048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|12399|18487|lyfalmen|||00|98|0|Icepharma hf|M.S.D.|196|
048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|3117|5462|lyfalmen|||00|100|0|Vistor hf|Recip AB|66,6667|
048447|G03AA0901|Marvelon|töflur|| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1411|2878|lyfalmen|||23|63|0|Icepharma hf|N.V. Organon|84|
048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|51030|66583|lyfalmen|||00|150|0|Icepharma hf|Roche|37,5|
048520|N04BD0104|Selegilin Merck NM|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2208|4088|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|100|
048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|7281|11385|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|200|
048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|379|850|lyfalmen|V0772|486|00|100|0|Icepharma hf|GlaxoSmithKline CH A/S|16,6667|
049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|15012|21740|lyfalmen|||00|3|0|Icepharma hf|Roche Registration Limited|0,5|
049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2149|3999|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim|25|
049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||23|60|0|Vistor hf|Janssen-Cilag AB|60|
049524|S01ED5110|Duotrav|augndr|| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2307|4239|lyfalmen|||00|2,5|0|K.Pétursson hf|Alcon||
049533|S01ED5110|Duotrav|augndr|| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|6791|10702|lyfalmen|||00|7,5|0|K.Pétursson hf|Alcon||
049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|5813|9338|lyfalmen|||23|5|0|Icepharma hf|Galderma Nordic AB|5|
049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|8417|12943|lyfalmen|V0343|5205|00|28|0|Vistor hf|Novartis Healthcare A/S-|28|
049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|1589|3148|lyfalmen|||00|30|0|Artasan ehf|Novartis Healthcare A/S-A|30|
049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|3945|6668|lyfalmen|||10|30|0|D.A.C. ehf|D.A.C. ehf|3|
049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|14475|21072|lyfalmen|||10|30|0|D.A.C. ehf|D.A.C. ehf|12|
049778|M05BA0405|Fosamax (D.A.C.) |töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|11837|17499|lyfalmen|V0718|16657|00|12|0|D.A.C. ehf|D.A.C. ehf|84|
049832|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|lykja||J06BA01|01.06.2007||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|10725|15220|lyfsjukr|||17|10|0|Vistor hf|Octapharma AB||
049842|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|lykjur||J06BA01|01.06.2007||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|107243|135385|lyfsjukr|||17|100|0|Vistor hf|Octapharma AB||
049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|61895|80110|lyfalmen|||00|300|0|Icepharma hf|Roche|37,5|
050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|6270|8977|lyfsjukr|||02|12|0|Vistor hf|Hospira Enterprises B.V.||
050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BHC|0|0|0|100|SEK|526723|657638|lyfsjukr|||00|112|0|Vistor hf|Bayer HealthCare AG||
050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2950|5215|lyfalmen|||00|14|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56|
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10521|15746|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|42|
050651|C02CA0402|Carduran Retard|forðatfl|4|mg|30|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2443|4445|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7372|11512|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100|
050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|376|844|lyfalmen|||04|10|0|Icepharma hf|GlaxoSmithKline CH A/S|3,3333|
051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1341|2771|lyfalmen|||10|100|0|Vistor hf|Desitin Artzneimittel|10|
051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|7128|11172|lyfalmen|V0391|11172|00|60|0|D.A.C. ehf|D.A.C. ehf||
051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1781|3440|lyfalmen|||10|100|0|Vistor hf|Desitin Artzneimittel|20|
051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|412|919|lyfalmen|||72|25|0|Vistor hf|AstraZeneca A/S DK|10|
051331|R06AX2602|Nefoxef|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MEK|0|0|1|100|SEK|958|2054|lyfalmen|V1910|2054|00|30|0|Actavis Group PTC ehf|Merck NM AB (A)|30|
051340|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MEK|0|0|1|100|SEK|2887|5120|lyfalmen|V1911|5120|00|100|0|Actavis Group PTC ehf|Merck NM AB (A)|100|
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MEK|0|0|1|100|SEK|1475|2975|lyfalmen|V1912|2975|00|30|0|Actavis Group PTC ehf|Merck NM AB (A)|45|
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MEK|0|0|1|100|SEK|4266|7135|lyfalmen|V1913|7135|00|100|0|Actavis Group PTC ehf|Merck NM AB (A)|150|
051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1562|3107|lyfalmen|||72|100|0|Vistor hf|AstraZeneca A/S DK|40|
051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|27535|36149|lyfsjukr|||00|50|0|Vistor hf|U.C.B|3,33|
051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|3308|5740|lyfalmen|V0084|5740|00|28|0|D.A.C. ehf|D.A.C. ehf|18,67|
052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|303220|379376|lyfsjukr|||00|60|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd ||
052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|610938|762485|lyfsjukr|||00|60|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd ||
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|617926|771185|lyfsjukr|||00|60|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd ||
052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|26103|34366|lyfsjukr|||63|25|0|Actavis Group hf|Pharmachemie|6,25|
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32138|41879|lyfsjukr|||00|8212|0|Icepharma hf|Fresenius Kabi|8,2|
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25820|34013|lyfsjukr|||00|7698|0|Icepharma hf|Fresenius Kabi|7,71|
052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|34851|45257|lyfsjukr|||63|10|0|Actavis Group hf|Pharmachemie|8,3333|
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|29877|39064|lyfsjukr|||00|7680|0|Icepharma hf|Fresenius Kabi|7,68|
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24821|32770|lyfsjukr|||00|7200|0|Icepharma hf|Fresenius Kabi|7,2|
052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33652|43764|lyfsjukr|||00|7880|0|Icepharma hf|Fresenius Kabi|7,9|
052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31309|40847|lyfsjukr|||00|7616|0|Icepharma hf|Fresenius Kabi|7,6|
053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|2419|4409|lyfalmen|V0903|4409|00|100|0|Actavis Group PTC ehf|Merck NM AB|100|
053025|G03HB0102|Diane mite|töflur|| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2193|4065|lyfalmen|||23|63|0|Icepharma hf|Bayer Schering Pharma AG|63|
053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|67724|86184|lyfsjukr|||00|120|0|Vistor hf|Abbott Laboratories Ltd|30|
053231|J07BB0201|Fluarix|bóluefni|| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|5070|8302|lyfalmen|||02|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
053270|A08AX0101|Acomplia|filmhtfl|20|mg|28|stk|1|þpakki||A08AX01|01.11.2006||R|A|3|0|0|0|0|SAA|0|0|0|100|NOK|11150|16584|lyfalmen|||00|28|0|Vistor hf|Sanofi - Aventis|28|
053279|A08AX0101|Acomplia|filmhtfl|20|mg|98|stk|1|þpakki||A08AX01|01.03.2008||R|A|3|0|0|0|0|SAA|0|0|0|100|NOK|30679|41246|lyfalmen|||00|98|0|Vistor hf|Sanofi - Aventis|98|
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|E|0|SDE|0|0|0|100|NOK|29373|39620|lyfalmen|||00|100|0|Vistor hf|Sanofi - aventis Deutschland GmbH|50|
053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|E|0|SDE|0|0|0|100|NOK|9101|13854|lyfalmen|||00|30|0|Vistor hf|Sanofi - aventis Deutschland GmbH|30|
053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|E|0|SDE|0|0|0|100|NOK|28100|38035|lyfalmen|||00|100|0|Vistor hf|Sanofi - aventis Deutschland GmbH|100|
053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|E|0|SDE|0|0|0|100|NOK|4366|7281|lyfalmen|||00|3|0|Vistor hf|Sanofi - aventis Deutschland GmbH|20|
053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|99810|126131|lyfsjukr|||43|120|0|Vistor hf|Janssen-Cilag International N.V.||
053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|515|1133|lyfalmen|V0902|1133|00|20|0|Actavis Group PTC ehf|Merck NM AB|20|
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|12954|19178|lyfalmen|||00|10|0|Icepharma hf|Martindale Pharmaceuticals|50|
053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|911|1956|lyfalmen|||20|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
054130|J01CA0405|Flemoxin|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1082|2312|lyfalmen|||08|100|0|Vistor hf|Astellas Pharma A/S|5|
054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|630|1372|lyfalmen|||28|20|0|Vistor hf|Astellas Pharma A/S|2|
054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2062|3867|lyfalmen|||02|0,5|0|Icepharma hf|Aventis Pasteur MSD A/S||
054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|30|DKK|56879|72682|lyfsjukr|||00|56|0|Icepharma hf|Roche Registration Limited|22,4|
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCB|0|0|1|100|SEK|1095|2339|lyfalmen|||00|200|0|Vistor hf|U.C.B|5,3333|
054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|10143|19492|vetalmen|||27|500|0|Vistor hf|Boehringer Ingelheim Danmark||
054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PFA|1|0|0|100|DKK|6133|10613|vetorma|||16|20|0|Icepharma hf|Pfizer Animal Health||
055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|616|1343|lyfalmen|||10|20|0|Vistor hf|Recip AB|5|
055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9279|14092|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
055434|P03AC0401|Nix|krem|50|mg/g|30|g|1|túpa||P03AC04|01.01.1996||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|1133|2418|lyfalmen|||00|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1004|2150|lyfalmen|||10|40|0|Vistor hf|Recip AB|10|
056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|20815|27782|lyfsjukr|||00|81|0|xxxxx|Paranova A/S||
056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|2|0|1|0|1|EPI|0|0|0|100|XEU|236452|296250|lyfsjukr|||00|15|0|Meda AB|Elan Pharma International|30|
056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|52961|67804|lyfsjukr|||00|30|0|PortFarma ehf|PortFarma |30|
057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|14823|20322|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|1,43|
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|5|0|1|0|1|NOH|0|0|0|100|DKK|7877|11278|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|0,71|
057422|B05XA3102|Tracel|irþ|| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5129|7343|lyfsjukr|||00|200|0|Icepharma hf|Fresenius Kabi|0,2|
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|5|0|1|0|1|NOH|0|0|0|100|DKK|4240|6071|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|0,36|
057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|19744|26449|lyfsjukr|||00|5|0|Icepharma hf|Roche|5|
057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|4261|7128|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|56|
057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|15161|21926|lyfalmen|||00|98|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|196|
057978|N07BA0301|Champix|filmhtfl|| |25|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|4010|6762|lyfalmen|||00|25|0|Vistor hf|Pfizer Limited|9,75|
057987|N07BA0301|Champix|filmhtfl|1|mg|28|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|4567|7574|lyfalmen|||00|28|0|Vistor hf|Pfizer Limited|14|
057996|N07BA0301|Champix|filmhtfl|1|mg|56|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|9285|14100|lyfalmen|||00|56|0|Vistor hf|Pfizer Limited|28|
058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|340|769|lyfalmen|||02|5|0|Vistor hf|Boehringer Ingelheim|1,6667|
058397|J07BM0101|Gardasil|stl|| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|16052|23035|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|763|1649|lyfalmen|||00|100|0|Vistor hf|Recip AB|2,5|
058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|90240|114216|lyfsjukr|||00|210|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |21|
058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1239|2616|lyfalmen|||43|100|0|Vistor hf|Sanofi-aventis Norge AS|75|
058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1954|3702|lyfalmen|||43|100|0|Vistor hf|Sanofi-aventis Norge AS|150|
058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3586|6145|lyfalmen|||51|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|1137|2426|lyfalmen|||00|250|0|Vistor hf|Recip AB|20,83|
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|82741|106063|lyfalmen|||02|2|0|Vistor hf|Astellas Pharma A/S||
059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|27382|37141|lyfalmen|||51|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|91161|115363|lyfsjukr|||00|30|0|PortFarma ehf|PortFarma ||
059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|5762|8250|lyfsjukr|||00|28|0|Vistor hf|Schering-Plough|7|
059824|C07AB0310|Atenolol Merck NM|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|680|1476|lyfalmen|V0290|1233|00|98|0|Actavis Group PTC ehf|Merck NM AB|32,6667|
059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|13079|18151|lyfsjukr|||00|28|0|Vistor hf|Schering-Plough|28|
060087|L04AC0101|Zenapax|irþ|5|mg/ml|5|ml|3|hgl||L04AC01|01.04.2005||R|K|3|0|0|0|1|RRL|0|0|0|100|DKK|135920|171088|lyfsjukr|||00|15|0|Icepharma hf|Roche Registration Limited|0,21|
060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|311598|390990|lyfalmen|||00|84|0|Vistor hf|Novartis Europharm Ltd||
060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|157803|199515|lyfalmen|||00|84|0|Vistor hf|Novartis Europharm Ltd||
060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|78902|101283|lyfalmen|||00|84|0|Vistor hf|Novartis Europharm Ltd||
060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|6065|9690|lyfalmen|||10|100|0|Vistor hf|Novartis Healthcare A/S-|75|
060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|1199|2555|lyfalmen|||22|120|0|Actavis Group hf|Actavis Group hf|24|
060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|1199|2555|lyfalmen|||22|120|0|Actavis Group hf|Actavis Group hf|12|
061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.08.2006||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|5957|9539|lyfalmen|V1030|9539|00|84|0|D.A.C. ehf|D.A.C. ehf|84|
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|DKK|||lyfalmen|||23|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|6079|9709|lyfalmen|V1030|9539|00|84|0|Icepharma hf|N.V. Organon|84|
061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PFI|0|0|0|100|DKK|843|1459|vetorma|||16|26|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|USD|121728|153419|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe||
061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|5251|7518|lyfsjukr|||00|10|0|Vistor hf|Novartis Healthcare A/S-|2|
061961|J01XX0901|Cubicin|irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|13796|19044|lyfsjukr|||00|1|0|Vistor hf|Novartis Europharm Ltd|1,25|
061970|J01XX0901|Cubicin|irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|19527|26179|lyfsjukr|||00|1|0|Vistor hf|Novartis Europharm Ltd|1,79|
062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|403|900|lyfalmen|||10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15|
062343|A10BD0401|Avaglim|filmhtfl|| |28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|4162|6984|lyfalmen|||00|28|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
062379|A10BD0401|Avaglim|filmhtfl|| |28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|6228|9917|lyfalmen|||00|28|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
062407|G03AA1202|Yasmin (D.A.C.)|töflur|| |63|stk|1|þpakki|3+0,03 mg|G03AA12|01.08.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|2281|4199|lyfalmen|V1040|4199|00|63|0|D.A.C. ehf|D.A.C. ehf|84|
062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|5191|7432|lyfsjukr|||02|20|0|Icepharma hf|Wyeth AB||
062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|588|842|lyfsjukr|||02|1|0|Icepharma hf|Wyeth AB||
062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|848|1825|lyfalmen|||10|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|1630|3210|lyfalmen|||00|100|0|Actavis Group hf|Actavis Group hf|100|
062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|14339|24814|vetorma|||16|1000|0|Vistor hf|Bayer HealthCare AG||
062987|J07BM0201|Cervarix|stl|| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|13778|20204|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA||
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|30|DKK|4089|6878|lyfalmen|||00|10|0|Vistor hf|Novartis Healthcare A/S-|1,6667|
063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1652|3244|lyfalmen|||23|14|0|Vistor hf|Astellas Pharma A/S|10,5|
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2943|5205|lyfalmen|V0343|5205|00|28|0|Actavis Group hf|Actavis hf|28|
063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1649|3239|lyfalmen|V1901|3239|00|30|0|D.A.C. ehf|D.A.C. ehf|30|
063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|3868|6556|lyfalmen|V1902|6556|00|100|0|D.A.C. ehf|D.A.C. ehf|100|
063724|A10BG0202|Avandia (D.A.C.)|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.11.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|GBP|6433|10203|lyfalmen|V0005|10203|00|56|0|D.A.C. ehf|D.A.C. ehf|37,3333|
063818|J06BB0102|Rhesonativ |stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|8745|12521|lyfsjukr|||17|2|0|Vistor hf|Octapharma AB||
063923|QP54AB5207|Equest Pramox vet|hlaup|| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2021|3497|vetorma|||16|11,8|0|Vistor hf|Fort Dodge Veterinär GmbH||
063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|848|1825|lyfalmen|||10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1726|3356|lyfalmen|||10|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1866|3569|lyfalmen|||10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
064733|J07BB0203|Vaxigrip|bóluefni|| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|696|1509|lyfalmen|||51|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
065032|D10AF5101|Duac|hlaup|| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|1935|3674|lyfalmen|||38|25|0|Vistor hf|Stiefel Laboratories (UK) Ltd.||
065060|J07BD5202|MMR II|bóluefni|| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|10420|15612|lyfalmen|||51|5|0|Icepharma hf|Aventis Pasteur MSD A/S||
065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||25|6|0|Vistor hf|Bayer A/S|6|
065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||25|1|0|Vistor hf|Bayer A/S|5|
065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2172|4034|lyfalmen|||06|2,5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|1701|3318|lyfalmen|V0195|2125|00|28|0|Icepharma hf|M.S.D.|7|
066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|5736|9231|lyfalmen|||00|60|0|Vistor hf|Boehringer Ingelheim International |8,3|
066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|26387|34719|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi|10|
066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|16684|31952|vetalmen|||16|10|0|Icepharma hf|Ceva Sante Animale||
066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|471|1042|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|10|
066621|N06AA0405|Klomipramin Merck NM|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|703|1524|lyfalmen|V0908|1370|00|100|0|Actavis Group PTC ehf|Merck NM AB|25|
066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1967|3722|lyfalmen|V0144|3722|70|30|0|D.A.C. ehf|D.A.C. ehf|15|
067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|513|1129|lyfalmen|||23|20|0|Vistor hf|Astellas Pharma A/S|2,5|
067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|5658|9122|lyfalmen|||00|84|0|Medico ehf|Solvay Duphar |56|
067579|N05BB0101|Atarax|töflur|25|mg|25|stk|1|þpakki||N05BB01|01.04.1995||R|A|5|0|0|0|0|UCB|0|0|1|100|SEK|314|715|lyfalmen|||00|25|0|Vistor hf|U.C.B|8,3333|
067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCB|0|0|0|100|SEK|1095|2339|lyfalmen|||00|100|0|Vistor hf|U.C.B|33,3333|
067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|602|1314|lyfalmen|V0901|1314|00|50|0|D.A.C. ehf|D.A.C. ehf|50|
067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1891|3607|lyfalmen|V0551|3607|10|7|0|Actavis Group hf|Actavis hf|1,75|
068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|4865|9438|vetalmen|||27|50|0|Icepharma hf|Vétoquinol AG||
068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|DKK|1645|3233|lyfalmen|||00|20|0|Vistor hf|Meda AB (V)|10|
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|DKK|4851|7988|lyfalmen|||00|100|0|Vistor hf|Meda AB (V)|50|
069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|DKK|||lyfalmen|||00|15|0|Artasan ehf|Novartis Healthcare A/S-A|15|
069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|4967|8156|lyfalmen|||00|14|0|Vistor hf|Novartis Healthcare A/S-|14|
069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|31992|42880|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|98|
070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|21795|29002|lyfsjukr|||00|10|0|Icepharma hf|Wyeth AB||
070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5635|8068|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi||
070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|4008|5738|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi||
070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7039|10078|lyfsjukr|||00|7500|0|Icepharma hf|Fresenius Kabi||
070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4480|6414|lyfsjukr|||00|10000|0|Icepharma hf|Fresenius Kabi||
070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|4406|8564|vetalmen|||27|100|0|Vistor hf|Pharmaxim Sweden AB||
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|13888|20341|lyfalmen|||00|100|0|Vistor hf|Janssen-Cilag AB|20|
071076|QA12CE9902|Selevitan, vet.|kyrni|| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|4666|9059|vetalmen|||16|1250|0|Vistor hf|Pharmaxim Sweden AB||
071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|49265|63202|lyfsjukr|||00|1|0|Vistor hf|Eisai Ltd|8,33|
071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|246328|308546|lyfsjukr|||00|5|0|Vistor hf|Eisai Ltd|41,65|
071670|J01CF0101|Diclocil|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.07.1991||R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|1431|2908|lyfalmen|V0452|1630|10|30|0|Vistor hf|Bristol-Myers Squibb|3,75|
071712|J01CF0101|Diclocil|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.07.1991||R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|1751|3394|lyfalmen|V0460|2299|10|30|0|Vistor hf|Bristol-Myers Squibb|7,5|
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|6197|11976|vetalmen|||27|5|0|Vistor hf|Orion-Farmos||
072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|11013|15579|lyfsjukr|||00|15|0|Icepharma hf|Roche as|5|
072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|15211|21988|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|495|709|lyfsjukr|||02|10|0|Vistor hf|Janssen-Cilag AB||
072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|158336|198996|lyfsjukr|||00|1,6|0|Vistor hf|Abbott|27,59|
072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1516|2171|lyfsjukr|||02|5|0|Vistor hf|Janssen-Cilag AB||
072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|IKR|11584|17162|lyfalmen|||00|1,2|0|A. Karlsson hf |Eli Lilly Nederland|20|
072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|IKR|11584|17162|lyfalmen|||00|2,4|0|A. Karlsson hf |Eli Lilly Nederland|40|
073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|3|0|0|*|0|LUN|0|1|0|100|DKK|1039|2222|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|8,3333|
073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|2570|4638|lyfalmen|||10|100|0|Medico ehf|Solvay Pharmaceuticals GmbH|100|
073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|3|0|0|*|0|LUN|0|1|0|100|DKK|1302|2712|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|16,6667|
073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|243|567|lyfalmen|V0844|306|00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5|
073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|654|1422|lyfalmen|V0848|574|00|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|12,5|
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|947|2031|lyfalmen|V0852|1021|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|410|915|lyfalmen|V0856|476|00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10|
073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|712|1543|lyfalmen|V0860|977|00|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1414|2882|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50|
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|2856|5073|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd||
074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|8317|12810|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd||
074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|3644|6229|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd||
074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|12039|18039|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd||
074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|3644|6229|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd||
074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|12039|18039|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd||
074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|5073|8306|lyfalmen|||00|28|0|Vistor hf|Abbott Laboratories A/S|28|
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|183|443|lyfalmen|||00|25|0|Actavis Group hf|Actavis Group hf|12,5|
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|370|832|lyfalmen|||00|50|0|Actavis Group hf|Actavis Group hf|25|
074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|16469|28500|vetorma|||58|25|0|Vistor hf|Scan Vet Animal Health AS||
074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|5073|8306|lyfalmen|||00|28|0|Vistor hf|Abbott Laboratories A/S|42|
074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1176|2507|lyfalmen|V1910|2054|00|30|0|Vistor hf|Sanofi-aventis Norge AS|30|
075028|C09AA0901|Monopril|töflur|10|mg|98|stk|1|þpakki||C09AA09|01.04.1995||R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|6883|10830|lyfalmen|||00|98|0|Vistor hf|Bristol-Myers Squibb|65,3333|
075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1257|2644|lyfalmen|||69|10|0|Vistor hf|Janssen-Cilag AB|10|
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1665|3264|lyfalmen|V1912|2975|00|30|0|Vistor hf|Sanofi-aventis Norge AS|45|
075101|C09AA0901|Monopril|töflur|20|mg|98|stk|1|þpakki||C09AA09|01.04.1995||R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|10494|15710|lyfalmen|||00|98|0|Vistor hf|Bristol-Myers Squibb|130,6667|
075382|V01AA0503|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075408|V01AA0504|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075424|V01AA0501|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075440|V01AA0502|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075465|V04CL0006|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075481|V04CL0004|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075507|V04CL0005|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075523|V04CL0002|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075549|V04CL0008|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075564|V04CL0003|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075580|V04CL0007|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075606|V04CL0001|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075663|V01AA0302|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075689|V01AA1103|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075705|V01AA1102|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075721|V01AA1101|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
075724|B02BD0402|BeneFIX|sts|| |1000|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|90202|114169|lyfsjukr|||00|1000|0|Icepharma hf|Wyeth Europe|2,86|
075787|QS02CA0102|Canaural|eyrnadr|| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|1302|2569|vetalmen|||13|25|0|Vistor hf|VetXX A/S||
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|21448|29753|lyfalmen|||00|98|0|Icepharma hf|M.S.D.||
076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|2038|3830|lyfalmen|||24|30|0|Vistor hf|Boehringer Ingelheim|33,25|
076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|5678|9826|vetorma|||27|100|0|Vistor hf|Merial (MSD)||
077533|S01LA0401|Lucentis|stl|10|mg/ml|0,3|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|1,5|0|1|0|1|NOE|0|0|0|100|DKK|138383|174154|lyfsjukr|||00|0,3|0|Vistor hf|Novartis Europharm Ltd||
077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|30|GBP|590|1289|lyfalmen|||02|10|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,8333|
077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|944|2025|lyfalmen|V0609|1085|10|30|0|D.A.C. ehf|D.A.C. ehf|15|
078121|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|ASZ|0|0|0|100|SEK|18742|25201|lyfsjukr|||00|1|0|Vistor hf|AstraZeneca UK Ltd||
078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|393|879|lyfalmen|||00|20|0|Vistor hf|Recip AB|2,5|
078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|599|1308|lyfalmen|||00|40|0|Vistor hf|Recip AB|5|
078766|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.10.1992||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|3764|5389|lyfsjukr|||00|5|0|Icepharma hf|Mayne Pharma Plc||
078774|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1992||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|3176|4547|lyfsjukr|||00|10|0|Icepharma hf|Mayne Pharma Plc||
078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|4647|6653|lyfsjukr|||00|5|0|Icepharma hf|Mayne Pharma Plc||
078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|13688|18909|lyfsjukr|||00|15|0|Icepharma hf|Mayne Pharma Plc||
078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|24584|32475|lyfsjukr|||00|45|0|Icepharma hf|Mayne Pharma Plc||
078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|119341|150447|lyfsjukr|||00|15|0|Icepharma hf|Schering AG|30|
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|7069|11090|lyfalmen|V0197|7507|00|98|0|Icepharma hf|M.S.D.|98|
079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|1779|2547|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB||
079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|3072|4398|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB||
079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|5520|7903|lyfsjukr|||00|1|0|Icepharma hf|Baxter Medical AB||
079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|2658|4772|lyfalmen|||00|10|0|Icepharma hf|Roche Registration Limited|4,67|
079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|6210|8891|lyfsjukr|||02|5|0|Icepharma hf|Mayne Pharma Plc||
079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|16517|23614|lyfalmen|||02|10|0|Vistor hf|Schering-Plough|154,5714|
079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|9719|13915|lyfsjukr|||02|10|0|Icepharma hf|Mayne Pharma Plc||
079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|1643|2352|lyfsjukr|||03|5|0|Vistor hf|Bristol-Myers Squibb|2,5|
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LUN|0|1|0|100|DKK|1782|3441|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|66,6667|
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|5143|8404|lyfalmen|||00|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|2773|4946|lyfalmen|||00|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|15|
080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|24171|41829|vetorma|||27|500|0|Vistor hf|Merial (MSD)||
080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|14584|20025|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|28750|37661|lyfsjukr|||00|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|23807|32690|lyfalmen|||02|12,5|0|Vistor hf|AstraZeneca A/S DK|34,7222|
081588|C10AA0302|Pravachol|töflur|40|mg|28|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|5655|9118|lyfalmen|||00|28|0|Vistor hf|Bristol-Myers Squibb|56|
081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1638|2345|lyfsjukr|||02|10|0|Icepharma hf|Roche|3,3333|
081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|4399|7329|lyfalmen|||02|15|0|Vistor hf|Sanofi - Aventis|37,5|
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|0|0|SDE|0|0|0|100|NOK|7677|11937|lyfalmen|||00|15|0|Vistor hf|Sanofi - aventis Deutschland GmbH|37,5|
082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|2637|4740|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
082701|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|519|1141|lyfalmen|||00|60|0|Actavis Group PTC ehf|Merck NM AB|3|
082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|4308|7197|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|50|
082792|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|812|1751|lyfalmen|||00|125|0|Actavis Group PTC ehf|Merck NM AB|6,25|
082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1298|2706|lyfalmen|||00|200|0|Actavis Group PTC ehf|Merck NM AB|10|
082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|SEK|4079|6863|lyfalmen|||00|100|0|Vistor hf|Draco Lakemedel AB|6,25|
082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|SEK|4482|7450|lyfalmen|||00|40|0|Vistor hf|Draco Lakemedel AB|12,5|
082990|N06DA0301|Exelon|hylki|1,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|23539|32356|lyfalmen|||00|112|0|Vistor hf|Novartis Healthcare A/S-|18,6667|
083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|14206|20737|lyfalmen|||00|28|0|Vistor hf|AstraZeneca UK Ltd|28|
083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|SEK|5699|9179|lyfalmen|||00|40|0|Vistor hf|Draco Lakemedel AB|25|
083204|N06DA0301|Exelon|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|22560|31137|lyfalmen|||00|112|0|Vistor hf|Novartis Healthcare A/S-|37,3333|
083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|39065|51686|lyfalmen|||03|10|0|Gróco ehf|Serono Nordic|10|
083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|79368|101863|lyfalmen|||03|10|0|Gróco ehf|Serono Nordic|20|
083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|60620|77339|lyfsjukr|||00|450|0|Vistor hf|Abbott Laboratories A/S|30|
083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|23539|32356|lyfalmen|||00|112|0|Vistor hf|Novartis Healthcare A/S-|74,6667|
083964|L02AE0101|Suprefact|nefúði|0,1|mg/sk|10|g|4|stk|+ sk-dæla|L02AE01|01.10.1987||R|A|2.5|0|1|0|1|SNO|0|0|0|100|NOK|33390|43438|lyfsjukr|||23|40|0|Vistor hf|Sanofi-aventis Norge AS|33,3333|
083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|6742|9653|lyfsjukr|||02|11|0|Vistor hf|Sanofi-aventis Norge AS|7,3333|
084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|212|503|lyfalmen|||02|10|0|Gróco ehf|Nycomed Danmark A/S|2,5|
084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|409|913|lyfalmen|||02|20|0|Gróco ehf|Nycomed Danmark A/S|5|
084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|50127|64276|lyfsjukr|||00|0,3|0|Icepharma hf|Roche Registration Limited||
084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|65366|83248|lyfsjukr|||00|0,3|0|Icepharma hf|Roche Registration Limited||
084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|77933|98894|lyfsjukr|||00|0,3|0|Icepharma hf|Roche Registration Limited||
084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|16812|22798|lyfsjukr|||00|0,3|0|Icepharma hf|Roche Registration Limited||
084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|25158|33189|lyfsjukr|||00|0,3|0|Icepharma hf|Roche Registration Limited||
084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|33465|43531|lyfsjukr|||00|0,3|0|Icepharma hf|Roche Registration Limited||
084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|835|1798|lyfalmen|||00|10|0|Vistor hf|Eisai Ltd||
084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|9654|14591|lyfalmen|||00|60|0|Vistor hf|Eisai Ltd||
084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|32185|43121|lyfalmen|||00|100|0|Vistor hf|Eisai Ltd||
085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|15389|22210|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100|
085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|2401|4381|lyfalmen|||00|15|0|Icepharma hf|Santen Oy||
085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|23539|32356|lyfalmen|||00|112|0|Vistor hf|Novartis Healthcare A/S-|56|
085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|649|1412|lyfalmen|||00|50|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5|
085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|10332|14731|lyfsjukr|||00|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|40|
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4087|6875|lyfalmen|V1911|5120|00|100|0|Vistor hf|Sanofi-aventis Norge AS|100|
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4991|8191|lyfalmen|V1913|7135|00|100|0|Vistor hf|Sanofi-aventis Norge AS|150|
086199|J01DD0202|Fortum|sts|500|mg/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|4234|6062|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,63|
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8325|11919|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25|
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|11865|16639|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2,5|
086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|50097|64238|lyfsjukr|||00|1|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |9,26|
087014|J05AF1101|Sebivo|filmhtfl|600|mg|28|stk|1|þpakki||J05AF11|01.07.2008||R|A|2|0|1|0|1|NOH|0|0|0|100|DKK|58460|74650|lyfsjukr|||00|28|0|Vistor hf|Novartis Healthcare A/S-||
087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|2551|4609|lyfalmen|||00|28|0|Icepharma hf|N.V. Organon|28|
087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|126827|159767|lyfsjukr|||00|60|0|Vistor hf|Pfizer Limited||
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|220|520|lyfalmen|||00|10|0|Vistor hf|Sanofi-aventis Norge AS|10|
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|195|468|lyfalmen|V0886|468|00|30|0|Vistor hf|Sanofi-aventis Norge AS|30|
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2285|4205|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|100|
087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|SER|0|0|0|100|SEK|649|1412|lyfalmen|||00|5|0|Gróco ehf|Serono|27,7778|
087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|12878|19083|lyfalmen|V0560|19083|00|30|0|Actavis Group hf|Actavis Group PTC ehf|30|
087932|A02BX1301|Gaviscon|tuggutfl|| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|30|DKK|||lyflausa|||00|20|0|Vistor hf|Nordic Drugs AB||
088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|21323|28415|lyfsjukr|||00|1,2|0|Lyfjaver ehf|Lyfjaver ehf|9|
088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|34731|45108|lyfsjukr|||00|1,2|0|Lyfjaver ehf|Lyfjaver ehf|15|
088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|71091|90376|lyfsjukr|||00|1,2|0|Lyfjaver ehf|Lyfjaver ehf|30|
088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1130|2412|lyfalmen|||00|120|0|GlaxoSmithKline ehf|Glaxo Group Limited||
088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1365|2808|lyfalmen|||14|20|0|Icepharma hf|Meda AB|20|
088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|6766|10667|lyfalmen|||14|100|0|Icepharma hf|Meda AB|100|
088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|401|896|lyfalmen|||04|6|0|Vistor hf|Sanofi-aventis Norge AS|4|
088623|C09CA0302|Diovan (D.A.C.)|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|8151|12589|lyfalmen|V1110|10349|00|98|0|D.A.C. ehf|D.A.C. ehf|98|
088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|11799|17449|lyfalmen|V1111|14335|00|98|0|D.A.C. ehf|D.A.C. ehf|196|
089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1084|2316|lyfalmen|V0408|1520|00|84|0|Icepharma hf|Bayer Schering Pharma AG|84|
089094|A02BX1301|Gaviscon|tuggutfl|| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|30|DKK|||lyflausa|||00|120|0|Vistor hf|Nordic Drugs AB||
089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|126827|159767|lyfsjukr|||00|60|0|Vistor hf|Pfizer Limited||
090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|1637|3221|lyfalmen|V0352|1530|00|100|0|Vistor hf|Ferrosan A/S|25|
090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|2|0|1|0|1|MRK|0|0|0|100|XEU|32115|41851|lyfsjukr|||00|20|0|Vistor hf|Merck KgaA (V)||
090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|2|0|1|0|1|MRK|0|0|0|100|XEU|160572|201780|lyfsjukr|||00|100|0|Vistor hf|Merck KgaA (V)||
090451|L04AB0102|Enbrel (Lyjaver)|sts|| |50|mg|4|hgl|+ leysir|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|144790|182131|lyfsjukr|||00|200|0|Lyfjaver ehf|Lyfjaver ehf|28,58|
090460|L04AB0102|Enbrel (Lyjaver)|stl|| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|69438|88318|lyfsjukr|||00|100|0|Lyfjaver ehf|Lyfjaver ehf|14,29|
090469|L04AB0102|Enbrel (Lyjaver)|stl|| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|144790|182131|lyfsjukr|||00|200|0|Lyfjaver ehf|Lyfjaver ehf|28,58|
090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1521|3045|lyfalmen|||24|16,5|0|Vistor hf|Sanofi-aventis Norge AS|30|
090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|339|767|lyfalmen|||00|60|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.||
091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|114075|143891|lyfsjukr|||00|28|0|Lyfjaver ehf|Lyfjaver ehf||
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1488|2995|lyfalmen|V0001|1879|00|90|0|Vistor hf|Aventis Pharma |45|
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2677|4801|lyfalmen|V0002|2832|00|90|0|Vistor hf|Aventis Pharma |90|
092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|114091|143911|lyfsjukr|||00|6|0|Lyfjaver ehf|Lyfjaver ehf|61,3953|
092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|146916|184778|lyfsjukr|||00|6|0|Lyfjaver ehf|Lyfjaver ehf|122,7907|
092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PFV|0|0|0|100|DKK|5737|11099|vetalmen|||16|100|0|Icepharma hf|Pfizer vet.||
092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7114|11152|lyfalmen|||00|28|0|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|28|
092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|8081|12496|lyfalmen|V1400|12061|00|100|0|D.A.C. ehf|D.A.C. ehf|33,3333|
093215|L01XC0602|Erbitux (Lyfjaver)|irl|2|mg/ml|50|ml|1|hgl|lausn|L01XC06|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|31637|41256|lyfsjukr|||00|50|0|Lyfjaver ehf|Lyfjaver ehf||
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|4476|7441|lyfalmen|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2|
093496|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|5581|9015|lyfalmen|||00|60|0|Icepharma hf|Schering Oy|32|
093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PFA|1|0|0|100|DKK|20751|35911|vetorma|||00|100|0|Icepharma hf|Pfizer Animal Health||
093641|QN05CM9202|Xylapan, vet.|stl|20|mg/ml|50|ml|1|hgl||QN05CM92|01.04.1992||R|A|3|0|0|0|0|VEQ|1|0|0|100|CHF|3421|6688|vetalmen|||00|50|0|Icepharma hf|Vétoquinol AG||
093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|10989|15549|lyfsjukr|||00|5|0|Icepharma hf|Wyeth AB||
093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|13899|20355|lyfalmen|||10|28|0|Icepharma hf|Norpharma |29,87|
093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|45825|60102|lyfalmen|||10|98|0|Icepharma hf|Norpharma |261,33|
093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|1371|2817|lyfalmen|||10|100|0|Icepharma hf|Goldshield Pharmaceuticals Ltd|33,3333|
093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2742|4899|lyfalmen|||10|100|0|Icepharma hf|Goldshield Pharmaceuticals Ltd|66,6667|
093969|G03FB0507|Trisekvens (D.A.C.)|töflur|| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2056|3857|lyfalmen|V0385|3857|23|84|0|D.A.C. ehf|D.A.C. ehf|84|
094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|10218|15342|lyfalmen|||00|50|0|Vistor hf|Astellas Phama Europe B.V.|5|
094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|14636|21272|lyfalmen|||00|50|0|Vistor hf|Astellas Phama Europe B.V.|10|
094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|65859|85045|lyfalmen|||00|50|0|Vistor hf|Astellas Phama Europe B.V.|10|
095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|2594|4675|lyfalmen|||00|50|0|Actavis Group hf|Actavis Group hf|100|
095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|15892|22836|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag International N.V.||
095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|31787|42625|lyfalmen|||00|56|0|Vistor hf|Janssen-Cilag International N.V.||
095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|15892|22836|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag International N.V.||
095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|28804|38911|lyfalmen|||00|56|0|Vistor hf|Janssen-Cilag International N.V.||
095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|25358|34621|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag International N.V.||
095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|50715|66190|lyfalmen|||00|56|0|Vistor hf|Janssen-Cilag International N.V.||
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHP|0|0|0|100|XEU|2859|5617|vetalmen|||00|100|0|Icepharma hf|Chanelle Pharmaceuticals ||
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHP|0|0|0|100|XEU|3773|7358|vetalmen|||00|100|0|Icepharma hf|Chanelle Pharmaceuticals ||
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHP|0|0|0|100|XEU|6870|13258|vetalmen|||00|100|0|Icepharma hf|Chanelle Pharmaceuticals ||
096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2048|2932|lyfsjukr|||02|60|0|Icepharma hf|Baxter Medical AB||
096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1198|2553|lyfalmen|||00|5|0|GlaxoSmithKline ehf|Glaxo Group Limited||
096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|12610|18750|lyfalmen|||00|30|0|Vistor hf|Novartis Europharm Ltd||
096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|619|1349|lyfalmen|V1500|1349|07|5|0|D.A.C. ehf|D.A.C. ehf||
096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|12610|18750|lyfalmen|||00|30|0|Vistor hf|Novartis Europharm Ltd||
096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1206|2566|lyfalmen|||00|30|0|Icepharma hf|Servier|18|
096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|25221|34450|lyfalmen|||00|60|0|Vistor hf|Novartis Europharm Ltd||
096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|69544|88450|lyfsjukr|||00|1|0|Vistor hf|Pfizer Limited||
097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|2692|4823|lyfalmen|V0426|4823|00|20|0|D.A.C. ehf|D.A.C. ehf|5|
097297|L02BG0402|Femar (D.A.C.)|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.06.2007||R|A|5|0|0|*|0|DAC|0|0|0|100|DKK|48410|63321|lyfalmen|V0563|63321|00|100|0|D.A.C. ehf|D.A.C. ehf|100|
097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13690|18912|lyfsjukr|||00|20|1|Distica|Distica - óskráð lyf||
097642|J07AJ5201|Infanrix|bóluefni|| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1489|2996|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6839|10769|lyfalmen|V0714|8260|10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|16,6667|
097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8958|13664|lyfalmen|V0715|10827|10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|22,2222|
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3476|5985|lyfalmen|V0003|3534|00|90|0|Vistor hf|Aventis Pharma |135|
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1284|2685|lyfalmen|V1151|2685|00|30|0|Actavis Group hf|Actavis Group PTC ehf|15|
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|6538|10349|lyfalmen|V1110|10349|00|98|0|Actavis Group hf|Actavis hf|98|
098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|9462|14335|lyfalmen|V1111|14335|00|98|0|Actavis Group hf|Actavis hf|196|
098228|J07AJ5201|Infanrix|bóluefni|| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|14487|21087|lyfalmen|||02|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
098722|J07BM0101|Gardasil|stl|| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15884|22826|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|634|1380|lyfalmen|V1500|1349|07|5|0|Vistor hf|LEO Pharma A/S||
099476|N05AH0404|Quetiapin Merck NM|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|5223|8516|lyfalmen|V0725|8256|00|100|0|Actavis Group PTC ehf|Merck NM AB (A)|6,25|
099485|N05AH0404|Quetiapin Merck NM|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|11662|17266|lyfalmen|V0726|16715|00|100|0|Actavis Group PTC ehf|Merck NM AB (A)|25|
099494|N05AH0404|Quetiapin Merck NM|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|18461|26034|lyfalmen|V0727|25217|00|100|0|Actavis Group PTC ehf|Merck NM AB (A)|50|
099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|447|992|lyfalmen|V0730|671|10|20|0|D.A.C. ehf|D.A.C. ehf|3,3333|
099861|H01AC0104|Saizen|sts|| |3,33|mg|10|hgl|+ leysir|H01AC01|01.07.1992||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|109515|138214|lyfsjukr|||02|33,3|0|Gróco ehf|Serono Nordic|50|
100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|38207|49435|lyfsjukr|||02|500|0|Icepharma hf|Bayer Schering Pharma AG||
100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|56558|72282|lyfsjukr|||02|1000|0|Icepharma hf|Bayer Schering Pharma AG||
100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|41371|53374|lyfsjukr|||02|500|0|Icepharma hf|Bayer Schering Pharma AG||
100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|91857|116229|lyfsjukr|||02|1000|0|Icepharma hf|Bayer Schering Pharma AG||
100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|11047|16447|lyfalmen|||00|1|0|Gróco ehf|Ares-Serono|1|
100412|M01AC0101|Felden|töflur|20|mg|30|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|1599|3163|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
101386|R06AX1301|Clarityn|mixtúra|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|3|0|0|E|0|SCP|0|0|1|100|DKK|638|1389|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|10|
101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|33141|44311|lyfalmen|||00|3|0|Gróco ehf|Ares-Serono|3|
101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|110472|140588|lyfalmen|||00|10|0|Gróco ehf|Ares-Serono|10|
101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|1649|3239|lyfalmen|||00|28|0|Vistor hf|Bayer HealthCare AG|18,6667|
101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|5174|8447|lyfalmen|||00|98|0|Vistor hf|Bayer HealthCare AG|65,3333|
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2085|3901|lyfalmen|V1152|3901|00|30|0|Actavis Group hf|Actavis Group PTC ehf|30|
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|7418|11576|lyfalmen|V1153|11576|00|96|0|Actavis Group hf|Actavis Group PTC ehf|96|
101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|6897|10850|lyfalmen|V0736|9416|00|100|0|D.A.C. ehf|D.A.C. ehf|50|
102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1201|2559|lyfalmen|||43|28|0|Vistor hf|AstraZeneca A/S DK|42|
102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2461|4473|lyfalmen|V0139|3028|43|98|0|Vistor hf|AstraZeneca A/S DK|147|
102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|1919|2748|lyfsjukr|||02|50|0|Vistor hf|AstraZeneca UK Ltd||
102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|3876|5549|lyfsjukr|||00|50|0|Vistor hf|AstraZeneca UK Ltd||
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|5936|9510|lyfalmen|V0198|9510|00|98|0|PortFarma ehf|PortFarma |98|
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|9826|14820|lyfalmen|V0193|14820|00|98|0|PortFarma ehf|PortFarma |196|
103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|30|GBP|2092|3912|lyfalmen|V0507|3912|00|10|0|PortFarma ehf|PortFarma |1,6667|
103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|30|GBP|8698|13318|lyfalmen|V0508|13236|00|40|0|PortFarma ehf|PortFarma |6,67|
103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|9596|14514|lyfalmen|V0955|14514|00|100|0|PortFarma ehf|PortFarma |75|
103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|18263|25788|lyfalmen|V0956|25788|00|100|0|PortFarma ehf|PortFarma |150|
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|532|1168|lyfalmen|||56|25|0|Vistor hf|Orion Pharma|5|
103952|A06AG0201|Toilax|innhl/tf|| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||00|1|0|Vistor hf|Orion Pharma|1|
104179|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|10183|15296|lyfalmen|V0933|7580|00|98|0|D.A.C. ehf|D.A.C. ehf|98|
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|2909|5153|lyfalmen|||23|2,5|0|Vistor hf|Ferring Lægemidler A/S|10|
104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2008|3785|lyfalmen|||00|21|0|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|0|
104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|8787|13436|lyfalmen|||04|28|0|Vistor hf|Ferring|18,6667|
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|4259|7125|lyfalmen|||56|700|0|Vistor hf|Ferring|4,6667|
104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5217|8507|lyfalmen|||10|100|0|Vistor hf|Ferring|33,3333|
105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|3308|5740|lyfalmen|V0084|5740|00|28|0|D.A.C. ehf|D.A.C. ehf|18,67|
105287|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|6522|10327|lyfalmen|V0086|10327|00|56|0|D.A.C. ehf|D.A.C. ehf|37,33|
105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|11525|17084|lyfalmen|V0087|17084|00|100|0|D.A.C. ehf|D.A.C. ehf|66,67|
105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|15559|22421|lyfalmen|V0089|22421|00|100|0|D.A.C. ehf|D.A.C. ehf|133,33|
105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|16692|23832|lyfalmen|||00|100|0|Icepharma hf|Cephalon France|33,3333|
105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|13771|20195|lyfalmen|||00|50|0|Icepharma hf|Cephalon France|25|
105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|25040|34225|lyfalmen|||00|100|0|Icepharma hf|Cephalon France|50|
105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|6886|10834|lyfalmen|||00|50|0|Icepharma hf|Cephalon France|8,3333|
105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|12519|18636|lyfalmen|||00|100|0|Icepharma hf|Cephalon France|16,6667|
105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|9181|13961|lyfalmen|||00|50|0|Icepharma hf|Cephalon France|16,6667|
105586|C09XA02|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|3644|6229|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd||
105597|C09XA02|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|11304|16789|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd||
105608|C09XA02|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|3644|6229|lyfalmen|||00|28|0|Vistor hf|Novartis Europharm Ltd||
105620|C09XA02|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|12039|18039|lyfalmen|||00|98|0|Vistor hf|Novartis Europharm Ltd||
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1941|3683|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK||
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2114|3946|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK||
105939|M05BA0703|Optinate Septimum (D.A.C.)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.10.2007||R|A|3|0|0|E|0|DAC|0|0|0|100|NOK|11162|16600|lyfalmen|V1080|16600|00|12|0|D.A.C. ehf|D.A.C. ehf|84|
106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|2612|4702|lyfalmen|||63|14|0|Vistor hf|Abbott Scandinavia AB|7|
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|30|GBP|15378|21013|lyfsjukr|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,625|
106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|30|GBP|8504|12176|lyfsjukr|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,3125|
106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|14760|21426|lyfalmen|||10|30|0|Icepharma hf|Leiras Oy|15|
107050|A10BD0401|Avaglim|filmhtfl|| |84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|12332|18404|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
107061|A10BD0401|Avaglim|filmhtfl|| |84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|18566|26165|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1522|3046|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|14760|21426|lyfalmen|||10|30|0|Icepharma hf|Leiras Oy|15|
107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||R|A|2|0|0|0|0|ICV|0|0|0|100|XEU|1209|2092|vetorma|||16|6,42|0|Icepharma hf|Icevet ehf||
108029|R03AK0604|Seretide Diskus (D.A.C.)|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.09.2007||R|A|1,5|0|0|B|0|DAC|0|0|0|100|DKK|7234|11320|lyfalmen|V0993|10253|23|60|0|D.A.C. ehf|D.A.C. ehf|30|
108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2533|4582|lyfalmen|||63|100|0|Vistor hf|Bayer HealthCare AG|33,3333|
108803|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|12|hgl|20mg/ml+36mcg/ml|QN01BB52|01.12.2003||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|967|1908|vetalmen|||27|1200|0|Icepharma hf|Kela Laboratoria NV||
108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|864|1859|lyfalmen|||24|120|0|Vistor hf|AstraZeneca A/S DK|19,2|
108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1244|2624|lyfalmen|V0965|2586|24|120|0|Vistor hf|AstraZeneca A/S DK|38,4|
109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|185|447|lyfalmen|V0775|293|00|20|0|Vistor hf|Sanofi-aventis Norge AS|6,6667|
109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|707|1532|lyfalmen|V0780|946|00|100|0|Vistor hf|Sanofi-aventis Norge AS|33,3333|
109421|V01AA0303|Alutard SQ, derm.farinae|stl|| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|18999|26704|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S||
109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|15211|21988|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
109462|V01AA0301|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|5905|9466|lyfalmen|||02|3|0|Vistor hf|ALK-Abello A/S||
110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|501|1104|lyfalmen|||06|5|0|Icepharma hf|Santen Oy|25|
110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|559|1224|lyfalmen|||06|5|0|Icepharma hf|Santen Oy|25|
110395|G03AA0902|Mercilon|töflur|| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1205|2565|lyfalmen|||23|63|0|Icepharma hf|N.V. Organon|84|
110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|3530|6063|lyfalmen|||10|100|0|Vistor hf|Orion Corporation|83,3333|
111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|587|1283|lyfalmen|||00|100|0|Icepharma hf|GlaxoSmithKline CH A/S|33,33|
112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|631|1374|lyfalmen|||06|5|0|Vistor hf|Schering-Plough||
112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1002|2146|lyfalmen|||68|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|2817|5013|lyfalmen|||23|30|0|Vistor hf|Meda AB (V)|90|
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2865|5086|lyfalmen|||00|2|0|Vistor hf|Sanofi-aventis Norge AS|10|
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4603|7626|lyfalmen|||00|4|0|Vistor hf|Sanofi-aventis Norge AS|20|
113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|30352|39656|lyfsjukr|||00|20|0|Lyfjaver ehf|Lyfjaver ehf||
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|576282|719339|lyfsjukr|||00|112|0|Vistor hf|Novartis Europharm Ltd||
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|529|1162|lyfalmen|||00|20|0|Vistor hf|Recip AB|10|
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|772|1667|lyfalmen|||00|30|0|Vistor hf|Recip AB|15|
113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1025|2193|lyfalmen|||00|40|0|Vistor hf|Recip AB|20|
114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|652|1418|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|15|
114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2153|4005|lyfalmen|V0989|3941|06|5|0|Icepharma hf|M.S.D.||
115285|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1491|2999|lyfalmen|||00|20|0|Actavis Group PTC ehf|Merck NM AB|15|
115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|1504|3019|lyfalmen|V1090|2973|06|5|0|Icepharma hf|M.S.D.|16,6667|
115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|952|2042|lyfalmen|||00|100|0|Icepharma hf|M.S.D.|33,3333|
115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3009|5304|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3229|4623|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2,5|
116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1688|2417|lyfsjukr|||03|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25|
116137|D07AC1301|Elocon|krem|1|mg/g|20|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|697|1511|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20|
116160|D07AC1301|Elocon|krem|1|mg/g|50|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1542|3077|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50|
116368|D07AC1301|Elocon|smyrsli|1|mg/g|20|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|697|1511|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20|
116400|D07AC1301|Elocon|smyrsli|1|mg/g|50|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1534|3065|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50|
116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|620|1351|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|33,3333|
116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|1.5|0|0|E|0|ACA|0|0|1|100|XEU|347|784|lyfalmen|V0673|780|00|30|0|Actavis Group hf|Actavis hf|15|
116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|1.5|0|0|E|0|ACA|0|0|1|100|XEU|839|1807|lyfalmen|V0678|1023|00|100|0|Actavis Group hf|Actavis hf|50|
116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|NOK|27219|36938|lyfalmen|V1702|36938|00|56|0|Lyfjaver ehf|Lyfjaver ehf|37,33|
117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|NOK|27219|36938|lyfalmen|V1703|36938|00|56|0|Lyfjaver ehf|Lyfjaver ehf|56|
117408|QA12AX0001|Calcimag vet. Kela|irl|| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|7894|15208|vetalmen|||00|6000|0|Icepharma hf|Kela Laboratoria NV||
117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|6741|10632|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|133,3333|
117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4568|7575|lyfalmen|||00|100|0|Icepharma hf|Roche|33,3333|
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|1883|3595|lyfalmen|||10|100|0|Icepharma hf|Roche|8,3333|
117721|D11AF01|Verucid|hlaup|| |5|g|1|túpa||D11AF|01.08.1984||L|A|2|0|0|0|0|GAN|0|0|0|100|DKK|||lyflausa|||23|5|0|Icepharma hf|Galderma Nordic AB|5|
117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BHC|0|0|0|100|DKK|7608|13166|vetorma|||00|250|0|Vistor hf|Bayer HealthCare AG||
117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2321|4260|lyfalmen|||61|28|0|Vistor hf|Bayer HealthCare AG|28|
117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|4268|7138|lyfalmen|||61|98|0|Vistor hf|Bayer HealthCare AG|98|
117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|9787|14768|lyfalmen|||61|98|0|Vistor hf|Bayer HealthCare AG|196|
117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|5514|10675|vetalmen|||00|1200|0|Icepharma hf|Kela Laboratoria NV||
117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|9671|18593|vetalmen|||00|6000|0|Icepharma hf|Kela Laboratoria NV||
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|3781|6429|lyfalmen|V0809|6429|00|28|0|Actavis Group hf|Actavis Group PTC ehf|7|
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|5374|8726|lyfalmen|V0810|8726|00|28|0|Actavis Group hf|Actavis Group PTC ehf|14|
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|20844|29001|lyfalmen|V0812|29001|00|56|0|Actavis Group hf|Actavis Group PTC ehf|56|
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|15923|22874|lyfalmen|V0815|22874|00|28|0|Actavis Group hf|Actavis Group PTC ehf|42|
118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1454|2943|lyfalmen|||65|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5|
118165|N06AX2103|Cymbalta (Lyfjaver)|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|3225|5619|lyfalmen|V1951|4295|00|28|0|Lyfjaver ehf|Lyfjaver ehf|14|
118176|N06AX2103|Cymbalta (Lyfjaver)|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|15447|22282|lyfalmen|V1955|20874|00|98|0|Lyfjaver ehf|Lyfjaver ehf|98|
118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|557|1220|lyfalmen|||04|5|0|Vistor hf|Novartis Healthcare A/S-|5|
118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|5581|9015|lyfalmen|||04|50|0|Vistor hf|Novartis Healthcare A/S-|50|
118349|D07AC1301|Elocon|áburður|1|mg/g|20|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|697|1511|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20|
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|16387|23452|lyfalmen|V0811|23452|00|56|0|Actavis Group hf|Actavis Group PTC ehf|42|
118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|7194|11264|lyfalmen|||00|50|0|Vistor hf|Ferring|33,3333|
118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|21162|29397|lyfalmen|||00|150|0|Vistor hf|Ferring|100|
118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|NOK|2622|4717|lyfalmen|V1401|4717|00|100|0|Lyfjaver ehf|Lyfjaver ehf|8,3333|
118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|NOK|7766|12061|lyfalmen|V1400|12061|00|100|0|Lyfjaver ehf|Lyfjaver ehf|33,3333|
119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|65776|83759|lyfsjukr|||00|5|0|Vistor hf|Amgen Europe B.V.||
119305|B05BA0109|Vamin Glukos|irl|| |1000|ml|6|fl||B05BA01|01.09.1998||R|A|1.5|0|0|0|1|FRP|0|0|0|100|DKK|15284|20896|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6|
119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|9937|14968|lyfalmen|||00|98|0|Icepharma hf|Roche|98|
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|633|1378|lyfalmen|||06|10|0|K.Pétursson hf|Alcon||
120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|0|0|LVR|0|0|0|100|NOK|10972|16347|lyfalmen|V1370|15181|00|28|0|Lyfjaver ehf|Lyfjaver ehf|14|
120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|0|0|LVR|0|0|0|100|NOK|33765|45088|lyfalmen|V1371|41731|00|84|0|Lyfjaver ehf|Lyfjaver ehf|84|
120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|30|NOK|2369|4333|lyfalmen|V0939|4333|00|28|0|Lyfjaver ehf|Lyfjaver ehf|28|
120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|30|NOK|17690|25074|lyfalmen|||00|200|0|Lyfjaver ehf|Lyfjaver ehf|200|
120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|NOK|14407|20987|lyfalmen|V1710|20987|00|100|0|Lyfjaver ehf|Lyfjaver ehf|25|
121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|635|1383|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|100|
121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|296|678|lyfalmen|||24|200|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|335|759|lyfalmen|||00|28|0|Actavis Group hf|Actavis UK Ltd.|28|
121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|629|1370|lyfalmen|V0908|1370|00|100|0|Vistor hf|Novartis Healthcare A/S-|25|
121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|2754|4918|lyfalmen|||98|30|0|Icepharma hf|Schering Oy|10|
123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|432|960|lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|5|
123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|673|1462|lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|10|
123319|M05BA0704|Optinate Septimum (Lyfjaver)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|11162|16600|lyfalmen|V1080|16600|00|12|0|Lyfjaver ehf|Lyfjaver ehf|84|
123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|267|617|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|37893|50227|lyfalmen|||00|56|0|Vistor hf|Aventis Pharma SA|28|
124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|783|1690|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|18,75|
126140|N06AX1606|Efexor Depot (Lyfjaver)|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|10463|15669|lyfalmen|V0955|14224|00|98|0|Lyfjaver ehf|Lyfjaver ehf|73,5|
126152|N06AX1606|Efexor Depot (Lyfjaver)|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|20080|28050|lyfalmen|V0956|25272|00|98|0|Lyfjaver ehf|Lyfjaver ehf|147|
126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|DAC|0|1|0|100|DKK|16923|24119|lyfalmen|V1701|24119|00|28|0|D.A.C. ehf|D.A.C. ehf|6,2|
126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|15562|22425|lyfalmen|V1732|22425|00|100|0|Lyfjaver ehf|Lyfjaver ehf|11,11|
126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|13808|20241|lyfalmen|V1730|20241|00|100|0|Lyfjaver ehf|Lyfjaver ehf|22,22|
126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|15562|22425|lyfalmen|V1731|22425|00|100|0|Lyfjaver ehf|Lyfjaver ehf|33,33|
126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||10|16|0|Vistor hf|Janssen-Cilag AB|3,2|
126363|N06AX1605|Efexor (Lyfjaver)|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|1738|3374|lyfalmen|V0951|3236|00|28|0|Lyfjaver ehf|Lyfjaver ehf|10,5|
126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|19878|26616|lyfsjukr|||00|1|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|0,5417|
126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|6626|9487|lyfsjukr|||00|1|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|0,1354|
126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1452|2940|lyfalmen|||10|100|0|Vistor hf|Janssen-Cilag AB|20|
126974|N06AX2104|Cymbalta (D.A.C.)|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.07.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|IKR|2344|4295|lyfalmen|V1951|4295|00|28|0|D.A.C. ehf|D.A.C. ehf|14|
128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|7375|11516|lyfalmen|V0810|8726|00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|14|
128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|376|844|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|16,6667|
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|964|2067|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|50|
128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|3528|5051|lyfsjukr|||02|100|0|Icepharma hf|Baxter Medical AB||
129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|22491|31052|lyfalmen|V0811|23452|00|56|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|42|
129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|28586|38640|lyfalmen|V0812|29001|00|56|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|56|
129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|1200|2557|lyfalmen|||00|100|0|Vistor hf|Recip AB||
129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4241|7099|lyfalmen|||00|120|0|Vistor hf|Boehringer Ingelheim|100|
130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|13631|20021|lyfalmen|V0726|16715|00|100|0|Vistor hf|AstraZeneca UK Ltd|25|
130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|21578|29915|lyfalmen|V0727|25217|00|100|0|Vistor hf|AstraZeneca UK Ltd|50|
130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|3128|5478|lyfalmen|||02|125|0|Gróco ehf|Nycomed Danmark A/S|31,25|
131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|346|782|lyfalmen|||00|100|0|Vistor hf|Recip AB|33,3333|
131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|664|1443|lyfalmen|||00|100|0|Vistor hf|Recip AB|15|
131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|727|1574|lyfalmen|||00|100|0|Vistor hf|Recip AB|50|
131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|805|1736|lyfalmen|||00|100|0|Vistor hf|Recip AB|100|
131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4852|7989|lyfalmen|||23|26|0|Vistor hf|Janssen-Cilag AB|182|
132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|209|497|lyfalmen|||00|28|0|Actavis Group hf|Actavis UK Ltd.|3,73|
132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|275|634|lyfalmen|||00|28|0|Actavis Group hf|Actavis UK Ltd.|9,33|
132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1278|2676|lyfalmen|||00|100|0|Vistor hf|Recip AB|25|
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|722|1563|lyfalmen|||06|15|0|K.Pétursson hf|Alcon||
132902|G03AB0402|Trinovum 28|töflur|| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|726|1572|lyfalmen|||23|84|0|Vistor hf|Janssen-Cilag AB|84|
133074|L03AA1001|Granocyte|sts|33,6|millj ae|1|stk|5|hgl|+ leysir|L03AA10|01.07.1994||R|A|2|0|1|0|1|CSA|0|0|0|100|NOK|69532|88435|lyfsjukr|||02|5|0|Vistor hf|Chugai sanofi-aventis|3,7571|
133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|7777|12077|lyfalmen|||10|100|0|Icepharma hf|Sandoz GmbH|25|
134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|86444|109490|lyfsjukr|||00|14|0|D.A.C. ehf|D.A.C. ehf|7|
134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|1855|3552|lyfalmen|||00|50|0|Vistor hf|Abbott Scandinavia AB|5|
134862|J05AR0601|Atripla|filmhtfl|| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|129209|162733|lyfsjukr|||00|30|0|Lyfjaver ehf|Gilead Science International (L)||
135095|M01AC0101|Felden|töflur|20|mg|60|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|3341|5788|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
135111|H01AC0101|Genotropin|sts|| |12|mg|1|rörlyk|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|56353|72027|lyfsjukr|||00|12|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|17,991|
135319|C08DA0107|Verapamil Merck NM|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|687|1491|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|33,3333|
135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|1846|3538|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10|
136168|G03AB0401|Trinovum|töflur|| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|726|1572|lyfalmen|||23|63|0|Vistor hf|Janssen-Cilag AB|84|
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|5398|8760|lyfalmen|||00|100|0|Vistor hf|Recip AB|100|
136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|88650|112237|lyfsjukr|||02|150|0|Icepharma hf|Bayer Schering Pharma AG||
136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|65645|83596|lyfsjukr|||02|100|0|Icepharma hf|Bayer Schering Pharma AG||
137141|N02BA5102|Treo|freyðit|| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||14|20|0|Vistor hf|McNeil Denmark ApS|3,3333|
137158|N02BA5102|Treo|freyðit|| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||14|60|0|Vistor hf|McNeil Denmark ApS|10|
137364|N05AB0301|Trilafon|töflur|4|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1161|2476|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|13,3333|
137455|N05AB0301|Trilafon|töflur|2|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|769|1661|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|6,6667|
137513|S01XA2011|Oculac|augndr|| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|278|640|lyfalmen|||00|10|0|Vistor hf|Novartis Healthcare A/S-||
137521|S01XA2011|Oculac|augndr|| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|613|1337|lyfalmen|||00|8|0|Vistor hf|Novartis Healthcare A/S-||
137679|A09AA0205|Creon|sh-hylki|| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|3411|5890|lyfalmen|||10|100|0|Medico ehf|Kali-Chemie|100|
137992|J01XA0106|Vancomycin Hospira |irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1676|2400|lyfsjukr|||00|500|0|Vistor hf|Hospira Enterprises B.V.|0,25|
138073|J01XA0106|Vancomycin Hospira |irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2279|3263|lyfsjukr|||00|1|0|Vistor hf|Hospira Enterprises B.V.|0,5|
138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1573|3124|lyfalmen|||00|15|0|Icepharma hf|Santen Oy|60|
138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1670|3271|lyfalmen|||00|30|0|Icepharma hf|Santen Oy|60|
139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|2122|3672|vetorma|||13|250|0|Icepharma hf|Intervet International B.V.||
139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|2333|4278|lyfalmen|||00|100|0|Artasan ehf|Novartis Healthcare A/S-A|50|
140118|A10BA0202|Glucophage (Lyfjaver)|töflur|1000|mg|180|stk|1|glas||A10BA02|01.07.2008||R|A|3|0|0|*|0|LVR|0|0|0|100|NOK|2374|4340|lyfalmen|||00|180|0|Lyfjaver ehf|Lyfjaver ehf|90|
140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1962|3715|lyfalmen|||19|100|0|Vistor hf|Boehringer Ingelheim|33,3333|
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1327|2750|lyfalmen|||00|30|0|Vistor hf|Boehringer Ingelheim International |1,06|
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LUN|0|1|0|100|DKK|11002|15565|lyfsjukr|||02|10|0|Lundbeck Export A/S|Lundbeck|33,3333|
140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|496|710|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|3,3333|
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1050|2245|lyfalmen|||03|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4|
141186|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.05.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|65621|83566|lyfsjukr|||00|336|0|D.A.C. ehf|D.A.C. ehf|28|
141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|6924|9913|lyfsjukr|||00|1200|0|D.A.C. ehf|D.A.C. ehf|4|
141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|20987|27996|lyfsjukr|||00|1|0|D.A.C. ehf|D.A.C. ehf|0,5|
141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|2566|4632|lyfalmen|||00|30|0|Vistor hf|Boehringer Ingelheim International |2,16|
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|7267|11366|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim International |7,2|
142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|226|532|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|6,25|
142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|496|1094|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|25|
142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|6686|9573|lyfsjukr|||02|30|0|Vistor hf|Sanofi-aventis Norge AS|7,5|
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|914|1963|lyfalmen|V0143|1884|70|30|0|Vistor hf|Sanofi-aventis Norge AS|30|
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|DKK|1885|3598|lyfalmen|||00|100|0|Vistor hf|Meda AB (V)|50|
142596|C07AA0509|Propranolol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|687|1491|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|50|
143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1599|3163|lyfalmen|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|6,25|
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3673|5259|lyfsjukr|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|569|1245|lyfalmen|||07|5|0|Vistor hf|Novartis Healthcare A/S-||
143511|J07BC2002|Twinrix Peadriatric|bóluefni|| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|2850|5063|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA||
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|596|1301|lyfalmen|||06|15|0|K.Pétursson hf|Alcon||
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1540|3074|lyfalmen|||00|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3,3333|
143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1737|3373|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim|25|
143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|718|1555|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30|
143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|937|2010|lyfalmen|||10|100|0|Actavis Group hf|Actavis Group hf|25|
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2197|4072|lyfalmen|V0429|4003|00|3|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5|
143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|3288|4708|lyfsjukr|||02|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|6319|9047|lyfsjukr|||02|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|2944|5206|lyfalmen|||10|100|0|Icepharma hf|M.S.D.|16,6667|
144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3708|6323|lyfalmen|||51|1|0|Icepharma hf|Sanofi Pasteur MSD||
144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|11593|16301|lyfsjukr|||02|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|74750|94931|lyfsjukr|||AC|1,5|0|Vistor hf|Novo-Nordisk|22,4888|
144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|46934|60300|lyfsjukr|||AC|1,5|0|Vistor hf|Novo-Nordisk|15,0675|
144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|30516|39860|lyfsjukr|||AC|1,5|0|Vistor hf|Novo-Nordisk|7,4213|
144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|702|1522|lyfalmen|||20|30|0|Vistor hf|Astellas Pharma A/S|30|
144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|326|740|lyfalmen|||00|24|0|Actavis Group hf|Actavis Group hf|8|
144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|563|1233|lyfalmen|||00|24|0|Actavis Group hf|Actavis Group hf|20|
145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2483|4506|lyfalmen|||51|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
145482|D07AC0104|Diproderm|krem|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|831|1790|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20|
145490|D07AC0104|Diproderm|krem|0,5|mg/g|50|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|2128|3967|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50|
145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|3845|6522|lyfalmen|||20|100|0|Vistor hf|Schering-Plough|100|
145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||24|30|0|Vistor hf|Recip AB||
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||23|8|0|Vistor hf|Recip AB||
145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||23|32|0|Vistor hf|Recip AB||
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|654|1422|lyfalmen|||41|10|0|Vistor hf|Sanofi-aventis Norge AS|2|
147512|G03DA0202|Perlutex|töflur|5|mg|50|stk|1|þpakki||G03DA02|01.03.1981||R|A|5|0|0|E|0|LEP|0|0|0|100|DKK|991|2123|lyfalmen|||00|50|0|Vistor hf|LEO Pharma A/S|50|
147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|10752|15254|lyfsjukr|||00|6000|0|Icepharma hf|Meda AB|6|
147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|17187|23265|lyfsjukr|||00|6000|0|Icepharma hf|Meda AB|6|
147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|31622|41237|lyfsjukr|||02|200|0|Vistor hf|Schering-Plough|33,3333|
148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|104546|133210|lyfalmen|||00|750|0|Icepharma hf|Roche as|30|
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|826|1780|lyfalmen|||00|100|0|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|20|
148650|G03AA0703|Neogynon|töflur|| |63|stk|1|þpakki||G03AA07|01.12.1974||R|A|5|0|0|0|0|SAG|0|0|0|100|SEK|845|1819|lyfalmen|||23|63|0|Icepharma hf|Schering AG|84|
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BHC|1|0|0|100|DKK|2835|5571|vetalmen|||27|25|0|Vistor hf|Bayer HealthCare AG||
150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|12035|18034|lyfalmen|||10|100|0|Icepharma hf|Sandoz GmbH|50|
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LUN|0|1|0|100|DKK|5596|9036|lyfalmen|||02|10|0|Lundbeck Export A/S|Lundbeck|50|
151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|882|1896|lyfalmen|||05|10|0|Vistor hf|Sanofi-aventis Norge AS|10|
151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1254|2639|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|865|1861|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10|
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|545|780|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|0,45|
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|DKK|||lyfalmen|||23|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3336|5781|lyfalmen|||23|200|0|Vistor hf|AstraZeneca A/S DK|25|
152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5163|8432|lyfalmen|||23|200|0|Vistor hf|AstraZeneca A/S DK|50|
152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|8452|12990|lyfalmen|||23|200|0|Vistor hf|AstraZeneca UK Ltd|100|
152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1404|2867|lyfalmen|||10|4|0|Vistor hf|Janssen-Cilag AB|2|
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1285|2686|lyfalmen|||17|100|0|Vistor hf|AstraZeneca A/S DK||
153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1435|2914|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK||
153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1359|2799|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK||
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GSC|0|0|0|100|DKK|289293|362037|lyfsjukr|||00|10|0|Swedish Orphan International AB|Gilead Science International (S) |14,2857|
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|4703|7772|lyfalmen|||10|15|0|Vistor hf|Janssen-Cilag AB|7,5|
153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|5343|8683|lyfalmen|||02|5|0|Vistor hf|Hexal A/S|250|
154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|4788|7896|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|40|
154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1053|2252|lyfalmen|||10|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10|
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|4122|6926|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50|
154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|10160|15265|lyfalmen|||00|90|0|Vistor hf|Sanofi-aventis Norge AS|120|
155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|1054|2254|lyfalmen|||00|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LUN|0|1|0|100|DKK|1315|2732|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|16,6667|
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LUN|0|1|0|100|DKK|407|908|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|5|
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|8899|13585|lyfalmen|||00|28|0|Vistor hf|Janssen-Cilag AB|14|
155903|J05AF0101|Retrovir|mixtúra|10|mg/ml|200|ml|1|glas||J05AF01|01.07.1995||R|A|2|0|1|0|1|GSK|0|0|0|100|GBP|4805|6880|lyfsjukr|||63|200|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|3,3333|
156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|4944|8123|lyfalmen|||00|42|0|Icepharma hf|Roche|14|
156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|7232|11317|lyfalmen|V0133|11116|00|84|0|Icepharma hf|Roche|28|
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|286|657|lyfalmen|||00|6|0|Vistor hf|Janssen-Cilag AB|3|
157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PFI|0|0|0|100|DKK|5700|9864|vetorma|||16|260|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
157909|D07XC0101|Diprosalic|áburður|| |100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|2633|4734|lyfalmen|||20|100|0|Vistor hf|Schering-Plough|100|
158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|787|1699|lyfalmen|||00|50|0|Vistor hf|Novartis Healthcare A/S-|10|
158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|876|1884|lyfalmen|||23|5|0|Vistor hf|Novartis Healthcare A/S-|13,3333|
159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|5080|8316|lyfalmen|V0925|3639|00|56|0|Lundbeck Export A/S|Lundbeck|56|
159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|20112|28090|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|10400|15585|lyfalmen|V0929|9453|00|56|0|Lundbeck Export A/S|Lundbeck|112|
159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|1471|2969|lyfalmen|V0921|1854|00|28|0|Lundbeck Export A/S|Lundbeck|14|
159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|2546|4602|lyfalmen|V0923|2876|00|28|0|Lundbeck Export A/S|Lundbeck|28|
159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|5246|8548|lyfalmen|V0927|3833|00|28|0|Lundbeck Export A/S|Lundbeck|56|
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|132873|167294|lyfsjukr|||00|2|0|Icepharma hf|Roche|1|
159806|QG51BE0001|Streptoc. m/sulfadim., vet.|legstil|| |50|stk|50|stilar||QG51BE00|01.11.1979||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|7922|15261|vetalmen|||00|2500|0|Vistor hf|Boehringer Ingelheim Danmark||
160051|C07AA0701|Sotacor|töflur|160|mg|100|stk|1|þpakki||C07AA07|01.05.1983||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|1678|3283|lyfalmen|V0274|3007|00|100|0|Vistor hf|Bristol-Myers Squibb|100|
160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|1778|2546|lyfsjukr|||02|50|0|Actavis Group hf|Actavis Group hf|25|
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|747|1615|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|5|
160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|1852|3548|lyfalmen|||42|50|0|Vistor hf|Bristol-Myers Squibb|14,2857|
160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|291|667|lyfalmen|||14|20|0|Vistor hf|Sanofi-aventis Norge AS|6,6667|
161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|599|1308|lyfalmen|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2|
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1402|2007|lyfsjukr|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|8,3333|
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|2404|3442|lyfsjukr|||03|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|16,6667|
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|550|1206|lyfalmen|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3,3333|
161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4319|7213|lyfalmen|||23|26|0|Vistor hf|Janssen-Cilag AB|136,5|
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|65228|84259|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100|
161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|1882|2695|lyfsjukr|||00|2,5|0|Icepharma hf|Wyeth AB|0,8333|
161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|DKK|||lyflausa|||01|120|0|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|120|
162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|3845|5505|lyfsjukr|||00|5|0|Icepharma hf|Wyeth AB|1,6667|
162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|10281|14667|lyfsjukr|||00|17,5|0|Icepharma hf|Wyeth AB|5,8333|
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1853|3549|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|1846|3538|lyfalmen|||24|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10|
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|933|2002|lyfalmen|V0953|2002|00|30|0|Vistor hf|Novartis Healthcare A/S-|10|
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1440|2922|lyfalmen|||41|30|0|Vistor hf|Sanofi-aventis Norge AS|6|
163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2460|4471|lyfalmen|||24|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2322|4261|lyfalmen|||00|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|5395|8755|lyfalmen|V0299|8755|98|60|0|Icepharma hf|Schering Oy|20|
165001|C05AA0102|Proctosedyl|eþ-stil|| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|NOK|||lyfalmen|||04|12|0|Vistor hf|Sanofi-aventis Norge AS||
165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4280|7156|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|49|
165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3637|6219|lyfalmen|V0324|4553|43|98|0|Vistor hf|AstraZeneca A/S DK|196|
165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2412|4398|lyfalmen|V0316|3194|43|98|0|Vistor hf|AstraZeneca A/S DK|98|
165589|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|5|hgl||QH02AB06|01.12.1972||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|5390|10438|vetalmen|||58|250|0|Icepharma hf|Intervet International B.V.||
165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|11302|16787|lyfalmen|||23|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15|
165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|761|1644|lyfalmen|||00|100|0|Vistor hf|U.C.B|50|
165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|270|624|lyfalmen|||00|25|0|Vistor hf|U.C.B|12,5|
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCB|0|0|1|100|SEK|||lyfalmen|||00|10|0|Vistor hf|U.C.B|5|
166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1940|3681|lyfalmen|||10|100|0|Vistor hf|Schering-Plough|100|
166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|789|1703|lyfalmen|||00|10|0|Vistor hf|Pharmaxim Sweden AB|1|
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|1981|3743|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|38,7597|
166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|20241|28250|lyfalmen|||23|8|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|22287|29615|lyfsjukr|||00|1|0|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|1,4286|
167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|44573|57361|lyfsjukr|||00|1|0|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|2,8571|
168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|898|1929|lyfalmen|||10|50|0|Vistor hf|Novartis Healthcare A/S-|10|
168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|2922|5173|lyfalmen|V0789|5150|10|200|0|Vistor hf|Novartis Healthcare A/S-|40|
168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|940|2017|lyfalmen|||10|30|0|Vistor hf|Novartis Healthcare A/S-|12|
168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5461|8847|lyfalmen|V0713|8623|10|200|0|Vistor hf|Novartis Healthcare A/S-|80|
168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|40150|51854|lyfsjukr|||00|10|0|Vistor hf|Pierre Fabre Pharma||
169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|182358|228903|lyfsjukr|||00|50|0|Vistor hf|Pierre Fabre Pharma||
169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|30|DKK|19021|25549|lyfsjukr|||00|5|0|Icepharma hf|Roche as|5|
169664|J07BK0101|Varilrix|bóluefni|| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|4597|7618|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2678|4802|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK||
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2877|5104|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK||
170092|J07BC2001|Twinrix Adult|bóluefni|| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|4210|7054|lyfalmen|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA||
170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|3836|6509|lyfalmen|||59|100|0|Vistor hf|Abbott Scandinavia AB|50|
170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|7045|11056|lyfalmen|||59|100|0|Vistor hf|Abbott Scandinavia AB|100|
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1205|2565|lyfalmen|||17|100|0|Vistor hf|AstraZeneca A/S DK||
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2698|4833|lyfalmen|||17|100|0|Vistor hf|AstraZeneca A/S DK||
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2907|5150|lyfalmen|||17|100|0|Vistor hf|AstraZeneca A/S DK||
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3794|6448|lyfalmen|V0709|6425|00|60|0|Vistor hf|Janssen-Cilag AB|5|
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5506|8910|lyfalmen|V0710|8910|00|60|0|Vistor hf|Janssen-Cilag AB|10|
171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|40294|52034|lyfsjukr|||02|75|0|Icepharma hf|Bayer Schering Pharma AG||
172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|34614|44962|lyfsjukr|||02|50|0|Icepharma hf|Bayer Schering Pharma AG||
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|10976|16352|lyfalmen|V0711|15857|00|60|0|Vistor hf|Janssen-Cilag AB|20|
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|20083|28054|lyfalmen|||00|60|0|Vistor hf|Janssen-Cilag AB|40|
172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|60160|76767|lyfsjukr|||02|100|0|Icepharma hf|Bayer Schering Pharma AG||
172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|2345|4296|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10966|16339|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK||
172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5210|8497|lyfalmen|||10|56|0|Icepharma hf|Norpharma |11,2|
172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9943|14976|lyfalmen|||10|56|0|Icepharma hf|Norpharma |22,4|
172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16537|23639|lyfalmen|||10|56|0|Icepharma hf|Norpharma |44,8|
172767|J07AJ5204|DiTeKik|bóluefni|| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|1798|3466|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut||
172775|J07AJ5204|DiTeKik|bóluefni|| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|1798|3466|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut||
172825|J07CA0203|DiTeKiPol|bóluefni|| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2561|4624|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut||
172874|D01AC0801|Fungoral|krem|20|mg/g|30|g|1|túpa||D01AC08|01.10.1989||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|747|1615|lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|30|
172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|18985|26687|lyfalmen|||10|56|0|Icepharma hf|Norpharma |67,2|
173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|614|1339|lyfalmen|V0901|1314|00|50|0|Icepharma hf|Valeant Pharmaceuticals B.V.|50|
173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2125|3962|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB (A)|16,6667|
173344|A06AG1101|Microlax|innhl|| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|1488|2995|lyfalmen|||56|60|0|Vistor hf|McNeil Denmark ApS|12|
173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|4535|7527|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB (A)|33,3333|
173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|ROC|0|0|1|100|DKK|728|1576|lyfalmen|||00|10|0|Icepharma hf|Roche|10|
173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|260|603|lyfalmen|||00|30|0|Actavis Group PTC ehf|Merck NM AB|20|
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1079|1545|lyfsjukr|||02|20|0|Actavis Group hf|Actavis Group hf|10|
174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|497|1096|lyfalmen|||00|14|0|Vistor hf|Recip AB|5,6|
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|509|1121|lyfalmen|||00|14|0|Vistor hf|Recip AB|7|
174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|242|565|lyfalmen|V0886|468|00|30|0|Actavis Group PTC ehf|Merck NM AB|30|
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|2092|3912|lyfalmen|V0507|3912|00|10|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,6667|
176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|IKR|5310|8637|lyfalmen|V0809|6429|00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|7|
177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|3511|6036|lyfalmen|||00|20|0|Vistor hf|Sanofi-aventis Norge AS|10|
177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|613|1337|lyfalmen|||43|40|0|Vistor hf|Sanofi-aventis Norge AS|5,3333|
177311|QJ51RC2202|Nafpenzal vet.|spenalyf|| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|497|981|vetalmen|||16|12|0|Icepharma hf|Intervet International B.V.||
177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|574|1256|lyfalmen|||03|1|0|Vistor hf|Schering-Plough Europe|4,67|
177741|D07CB0102|Kenalog Comp med Mycostatin|smyrsli|| |15|g|1|túpa||D07CB01|01.12.1972||R|A|4|0|0|B|0|BRS|0|0|1|100|DKK|373|838|lyfalmen|||00|15|0|Vistor hf|Bristol-Myers Squibb|15|
179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|8261|11828|lyfsjukr|||00|60|0|Icepharma hf|N.V. Organon||
180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|4513|7495|lyfalmen|||10|100|0|Vistor hf|U.C.B|25|
180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|12031|18029|lyfalmen|||00|98|0|Vistor hf|Bristol-Myers Squibb|98|
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|683|1482|lyfalmen|||30|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||23|50|0|Vistor hf|Bayer A/S|5|
181396|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|345|780|lyfalmen|V0673|780|00|30|0|Actavis Group hf|Actavis hf|15|
181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|5844|11303|vetalmen|||16|100|0|Icepharma hf|Pfizer vet.||
181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|20810|27776|lyfsjukr|||00|10|0|Icepharma hf|Wyeth AB||
181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|28363|37179|lyfsjukr|||00|50|0|Icepharma hf|Wyeth AB||
182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|SPA|0|0|0|100|DKK|3828|7463|vetalmen|||16|100|0|Vistor hf|Schering-Plough A/S||
183293|D08AG0201|Betadine|smyrsli|100|mg/g|40|g|1|túpa||D08AG02|01.07.1988||L|A|3|0|0|0|0|NAP|0|0|0|100|CHF|||lyflausa|||00|40|0|Icepharma hf|Napp|40|
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|4231|8231|vetalmen|||27|50|0|Vistor hf|Schering-Plough A/S||
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|933|2002|lyfalmen|||00|100|0|Vistor hf|Bristol-Myers Squibb|100|
183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|718|1555|lyfalmen|||41|21|0|Vistor hf|Sanofi-aventis Norge AS|2,1|
184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|1363|2805|lyfalmen|||00|2|0|Vistor hf|AstraZeneca UK Ltd|2|
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|3742|6372|lyfalmen|||98|700|0|Icepharma hf|Schering Oy|4,6667|
184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|18293|25825|lyfalmen|||00|30|0|Vistor hf|Novartis Healthcare A/S-|30|
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|49397|64550|lyfalmen|V0563|63321|00|100|0|Vistor hf|Novartis Healthcare A/S-|100|
184309|R03DA0404|Theo-Dur|forðatfl|200|mg|100|stk|1|glas||R03DA04|01.11.1981||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1257|2644|lyfalmen|||10|100|0|Vistor hf|AstraZeneca A/S DK|50|
184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4104|6899|lyfalmen|||00|6|0|Vistor hf|AstraZeneca UK Ltd|6|
184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MNA|0|1|0|100|SEK|881|1894|lyfalmen|V1140|1894|00|90|0|Actavis Group PTC ehf|Merck NM AB|15|
186742|R03DA0404|Theo-Dur|forðatfl|300|mg|100|stk|1|glas||R03DA04|01.11.1981||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1782|3441|lyfalmen|||10|100|0|Vistor hf|AstraZeneca A/S DK|75|
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2302|4231|lyfalmen|||00|250|0|Vistor hf|Desitin Artzneimittel|10|
188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|1599|3163|lyfalmen|||00|100|0|Icepharma hf|Goldshield Pharmaceuticals Ltd|33,3333|
189126|L02BB0301|Casodex|töflur|150|mg|30|stk|1|þpakki||L02BB03|01.05.2000||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|42927|56494|lyfalmen|||00|30|0|Vistor hf|AstraZeneca UK Ltd|90|
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|8168|11695|lyfsjukr|||00|10|0|Icepharma hf|Novartis Healthcare A/S||
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2383|4354|lyfalmen|||03|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10|
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1019|2181|lyfalmen|||03|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4|
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|534|1173|lyfalmen|||03|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2|
190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|633|1378|lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|10|
190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|343|775|lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|5|
190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1391|2847|lyfalmen|||10|100|0|Actavis Group hf|Actavis Group hf|25|
191064|B05XC03|Vitalipid Infant|irþ|| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|3508|5023|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1|
191247|B05XC02|Vitalipid Adult|irþ|| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|3578|5123|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1|
191254|B05XC01|Soluvit|irs|| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|4620|6615|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1|
191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|389|871|lyfalmen|||07|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1261|2650|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|100|
192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|351|792|lyfalmen|||10|25|0|Vistor hf|LEO Pharma A/S|25|
193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|529|1162|lyfalmen|||10|25|0|Vistor hf|Schering-Plough|25|
193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|883|1898|lyfalmen|||02|50|0|Vistor hf|Sandoz A/S|2,5091|
194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|818|1171|lyfsjukr|||02|2|0|Icepharma hf|Wyeth AB||
194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1613|3185|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim|16,6667|
194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|388|869|lyfalmen|||00|20|0|Vistor hf|Boehringer Ingelheim|3,3333|
194795|M05BA0301|Aredia|irs|90|mg/hgl|1|hgl|1|pakki|+ 10 ml leysir|M05BA03|01.03.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|33975|44166|lyfsjukr|||00|1|0|Vistor hf|Novartis Healthcare A/S-|1,5|
194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|1570|3119|lyfalmen|V0514|879|00|10|0|Vistor hf|Bayer HealthCare AG|2,5|
194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|3404|5880|lyfalmen|V0518|1389|00|20|0|Vistor hf|Bayer HealthCare AG|5|
195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|3334|5778|lyfalmen|V0522|1407|00|10|0|Vistor hf|Bayer HealthCare AG|5|
195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|6467|10250|lyfalmen|V0526|2491|00|20|0|Vistor hf|Bayer HealthCare AG|10|
195149|B03BA0201|Betolvex |stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2477|4497|lyfalmen|||03|5|0|Actavis Group hf|Actavis Group hf|250|
195156|B03BA0201|Betolvex |stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|617|1345|lyfalmen|||03|1|0|Actavis Group hf|Actavis Group hf|50|
195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|767|1657|lyfalmen|||10|40|0|Vistor hf|Janssen-Cilag AB|8|
195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|17023|24244|lyfalmen|||00|1|0|Icepharma hf|N.V. Organon|1014,9254|
195669|D01AC2002|Pevisone|krem|| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|400|894|lyfalmen|||20|15|0|Vistor hf|Janssen-Cilag AB|15|
195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|285|655|lyfalmen|||10|30|0|Vistor hf|Recip AB|15|
195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|676|1468|lyfalmen|||10|100|0|Vistor hf|Recip AB|50|
196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1076|2299|lyfalmen|||23|63|0|Icepharma hf|Bayer Schering Pharma AG|84|
197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2006|3958|vetalmen|||27|10|0|Icepharma hf|Intervet International B.V.||
197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|9550|18363|vetalmen|||27|50|0|Icepharma hf|Intervet International B.V.||
197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|2919|5168|lyfalmen|||00|60|0|Vistor hf|McNeil Denmark ApS|60|
197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|597|1304|lyfalmen|||06|10|0|Vistor hf|Novartis Healthcare A/S-||
197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3690|6296|lyfalmen|V0705|6296|00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|18,6667|
197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|668|1451|lyfalmen|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|20|
197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3164|5530|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100|
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2067|3874|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK||
198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1417|2887|lyfalmen|||00|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|7966|11405|lyfsjukr|||02|200|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|326|467|lyfsjukr|||02|5|0|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|2,5|
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|29075|39249|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|691|1499|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6012|9616|lyfalmen|||44|8|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4|
370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|447|640|lyfsjukr|||02|1|0|Icepharma hf|Roche|0,5|
370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|15570|21252|lyfsjukr|||02|200|0|Icepharma hf|Bayer Schering Pharma AG||
372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|2405|4388|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|3,75|
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|6743|10635|lyfalmen|||00|90|0|Vistor hf|Sanofi-aventis Norge AS|11,25|
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3226|5620|lyfalmen|||00|100|0|Icepharma hf|Roche|16,6667|
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|42|0|Vistor hf|McNeil Denmark ApS|7|
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|18|0|Vistor hf|McNeil Denmark ApS|3|
372615|M05BA0401|Fosamax|töflur|10|mg|98|stk|1|þpakki||M05BA04|01.01.1996||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|14669|21313|lyfalmen|||00|98|0|Icepharma hf|M.S.D.|98|
372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|8040|12441|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|15|
372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|108032|136367|lyfsjukr|||00|1|0|Vistor hf|Novo-Nordisk||
372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|215714|270431|lyfsjukr|||00|1|0|Vistor hf|Novo-Nordisk||
372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|430945|538394|lyfsjukr|||00|1|0|Vistor hf|Novo-Nordisk||
373001|G03AB0501|Gracial|töflur|| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1956|3706|lyfalmen|||23|66|0|Icepharma hf|N.V. Organon|88|
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|21319|29592|lyfalmen|||00|90|0|Vistor hf|Sanofi-aventis Norge AS|45|
373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|3591|6152|lyfalmen|||23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|DKK|5695|9174|lyfalmen|V0992|7893|23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|DKK|7382|11526|lyfalmen|V0993|10253|23|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2282|4201|lyfalmen|||44|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1|
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|614|1339|lyfalmen|||00|100|0|Icepharma hf|Merck Santé s.a.s.|25|
374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|3877|6569|lyfalmen|||00|30|0|Vistor hf|Yamanouchi Europe|30|
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|30|GBP|9430|14293|lyfalmen|||00|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5|
374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|16591|23706|lyfalmen|V0560|19083|00|30|0|Vistor hf|AstraZeneca UK Ltd|30|
374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2170|4031|lyfalmen|||23|15|0|Vistor hf|Sanofi-aventis Norge AS|15|
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6233|9924|lyfalmen|||00|6|0|Vistor hf|Sanofi-aventis Norge AS|30|
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7016|11016|lyfalmen|||00|8|0|Vistor hf|Sanofi-aventis Norge AS|40|
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|9449|14318|lyfalmen|||00|10|0|Vistor hf|Sanofi-aventis Norge AS|50|
377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3516|6043|lyfalmen|||63|14|0|Vistor hf|Abbott Scandinavia AB|14|
377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|28665|38738|lyfalmen|||63|100|0|Vistor hf|Abbott Scandinavia AB|100|
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|9134|13898|lyfalmen|V0508|13898|00|42|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|7|
379669|H01CB0202|Sandostatin Lar|sts|5|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|123031|155041|lyfsjukr|||00|2|0|Vistor hf|Novartis Healthcare A/S-|14,29|
379677|H01CB0202|Sandostatin Lar|sts|10|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|145680|183239|lyfsjukr|||00|2|0|Vistor hf|Novartis Healthcare A/S-|28,57|
379685|H01CB0202|Sandostatin Lar|sts|15|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|172366|216463|lyfsjukr|||00|2|0|Vistor hf|Novartis Healthcare A/S-|42,86|
379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1177|2509|lyfalmen|||00|12,5|0|Actavis Group hf|Actavis Group hf|2,5|
379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1455|2945|lyfalmen|||00|12,5|0|Actavis Group hf|Actavis Group hf|5|
379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|22813|30270|lyfsjukr|||00|0,5|0|Vistor hf|Aventis Pharma SA||
379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|91462|115738|lyfsjukr|||00|2|0|Vistor hf|Aventis Pharma SA||
382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|11867|17539|lyfalmen|V0367|3440|00|98|0|Icepharma hf|M.S.D.|261,3333|
383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5154|8419|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|50|
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BHC|0|0|0|100|DKK|772|1336|vetorma|||00|2|0|Vistor hf|Bayer HealthCare AG||
383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BHC|0|0|0|100|DKK|6044|10459|vetorma|||00|20|0|Vistor hf|Bayer HealthCare AG||
386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|45200|59324|lyfalmen|||00|98|0|Vistor hf|AstraZeneca UK Ltd|98|
387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|572|1129|vetalmen|||00|100|0|Icepharma hf|Icepharma hf||
387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|175157|219938|lyfsjukr|||00|200|0|Zeneus Pharma Limited|Zeneus Pharma Limited|28,5714|
388256|N01BB2001|Emla|krem|| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2732|4884|lyfalmen|||00|25|0|Vistor hf|AstraZeneca A/S DK|5|
388264|N01BB2001|Emla|krem|| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3081|5409|lyfalmen|||00|30|0|Vistor hf|AstraZeneca A/S DK|30|
388280|N01BB2001|Emla|plástur|| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|5750|9250|lyfalmen|||23|20|0|Vistor hf|AstraZeneca A/S DK||
388439|M05BB0101|Didronate/Calcium Procter & Gamble|töflur|400|mg|90|stk|1|pakki|þp (14 + 76 stk)|M05BB01|01.06.1998||R|A|3|0|0|E|0|PGA|0|0|0|100|DKK|8182|12630|lyfalmen|||00|90|0|Sofus Consulting AB|Procter & Gamble-|90|
389106|G03FA0103|Femanor|töflur|| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|1857|3555|lyfalmen|V0388|3555|23|84|0|Vistor hf|BioPhausia AB|84|
389122|G03FB0503|Femasekvens|töflur|| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|1697|3312|lyfalmen|||23|84|0|Vistor hf|BioPhausia AB|84|
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|701|1520|lyfalmen|V0408|1520|00|84|0|Vistor hf|BioPhausia AB|84|
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|498|1098|lyfalmen|||00|84|0|Vistor hf|BioPhausia AB|42|
389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|272766|341461|lyfsjukr|||02|4000|0|Icepharma hf|Bayer Schering Pharma AG||
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|759|1640|lyfalmen|||00|3|0|Vistor hf|Novartis Healthcare A/S-||
389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|10366|14773|lyfsjukr|||00|5|0|Icepharma hf|Roche as|5|
389783|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2097|3920|lyfalmen|||00|30|0|Vistor hf|Recip AB|7,5|
390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|2646|4754|lyfalmen|||01|100|0|Vistor hf|Bristol-Myers Squibb|6,6667|
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|6006|9607|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50|
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2351|4305|lyfalmen|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|20|
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|11046|16445|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100|
391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2489|4515|lyfalmen|||00|50|0|Vistor hf|AstraZeneca A/S DK||
393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PFV|0|0|0|100|XEU|3932|7661|vetalmen|||16|24|0|Icepharma hf|Pfizer vet.||
395715|D10AD0301|Differin|hlaup|0,1|%|30|g|1|túpa||D10AD03|01.07.2001||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|825|1778|lyfalmen|||00|30|0|Icepharma hf|Galderma Nordic AB|30|
395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|176256|221306|lyfsjukr|||02|300|0|Icepharma hf|Bayer Schering Pharma AG||
397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|8409|12040|lyfsjukr|||00|60|0|Icepharma hf|Roche||
397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|48747|62558|lyfsjukr|||00|120|0|Icepharma hf|Roche||
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|8474|13019|lyfalmen|||02|3|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|DKK|||lyfalmen|||00|2|0|Artasan ehf|Novartis Healthcare A/S-A|2|
400044|S03CA0102|Sofradex|aug.eydr|| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1338|2767|lyfalmen|||06|8|0|Vistor hf|Sanofi-aventis Norge AS||
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|4362|7275|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|284|653|lyfalmen|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|12,5|
400275|N05BA0402|Sobril|töflur|15|mg|250|stk|1|glas||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1805|3476|lyfalmen|||00|250|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|75|
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|462|1023|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|202|482|lyfalmen|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7,5|
400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|7|0|Vistor hf|McNeil Denmark ApS|7,5|
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LUN|0|1|0|100|DKK|594|1297|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|13,3333|
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LUN|0|1|0|100|DKK|951|2040|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|33,3333|
402651|J07BB0205|Influvac|bóluefni|| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOP|0|0|0|100|XEU|512|1127|lyfalmen|||51|0,5|0|Icepharma hf|Solvay Pharmaceuticals||
402743|QJ01RA0102|Streptocillin, vet.|stl|| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1246|2459|vetalmen|||58|100|0|Vistor hf|Boehringer Ingelheim Danmark||
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|4025|7838|vetalmen|||27|20|0|Vistor hf|Schering-Plough A/S||
403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5483|8878|lyfalmen|||10|100|0|Vistor hf|Novartis Healthcare A/S-|50|
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1069|2285|lyfalmen|||06|13,5|0|Vistor hf|Sanofi-aventis Norge AS||
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|502|1106|lyfalmen|||00|10|0|Icepharma hf|Santen Oy||
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|77559|98428|lyfsjukr|||02|1|0|Vistor hf|Boehringer Ingelheim|0,5|
404640|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|10677|15954|lyfalmen|V0125|14049|00|28|0|Actavis Group hf|Alpharma ApS|1,75|
404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|491|703|lyfsjukr|||02|5|0|Icepharma hf|Roche|2,5|
405589|J07BD5203|Priorix|bóluefni|| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1468|2964|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
405597|J07BD5203|Priorix|bóluefni|| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|18116|25605|lyfalmen|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|16151|23158|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|21|
406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|16151|23158|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|28|
406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|16151|23158|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|35|
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|16312|23359|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|25|
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|49177|64276|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|75|
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|53338|69456|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|100|
406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|57499|74637|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|125|
406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LUN|0|1|0|100|DKK|5450|8832|lyfalmen|||00|30|0|Lundbeck Export A/S|Lundbeck|7,5|
406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|448|994|lyfalmen|||10|30|0|Actavis Group hf|Actavis Group hf|7,5|
407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1681|3288|lyfalmen|||00|100|0|Vistor hf|Recip AB|50|
407403|A01AB0402|Fungizone|sogtfl|10|mg|60|stk|1|þpakki||A01AB04|01.04.1993||R|A|1,5|0|0|E|0|BRS|0|0|1|100|DKK|850|1830|lyfalmen|||00|60|0|Vistor hf|Bristol-Myers Squibb|15|
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|191|459|lyfalmen|||00|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5|
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|538|1181|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|20|
408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|831|1790|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20|
408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3815|6478|lyfalmen|||20|100|0|Vistor hf|Schering-Plough|100|
408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|831|1790|lyfalmen|||20|20|0|Vistor hf|Schering-Plough|20|
408765|D07AC0104|Diproderm|áburður|0,5|mg/ml|50|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1919|3649|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50|
408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2272|4185|lyfalmen|||20|100|0|Vistor hf|Schering-Plough|100|
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|4084|6870|lyfalmen|||08|35|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1,75|
409193|N02BE0101|Panodil|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.07.1975||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|20|0|Icepharma hf|GlaxoSmithKline CH A/S|3,3333|
409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|3016|5315|lyfalmen|||00|28|0|Vistor hf|Boehringer Ingelheim International |56|
409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|3273|5689|lyfalmen|V0966|5594|23|200|0|Vistor hf|AstraZeneca A/S DK|100|
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|9744|14711|lyfalmen|||00|98|0|Vistor hf|Boehringer Ingelheim International |196|
409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|2377|4345|lyfalmen|||00|28|0|Vistor hf|Boehringer Ingelheim International |28|
409524|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|826|1780|lyfalmen|||43|28|0|Vistor hf|AstraZeneca A/S DK|21|
409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|8293|15968|vetalmen|||27|120|0|Vistor hf|Pharmaxim Sweden AB||
409748|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2070|3879|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|73,5|
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|7896|12243|lyfalmen|||00|98|0|Vistor hf|Boehringer Ingelheim International |98|
410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|977|2094|lyfalmen|||00|20|0|Vistor hf|Recip AB|10|
410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|572|1252|lyfalmen|||23|30|0|Vistor hf|Janssen-Cilag AB|30|
411033|M03BX0104|Baklofen Merck NM|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|500|1102|lyfalmen|||00|50|0|Actavis Group PTC ehf|Merck NM AB|10|
411157|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1411|2878|lyfalmen|V0712|2464|00|50|0|Actavis Group PTC ehf|Merck NM AB|25|
411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|5729|8202|lyfsjukr|||02|50|0|Icepharma hf|Roche|16,6667|
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|20802|27766|lyfsjukr|||00|60|0|GlaxoSmithKline ehf|Glaxo Group Limited|30|
411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|614|1339|lyfalmen|||67|100|0|Vistor hf|Novartis Healthcare A/S-|25|
411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|6507|10306|lyfalmen|||98|6|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|6|
412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|18687|26316|lyfalmen|||00|1|0|Vistor hf|AstraZeneca UK Ltd|27,907|
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|2771|3967|lyfsjukr|||00|3|0|Vistor hf|Sanofi-aventis Norge AS|15|
412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|7840|15105|vetalmen|||02|100|0|Vistor hf|Merial||
412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1659|3254|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|50|
412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1060|2266|lyfalmen|||00|30|0|Actavis Group PTC ehf|Merck NM AB|30|
413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|93176|117872|lyfsjukr|||00|12|0|Icepharma hf|CSL Denmark ApS||
413369|S01AX1201|Noroxin|augndr|3|mg/ml|5|ml|1|glas||S01AX12|01.04.1992||R|A|3|0|0|E|0|LBO|0|0|1|100|XEU|507|1116|lyfalmen|||06|5|0|Laboratories THEA|Laboratories THEA||
413856|M05BA0301|Aredia|irs|15|mg/hgl|4|hgl|1|pakki|+ 4 x 5 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|25795|33982|lyfsjukr|||00|4|0|Vistor hf|Novartis Healthcare A/S-|1|
413864|M05BA0301|Aredia|irs|30|mg/hgl|2|hgl|1|pakki|+ 2 x 10 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|25795|33982|lyfsjukr|||00|2|0|Vistor hf|Novartis Healthcare A/S-|1|
414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|3557|6103|lyfalmen|||00|90|0|Icepharma hf|Servier|54|
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1136|2424|lyfalmen|||00|300|0|Vistor hf|Novartis Healthcare A/S-|6|
415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki|+stjaka|G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|1603|3169|lyfalmen|V0418|3121|05|15|0|Vistor hf|Novo-Nordisk|15|
415687|V08BA0101|E-Z-HD|mixtduft|| |12|0z|24|stk|plastdósir|V08BA01|01.01.1988||R|A|4|0|0|0|1|EZE|0|0|0|100|USD|11091|15676|lyfsjukr|||08|288|0|Icepharma hf|E-Z-Em||
415711|V08BA0102|Polibar ACB|innhl|933|mg/g|16|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|31182|40689|lyfsjukr|||00|384|0|Icepharma hf|E-Z-Em||
415737|V08BA0102|Polibar ACB|innhl|933|mg/g|20|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|38979|50396|lyfsjukr|||00|480|0|Icepharma hf|E-Z-Em||
416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2807|4998|lyfalmen|||00|28|0|Icepharma hf|M.S.D.|28|
416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|7490|11677|lyfalmen|V0198|9510|00|98|0|Icepharma hf|M.S.D.|98|
416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|2267|4178|lyfalmen|||23|10|0|Icepharma hf|Colgate Palmolive A/S||
416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|19065|26786|lyfalmen|||23|150|0|Icepharma hf|Colgate Palmolive A/S||
416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|906|1946|lyfalmen|||00|30|0|Icepharma hf|Intendis GmbH Berlin|30|
417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|415|819|vetalmen|||00|10|0|Vistor hf|Merial||
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|34047|44256|lyfsjukr|||00|60|0|GlaxoSmithKline ehf|Glaxo Group Limited|30|
418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|3635|6216|lyfalmen|||10|100|0|Vistor hf|Sanofi-aventis Norge AS|16,6667|
418665|D07XC0101|Diprosalic|smyrsli|| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1363|2805|lyfalmen|||20|50|0|Vistor hf|Schering-Plough|50|
418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|7393|11541|lyfalmen|V0299|8755|00|60|0|Vistor hf|Sanofi-aventis Norge AS|20|
418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|1526|3011|vetalmen|||13|200|0|Vistor hf|Boehringer Ingelheim Danmark||
418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|1980|3907|vetalmen|||13|200|0|Vistor hf|Boehringer Ingelheim Danmark||
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3198|5580|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|25|
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7552|11763|lyfalmen|||10|100|0|Vistor hf|LEO Pharma A/S|100|
419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|61658|78632|lyfsjukr|||00|10|0|Vistor hf|Schering-Plough||
419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|43452|55965|lyfsjukr|||00|180|0|Icepharma hf|M.S.D.|30|
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|36672|47524|lyfsjukr|||00|100|0|Swedish Orphan International AB|Orphan  Europe (S)|7,5|
419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|688|1493|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|9444|14311|lyfalmen|||02|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|40|
420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|9461|13546|lyfsjukr|||00|40|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|40|
420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|4114|6914|lyfalmen|||02|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10|
420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5973|9561|lyfalmen|||02|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|20|
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|2007|3783|lyfalmen|V0144|3722|70|30|0|Vistor hf|Sanofi-aventis Norge AS|15|
422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2748|4908|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|62,07|
422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5411|8778|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|124,13|
422402|G03FB0505|Estracomb|forðapl|| |8|stk|1|pakki|samsett pk|G03FB05|01.04.1993||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2009|3786|lyfalmen|||23|8|0|Vistor hf|Novartis Healthcare A/S-|28|
422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|DKK|6281|9991|lyfalmen|||49|100|0|Icepharma hf|Meda AS|50|
424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|917|1587|vetorma|||16|24|0|Icepharma hf|Intervet International B.V.||
425181|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|786|1696|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|100|
425538|N04BC0102|Parlodel |hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|DKK|21796|30186|lyfalmen|||52|100|0|Icepharma hf|Meda AS|25|
426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2679|4804|lyfalmen|V0555|3166|10|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1,5|
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|497|1096|lyfalmen|||00|20|0|Vistor hf|Recip AB|5|
426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|649|1412|lyfalmen|||00|30|0|Vistor hf|Recip AB|7,5|
427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|14|0|Vistor hf|McNeil Denmark ApS|5|
427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|14|0|Vistor hf|McNeil Denmark ApS|10|
427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|14|0|Vistor hf|McNeil Denmark ApS|15|
428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|779|1682|lyfalmen|||20|30|0|Vistor hf|Schering-Plough|30|
428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|709|1536|lyfalmen|||20|30|0|Vistor hf|Schering-Plough|30|
428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|25645|33796|lyfsjukr|||00|1000|0|Vistor hf|Bayer HealthCare AG|4|
428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|40162|51869|lyfsjukr|||00|2000|0|Vistor hf|Bayer HealthCare AG|8|
428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|393|879|lyfalmen|||23|14|0|Vistor hf|Astellas Pharma A/S|1,75|
428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|649|1412|lyfalmen|||23|14|0|Vistor hf|Astellas Pharma A/S|3,5|
429167|J07CA0602|Pentavac|bóluefni|| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4357|7268|lyfalmen|||AC|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
429225|J07CA0602|Pentavac|bóluefni|| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|32592|43627|lyfalmen|||AC|5|0|Icepharma hf|Sanofi Pasteur MSD||
429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|4490|7462|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|133,3333|
430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1453|2080|lyfsjukr|||02|50|0|Vistor hf|Janssen-Cilag AB||
430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1527|2186|lyfsjukr|||02|50|0|Icepharma hf|Roche|3,3333|
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|2997|5880|vetalmen|||27|100|0|Vistor hf|Schering-Plough A/S||
430710|J07AP0301|Typhim Vi|bóluefni|| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|1992|3760|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|2|
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|596|1301|lyfalmen|||20|15|0|Vistor hf|LEO Pharma A/S|15|
431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|898|1929|lyfalmen|||00|100|0|Vistor hf|Recip AB|16,6667|
431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|McNeil Denmark ApS|14|
431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|4|
431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|Vistor hf|McNeil Denmark ApS|28|
432336|J01GB0701|Netilyn|stl/irþ|10|mg/ml|1,5|ml|10|lykjur||J01GB07|01.01.1986||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|2058|2947|lyfsjukr|||02|15|0|Vistor hf|Schering-Plough|0,4286|
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11439|16969|lyfalmen|V0729|16664|00|100|0|Vistor hf|Orion Corporation|20|
433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1942|3684|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|8,4|
433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3563|6111|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|16,8|
433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|4765|7862|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25,2|
433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5965|9550|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|33,6|
433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6873|10816|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|42|
433359|N02AA0106|Contalgin Uno|forðahlk|200|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9279|14092|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56|
434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|583|1009|vetorma|||99|10|0|Icepharma hf|Intervet International B.V.||
434670|D01AC2001|Daktacort|krem|| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|1220|2588|lyfalmen|||20|50|0|Vistor hf|Janssen-Cilag AB|50|
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|5665|9132|lyfalmen|||00|1|0|Vistor hf|ALK-Abello A/S|0,6|
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|5665|9132|lyfalmen|||00|1|0|Vistor hf|ALK-Abello A/S|0,3|
435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4939|8116|lyfalmen|||00|6|0|Vistor hf|AstraZeneca UK Ltd|12|
435578|N02CC0301|Zomig|töflur|2,5|mg|3|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|2115|3947|lyfalmen|||00|3|0|Vistor hf|AstraZeneca UK Ltd|3|
435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4132|6940|lyfalmen|||00|6|0|Vistor hf|AstraZeneca UK Ltd|6|
435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|6105|9745|lyfalmen|V0725|8256|00|100|0|Vistor hf|AstraZeneca UK Ltd|6,25|
435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|2090|3909|lyfalmen|||00|250|0|Vistor hf|Recip AB|41,67|
436022|C09DA0305|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2915|5162|lyfalmen|||00|28|0|Vistor hf|Novartis Healthcare A/S-|28|
436030|C09DA0305|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|8354|12859|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|98|
436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4985|8183|lyfalmen|||00|210|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|8,75|
436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|839|1807|lyfalmen|||00|21|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,75|
436147|M01AE0216|Naproxen-E Merck NM |sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|E|0|MNA|0|0|1|100|SEK|430|956|lyfalmen|||10|20|0|Actavis Group PTC ehf|Merck NM AB|10|
436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|5486|8882|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|14|
436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|9947|14981|lyfalmen|V0728|14646|00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|28|
436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|21144|29375|lyfalmen|||00|84|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|70|
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|580|1268|lyfalmen|||20|15|0|Vistor hf|LEO Pharma A/S|15|
436527|M01AE0216|Naproxen-E Merck NM |sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1637|3221|lyfalmen|||10|100|0|Actavis Group PTC ehf|Merck NM AB|50|
436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|656|1426|lyfalmen|||10|20|0|Actavis Group PTC ehf|Merck NM AB|15|
436626|M01AE0216|Naproxen-E Merck NM |sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|2709|4849|lyfalmen|||10|100|0|Actavis Group PTC ehf|Merck NM AB|75|
436808|M01AE0216|Naproxen-E Merck NM |sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3098|5434|lyfalmen|||10|100|0|Actavis Group PTC ehf|Merck NM AB|100|
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|763|1649|lyfalmen|||00|100|0|Vistor hf|Janssen-Cilag AB|12,5|
436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|2673|4795|lyfalmen|||00|100|0|Vistor hf|Janssen-Cilag AB|50|
438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|12324|18394|lyfalmen|V0955|14514|00|100|0|Icepharma hf|Wyeth AB|75|
438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|6270|9975|lyfalmen|V0954|8857|00|28|0|Icepharma hf|Wyeth AB|42|
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|798|1721|lyfalmen|||00|10|0|K.Pétursson hf|Alcon||
438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|3306|5737|lyfalmen|||00|28|0|Icepharma hf|Wyeth AB|21|
438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|11387|16900|lyfalmen|V0955|14224|00|98|0|Icepharma hf|Wyeth AB|73,5|
438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|21518|29840|lyfalmen|V0956|25272|00|98|0|Icepharma hf|Wyeth AB|147|
438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|23267|32018|lyfalmen|V0956|25788|00|100|0|Icepharma hf|Wyeth AB|150|
438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|1536|3068|lyfalmen|V0982|1678|00|30|0|Vistor hf|Schering-Plough|30|
438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|4638|7677|lyfalmen|V0984|3892|00|100|0|Vistor hf|Schering-Plough|100|
439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1890|3605|lyfalmen|||66|14|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|7|
439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8558|13131|lyfalmen|||00|98|0|Vistor hf|AstraZeneca A/S DK|98|
440123|S01BA0401|Ultracortenol|augndr|5|mg/ml|5|ml|1|glas||S01BA04|01.12.1972||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|569|1245|lyfalmen|||29|5|0|Vistor hf|Novartis Healthcare A/S-||
440677|J01CE0105|Penicillin Alpharma|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1159|1659|lyfsjukr|||00|10|0|Actavis Group hf|Actavis Group hf|1,67|
440693|J01CE0105|Penicillin Alpharma|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1831|2622|lyfsjukr|||00|10|0|Actavis Group hf|Actavis Group hf|3,33|
441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1133|2418|lyfalmen|V0221|2405|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|33,3333|
441279|D01AC2002|Pevisone|krem|| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|720|1559|lyfalmen|||20|30|0|Vistor hf|Janssen-Cilag AB|30|
441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|GBP|||lyflausa|||00|59|0|GlaxoSmithKline ehf|ACO Hud AB||
441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|735|1590|lyfalmen|||00|30|0|Icepharma hf|Bayer Schering Pharma AG|30|
442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|25030|33030|lyfsjukr|||61|40|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|16,6667|
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|2871|5095|lyfalmen|||02|1|0|Vistor hf|Novo-Nordisk|1|
443333|N02AA0101|Contalgin|forðatfl|200|mg|30|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|8486|13035|lyfalmen|||10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|24837|33972|lyfalmen|||10|90|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|180|
444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|35340|45866|lyfsjukr|||00|56|0|Vistor hf|Bristol-Myers Squibb|21|
444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|35845|46495|lyfsjukr|||00|56|0|Vistor hf|Bristol-Myers Squibb|28|
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2235|4129|lyfalmen|||00|100|0|Icepharma hf|Roche|8,3333|
444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|14511|19934|lyfsjukr|||00|2|0|Icepharma hf|Roche|0,33|
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1411|2878|lyfalmen|||00|30|0|Vistor hf|LEO A/S|30|
445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|12024|18020|lyfalmen|V0411|8146|10|98|0|Icepharma hf|M.S.D.|98|
445965|H01AC0104|Saizen|sts|| |1,33|mg|1|hgl|+ leysir|H01AC01|01.07.1992||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|4380|6271|lyfsjukr|||02|1,33|0|Gróco ehf|Serono Nordic|2|
446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1132|2234|vetalmen|||27|50|0|Icepharma hf|Intervet International B.V.||
446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3165|5532|lyfalmen|V0551|3607|10|7|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1,75|
446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1348|2782|lyfalmen|V0554|1767|10|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,75|
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8822|13483|lyfalmen|||00|3,6|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3,6|
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|5033|8251|lyfalmen|||00|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2|
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6165|9829|lyfalmen|||00|2,5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2,5|
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7402|11554|lyfalmen|||00|3|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3|
448217|C05AA0801|Doloproct|eþ-stil|| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|466|1031|lyfalmen|||04|10|0|Icepharma hf|Intendis GmbH Berlin||
448233|C05AA0802|Doloproct Comp.|eþ-krem|| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|910|1954|lyfalmen|||00|30|0|Icepharma hf|Intendis GmbH Berlin||
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1155|2464|lyfalmen|V0712|2464|00|50|0|Vistor hf|Novartis Healthcare A/S-|25|
449595|C07AB0310|Atenolol Merck NM|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|700|1518|lyfalmen|V0298|1304|00|98|0|Actavis Group PTC ehf|Merck NM AB|65,3333|
449611|C07AB0310|Atenolol Merck NM|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1028|2200|lyfalmen|V0306|1722|00|98|0|Actavis Group PTC ehf|Merck NM AB|130,6667|
449819|J01CE0105|Penicillin Alpharma|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|4341|6215|lyfsjukr|||00|10|0|Actavis Group hf|Actavis Group hf|8,33|
450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2381|lyfalmen|V0466|2378|00|12|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10,5|
450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|934|2004|lyfalmen|V0902|1133|00|20|0|Vistor hf|Sanofi-aventis Norge AS|20|
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3475|5983|lyfalmen|V0903|4409|00|100|0|Vistor hf|Sanofi-aventis Norge AS|100|
451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|4483|7451|lyfalmen|||00|28|0|Lundbeck Export A/S|Lundbeck|42|
451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LUN|0|1|0|30|DKK|14870|21563|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|150|
452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|12991|19224|lyfalmen|V0552|12059|10|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7,5|
452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|909|1952|lyfalmen|||00|5|0|Icepharma hf|Roche as|5|
452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|43507|57216|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|DKK|10176|15287|lyfalmen|||00|3000|0|Vistor hf|Laboratories 3M Santé|3|
452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2001|3774|lyfalmen|||10|28|0|Icepharma hf|Norpharma |3,73|
452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|6587|10417|lyfalmen|||10|98|0|Icepharma hf|Norpharma |13,07|
452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2166|4024|lyfalmen|||10|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|33,3333|
452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|3780|6427|lyfalmen|||10|28|0|Icepharma hf|Norpharma |7,47|
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|1156|2001|vetorma|||16|6,4|0|Vistor hf|Merial (MSD)||
453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|11967|17672|lyfalmen|||10|98|0|Icepharma hf|Norpharma |26,13|
453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7614|11850|lyfalmen|||10|28|0|Icepharma hf|Norpharma |14,93|
453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|24856|33996|lyfalmen|||10|98|0|Icepharma hf|Norpharma |52,27|
453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|2828|4049|lyfsjukr|||02|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,5|
453795|J07AL0102|Pneumo 23|bóluefni|| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|1803|3473|lyfalmen|||00|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|7969|12345|lyfalmen|V0365|2462|00|98|0|Icepharma hf|M.S.D.|130,6667|
454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12038|18038|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|18,6667|
454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|37531|49776|lyfalmen|V0375|49776|00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|65,3333|
454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|13582|19960|lyfalmen|||00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|37,3333|
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|40740|53772|lyfalmen|V0376|53772|00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|130,6667|
454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|43870|56486|lyfsjukr|||00|1|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|857|1691|vetalmen|||16|100|0|Vistor hf|Boehringer Ingelheim Danmark||
455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|750|1622|lyfalmen|||00|30|0|Vistor hf|Bayer HealthCare AG|5|
455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|2695|4828|lyfalmen|||00|120|0|Vistor hf|Bayer HealthCare AG|20|
455428|B03XA0103|NeoRecormon |sts|10000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|50096|64237|lyfsjukr|||00|3|0|Icepharma hf|Roche|30|
455527|B03XA0103|NeoRecormon |sts|20000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|99605|125876|lyfsjukr|||00|3|0|Icepharma hf|Roche|60|
455576|B03XA0103|NeoRecormon |sts|100000|ae/hgl|5|ml|1|hgl|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|162974|204770|lyfsjukr|||00|5|0|Icepharma hf|Roche|10|
455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|30|DKK|17176|24434|lyfalmen|||00|21|0|Vistor hf|Novartis Healthcare A/S-|14|
455717|C05AD0102|Sulgan|eþ-smyr|| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|CHF|||lyfalmen|||00|30|0|Icepharma hf|Doetsch Grether||
455725|C05AD0102|Sulgan|eþ-stil|| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|CHF|||lyfalmen|||00|10|0|Icepharma hf|Doetsch Grether||
456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|3605|5161|lyfsjukr|||00|12000|0|Icepharma hf|Baxter|12|
456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|3605|5161|lyfsjukr|||00|12000|0|Icepharma hf|Baxter|12|
456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|3935|5634|lyfsjukr|||00|10000|0|Icepharma hf|Baxter||
456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|3935|5634|lyfsjukr|||00|10000|0|Icepharma hf|Baxter||
457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5892|8436|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10|
457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5892|8436|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10|
457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5892|8436|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10|
457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7375|10559|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10|
457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7190|10294|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10|
457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9559|13686|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10|
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|866|1863|lyfalmen|||00|25|0|Vistor hf|Astra|5|
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1431|2908|lyfalmen|||43|20|0|Vistor hf|LEO Pharma A/S|6,6667|
458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2072|3882|lyfalmen|||43|30|0|Vistor hf|LEO Pharma A/S|10|
458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|6843|10774|lyfalmen|V0456|10774|00|100|0|Vistor hf|LEO Pharma A/S|33,3333|
458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9634|13793|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10|
458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9634|13793|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10|
458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9634|13793|lyfsjukr|||00|10000|0|Icepharma hf|Baxter|10|
459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|| |2000|ml|5|pokar||B05DB00|01.06.2004||R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|11462|16138|lyfsjukr|||00|10000|0|Icepharma hf|Baxter Medical AB|10|
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1114|1595|lyfsjukr|||02|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,1667|
459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|66903|85162|lyfsjukr|||00|10|0|Icepharma hf|Roche|1,67|
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1366|1956|lyfsjukr|||02|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,3333|
459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1585|3142|lyfalmen|||06|15|0|Icepharma hf|Santen Oy|75|
459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1738|3374|lyfalmen|||06|15|0|Icepharma hf|Santen Oy|75|
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|1757|3403|lyfalmen|||00|30|0|Icepharma hf|Meda AS|7,5|
459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|3572|6124|lyfalmen|||00|60|0|Icepharma hf|Meda AS|15|
460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|789|1703|lyfalmen|||23|20|0|Vistor hf|Astellas Pharma A/S|5|
460170|J07BC0202|Avaxim|bóluefni|| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|3330|5772|lyfalmen|||51|0,5|0|Icepharma hf|Aventis Pasteur MSD A/S||
460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1181|2518|lyfalmen|||23|20|0|Vistor hf|Astellas Pharma A/S|10|
460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2147|3996|lyfalmen|||23|20|0|Vistor hf|Astellas Pharma A/S|15|
460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|14184|19527|lyfsjukr|||00|20|0|Vistor hf|Schering-Plough||
460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1491|2999|lyfalmen|V0355|2058|23|120|0|Vistor hf|Janssen-Cilag AB|120|
460972|J07BB0205|Influvac|bóluefni|| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOP|0|0|0|100|XEU|4763|7859|lyfalmen|||51|5|0|Icepharma hf|Solvay Pharmaceuticals||
461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|56732|72499|lyfsjukr|||00|20|0|Vistor hf|Schering-Plough||
461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|69358|88218|lyfsjukr|||00|5|0|Vistor hf|Schering-Plough||
461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|177285|222587|lyfsjukr|||00|5|0|Vistor hf|Schering-Plough||
462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|550|1206|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
462036|D07AD0101|Dermovat|krem|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2162|4018|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|550|1206|lyfalmen|||20|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
462051|D07AD0101|Dermovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2162|4018|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
462143|B05AA0703|Hemohes 10%|irl|100|mg/ml|500|ml|10|fl||B05AA07|01.11.1999||R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|16825|22815|lyfsjukr|||00|5000|0|Actavis Group hf|Braun|5|
462226|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|10|fl||B05AA07|01.11.1999||R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|12675|17648|lyfsjukr|||00|5000|0|Actavis Group hf|Braun|5|
462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6329|10058|lyfalmen|V0297|9540|56|7|0|Vistor hf|AstraZeneca A/S DK|7|
462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PFI|1|0|0|100|DKK|5252|10175|vetalmen|||02|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4190|8153|vetalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|OVA|0|1|0|100|DKK|1386|2840|lyfalmen|||00|100|0|Swedish Orphan International AB|Ovation Healthcare International Ltd.|8,3333|
465203|QJ01RA0103|Depomycine, vet.|stl|| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|S|3|0|0|0|0|INI|0|0|0|100|DKK|931|1837|vetalmen|||58|100|0|Icepharma hf|Intervet International B.V.||
465237|QJ01CR5001|Duplocillin L.A., vet.|stl|| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|879|1735|vetalmen|||58|100|0|Icepharma hf|Intervet International B.V.||
465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|942|1859|vetalmen|||27|100|0|Icepharma hf|Intervet International B.V.||
465278|QJ51RC2301|Nafpenzal DC,  vet.|spenalyf|| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|497|981|vetalmen|||16|12|0|Icepharma hf|Intervet International B.V.||
466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|588|1285|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2,5|
466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2063|3868|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10|
466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1250|2633|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|7,5|
466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5019|8231|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2404|4386|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|15|
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|6709|10588|lyfalmen|||10|50|0|Vistor hf|Novartis Healthcare A/S-|5|
466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3849|6528|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|25|
466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|ROC|0|1|0|100|DKK|3918|6628|lyfalmen|||64|100|0|Icepharma hf|Roche|50|
467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|12430|17343|lyfsjukr|||00|0,5|0|Vistor hf|Amgen Europe B.V.|0,86|
467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|19480|26120|lyfsjukr|||00|0,5|0|Vistor hf|Amgen Europe B.V.|1,37|
467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|21093|28128|lyfsjukr|||00|1,2|0|Vistor hf|Schering-Plough|9|
467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|34357|44642|lyfsjukr|||00|1,2|0|Vistor hf|Schering-Plough|15|
467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|USD|25989|35407|lyfalmen|||00|60|0|Icepharma hf|Wyeth Europe|20|
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|13007|19244|lyfalmen|||10|50|0|Vistor hf|Novartis Healthcare A/S-|10|
467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|70327|89425|lyfsjukr|||00|1,2|0|Vistor hf|Schering-Plough|30|
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|24617|33698|lyfalmen|||10|50|0|Vistor hf|Novartis Healthcare A/S-|20|
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|616|882|lyfsjukr|||00|5|0|Vistor hf|Janssen-Cilag AB|3,125|
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|5021|8234|lyfalmen|V0922|5553|00|100|0|Lundbeck Export A/S|Lundbeck|50|
468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|359|514|lyfsjukr|||02|10|0|Vistor hf|Janssen-Cilag AB||
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|8760|13400|lyfalmen|V0926|5301|00|100|0|Lundbeck Export A/S|Lundbeck|100|
468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LUN|0|1|0|30|DKK|18473|26049|lyfalmen|V0930|10443|00|100|0|Lundbeck Export A/S|Lundbeck|200|
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|7962|12335|lyfalmen|||00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|49|
469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2274|4189|lyfalmen|||00|20|0|Icepharma hf|Grunenthal|13,3333|
469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|9268|14077|lyfalmen|V0738|12008|00|100|0|Icepharma hf|Grunenthal|66,6667|
469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1778|3435|lyfalmen|||00|20|0|Icepharma hf|Grunenthal|10|
469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|7037|11045|lyfalmen|V0736|9416|00|100|0|Icepharma hf|Grunenthal|50|
469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1208|2569|lyfalmen|V0733|2160|00|20|0|Icepharma hf|Grunenthal|6,6667|
469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|4807|7923|lyfalmen|V0734|6492|00|100|0|Icepharma hf|Grunenthal|33,3333|
470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4438|7386|lyfalmen|||24|120|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|50|
471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1559|3103|lyfalmen|||68|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50|
471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|1058|1831|vetorma|||99|20|0|Icepharma hf|Intervet International B.V.||
471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|1816|3493|lyfalmen|||00|100|0|Icepharma hf|Baxter Medical AB||
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|3730|7276|vetalmen|||27|10|0|Vistor hf|Orion Corporation||
472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1821|3500|lyfalmen|||43|98|0|Vistor hf|AstraZeneca A/S DK|31,03|
472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2055|3856|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|11425|16092|lyfsjukr|||00|400|0|Icepharma hf|Meda AB|0,4|
474106|M02AA1301|Deep Relief |hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|GBP|||lyflausa|||00|50|0|Icepharma hf|Mentholatum Company Ltd.||
474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|819|1765|lyfalmen|||00|30|0|Vistor hf|Recip AB|15|
474197|M02AA1301|Deep Relief |hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|GBP|||lyflausa|||00|15|0|Icepharma hf|Mentholatum Company Ltd.||
474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|32640|42504|lyfsjukr|||00|60|0|Vistor hf|Boehringer Ingelheim International |30|
474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1511|3030|lyfalmen|||00|140|0|Vistor hf|Schering-Plough|35|
475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3334|5778|lyfalmen|||23|26|0|Vistor hf|Janssen-Cilag AB|91|
475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|4886|8038|lyfalmen|||00|98|0|Icepharma hf|Roche|98|
475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2726|4875|lyfalmen|||00|60|0|Vistor hf|AstraZeneca A/S DK|11,25|
475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|3549|6091|lyfalmen|||00|60|0|Vistor hf|AstraZeneca A/S DK|22,5|
475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|9370|14213|lyfalmen|||00|98|0|Icepharma hf|Roche|196|
476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|948|2033|lyfalmen|||00|50|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10|
476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|5560|8985|lyfalmen|||00|30|0|Vistor hf|AstraZeneca UK Ltd|7,5|
476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|8450|12987|lyfalmen|||00|30|0|Vistor hf|AstraZeneca UK Ltd|15|
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|3723|6344|lyfalmen|||00|12|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|3|
477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|200|0|Icepharma hf|Fresenius Kabi||
477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|500|0|Icepharma hf|Fresenius Kabi||
477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|1000|0|Icepharma hf|Fresenius Kabi||
479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|DKK|7287|11394|lyfalmen|||00|98|0|Icepharma hf|Meda AS|130,6667|
479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|DKK|15634|22515|lyfalmen|||00|98|0|Icepharma hf|Meda AS|261,3333|
481168|N06AX1201|Zyban |forðatfl|150|mg|60|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|6234|9925|lyfalmen|V1155|9752|00|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
481176|N06AX1201|Zyban |forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|9621|14547|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|50|
481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|31075|40556|lyfsjukr|||02|1|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB||
483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|48627|63591|lyfalmen|V0557|36618|10|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|28|
483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|2819|4036|lyfsjukr|||00|50|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|0,5|
483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|Vistor hf|McNeil Denmark ApS|2|
483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|Vistor hf|McNeil Denmark ApS|7|
483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5570|7975|lyfsjukr|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1|
484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|64468|82130|lyfsjukr|||00|3|0|Vistor hf|Ferring|83,9552|
484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|5247|8549|lyfalmen|||00|28|0|Icepharma hf|M.S.D.|28|
484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|DKK|961|2060|lyfalmen|||00|300|0|Vistor hf|Meda AB (V)||
486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|E|0|MNA|0|0|1|100|SEK|195|468|lyfalmen|||00|20|0|Actavis Group PTC ehf|Merck NM AB|10|
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|442|981|lyfalmen|||29|5|0|K.Pétursson hf|Alcon||
486886|S01CA0101|Maxitrol|augndr|| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|435|967|lyfalmen|||29|5|0|K.Pétursson hf|Alcon||
487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|1950|3696|lyfalmen|||00|30|0|Icepharma hf|Servier|15|
487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|2845|5056|lyfalmen|||00|30|0|Icepharma hf|Servier|30|
487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|653|1420|lyfalmen|||00|25|0|Vistor hf|Recip AB|6,25|
488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|702|1522|lyfalmen|||00|20|0|Icepharma hf|Meda AB|10|
488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2090|3909|lyfalmen|||00|60|0|Icepharma hf|Meda AB|30|
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ROC|0|0|0|100|DKK|7627|11868|lyfalmen|||67|50|0|Icepharma hf|Roche|14,2857|
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ROC|0|0|0|100|DKK|13767|20190|lyfalmen|||67|50|0|Icepharma hf|Roche|35,7143|
489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|DKK|339|767|lyfalmen|||67|10|0|Vistor hf|Novartis Healthcare A/S-|5|
489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|DKK|963|2064|lyfalmen|V0609|1085|67|30|0|Vistor hf|Novartis Healthcare A/S-|15|
490417|G03FB0504|Evorel Sequi|forðapl|| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|1964|3718|lyfalmen|||23|8|0|Vistor hf|Janssen-Cilag AB|28|
490425|G03FA0104|Evorel Conti|forðapl|| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2302|4231|lyfalmen|||23|8|0|Vistor hf|Janssen-Cilag AB|28|
490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|6720|9621|lyfsjukr|||00|5|0|Icepharma hf|Roche as|1,6667|
490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3697|6307|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8480|13027|lyfalmen|V0337|8383|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|100|
490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5737|9232|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12035|18034|lyfalmen|V0338|11380|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|200|
490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8906|13595|lyfalmen|||00|30|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|120|
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|15307|22107|lyfalmen|V0339|14060|00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|400|
491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|17267|24548|lyfalmen|||00|120|0|Vistor hf|Novartis Europharm Ltd|26,67|
491753|C10AC0102|Questran Loc|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1992||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|2047|3844|lyfalmen|||00|50|0|Vistor hf|Bristol-Myers Squibb|14,2857|
491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|37916|49073|lyfsjukr|||00|3|0|Icepharma hf|N.V. Organon|21,0084|
492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2659|4773|lyfalmen|||10|100|0|Icepharma hf|Roche|16,6667|
492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|6620|10463|lyfalmen|||00|100|0|Vistor hf|AstraZeneca A/S DK|50|
492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1155|2464|lyfalmen|V1140|2104|00|100|0|Actavis Group PTC ehf|Merck NM AB|16,6667|
492678|N06AX0303|Mianserin NM Pharma|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|3068|5390|lyfalmen|||00|100|0|Actavis Group PTC ehf|Merck NM AB|50|
493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|3355|5808|lyfalmen|||00|28|0|Vistor hf|Bristol-Myers Squibb|28|
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1272|2667|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|16,6667|
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3077|5403|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|33,3333|
494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|68440|87075|lyfsjukr|||00|20|0|Icepharma hf|Roche Registration Limited||
494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|171101|214888|lyfsjukr|||00|50|0|Icepharma hf|Roche Registration Limited||
494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1777|3434|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|60|
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2027|3813|lyfalmen|V0408|1520|23|84|0|Vistor hf|Novo-Nordisk|84|
494724|G03FA0102|Kliogest|töflur|| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2571|4640|lyfalmen|V0388|3555|23|84|0|Vistor hf|Novo-Nordisk|84|
494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|2476|4495|lyfalmen|||00|60|0|Vistor hf|Boehringer Ingelheim International |30|
495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|E|0|GSK|0|0|0|30|GBP|2622|4717|lyfalmen|||14|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|15|
495267|A04AA0101|Zofran|töflur|4|mg|100|stk|1|glas||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|70737|89935|lyfsjukr|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|25|
495275|A04AA0101|Zofran|töflur|8|mg|100|stk|1|glas||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|99649|125931|lyfsjukr|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|50|
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|15277|20887|lyfsjukr|||00|15|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|7,5|
495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|5942|8507|lyfsjukr|||02|10|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25|
495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8489|12154|lyfsjukr|||02|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2,5|
495572|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|13443|19787|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|33,33|
495580|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|22661|31263|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|44,44|
495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2331|4275|lyfalmen|||00|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5|
496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3367|5826|lyfalmen|||02|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,8333|
496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|850|1830|lyfalmen|||00|50|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|8,3333|
496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|2668|4787|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|33,3333|
496935|N02AG0201|Ketogan|eþ-stil|| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|437|971|lyfalmen|||04|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4|
496950|N02AG0201|Ketogan|töflur|| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|664|1443|lyfalmen|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2|
497099|N02AG0201|Ketogan|töflur|| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|2528|4574|lyfalmen|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10|
497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|SEK|||lyflausa|||00|250|0|Icepharma hf|Bioglan AB|250|
497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|649|1412|lyfalmen|||20|30|0|Icepharma hf|Bioglan AB|30|
498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1066|2279|lyfalmen|||03|2|0|Vistor hf|Schering-Plough|35|
498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|14342|20906|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|14|
498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|15462|22300|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|28|
499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|20922|29098|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|42|
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|24042|32983|lyfalmen|||00|56|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56|
500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|649|1412|lyfalmen|||20|30|0|Icepharma hf|Bioglan AB|30|
500751|M01AB0101|Confortid|hylki|50|mg|30|stk|1|plglas||M01AB01|01.01.1977||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|748|1617|lyfalmen|||10|30|0|Actavis Group hf|Actavis Group hf|15|
500769|M01AB0101|Confortid|hylki|50|mg|100|stk|1|glas||M01AB01|01.01.1977||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2297|4223|lyfalmen|||10|100|0|Actavis Group hf|Actavis Group hf|50|
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2775|4949|lyfalmen|||10|100|0|Icepharma hf|Roche|16,6667|
502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1652|3244|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100|
502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2337|4284|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|25|
502930|N05AB0301|Trilafon|töflur|16|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|3405|5881|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|53,3333|
503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|24187|31980|lyfsjukr|||00|1|0|Vistor hf|Ferring|27,9851|
503722|A01AC0102|Kenalog|munnh.pa|1|mg/g|10|g|1|túpa||A01AC01|01.05.1998||R|A|5|0|0|E|0|BRS|0|0|1|100|DKK|887|1906|lyfalmen|||20|10|0|Vistor hf|Bristol-Myers Squibb||
503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|1773|3428|lyfalmen|||20|50|0|Vistor hf|Sanofi-aventis Norge AS|50|
504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1740|3377|lyfalmen|||00|90|0|Icepharma hf|N.V. Organon|45|
504746|R06AB0201|Polaramin|forðatfl|6|mg|50|stk|1|þpakki||R06AB02|01.01.1977||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1014|2171|lyfalmen|||10|50|0|Vistor hf|Schering-Plough|50|
504753|R06AB0201|Polaramin|töflur|2|mg|50|stk|1|pakki|þp|R06AB02|01.06.2007||R|A|5|0|0|E|0|SCP|0|0|0|100|DKK|473|1046|lyfalmen|||00|50|0|Vistor hf|Schering-Plough||
504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1000|2141|lyfalmen|||00|100|0|Icepharma hf|Roche|30|
505644|A01AA0104|Fluorette|tyggigúm|0,25|mg|90|stk|1|stk||A01AA01|01.01.1996||L|A|1,5|0|0|0|0|FET|0|0|1|100|DKK|||lyfalmen|||00|90|0|Icepharma hf|Fertin A/S|20,4545|
505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|6429|10197|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|75|
505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|2588|3705|lyfsjukr|||02|5|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|5038|7213|lyfsjukr|||02|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|8939|12798|lyfsjukr|||02|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|2447|3503|lyfsjukr|||02|20|0|Vistor hf|Schering-Plough|0,8333|
506949|N01AB0601|Forene|innönd.l|| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|22685|30110|lyfsjukr|||00|250|0|Vistor hf|Abbott Scandinavia AB||
506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1918|3648|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|50|
506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||10|25|0|Vistor hf|Orion Pharma|12,5|
507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|313|713|lyfalmen|||10|100|0|Vistor hf|Orion Pharma|50|
507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PFI|0|0|0|100|DKK|516|893|vetorma|||16|24|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PFI|0|0|0|100|DKK|2193|3795|vetorma|||16|120|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|7118|12318|vetorma|||13|1000|0|Icepharma hf|Intervet International B.V.||
507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|1969|3885|vetalmen|||27|50|0|Vistor hf|Schering-Plough A/S||
508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|4182|7013|lyfalmen|||10|98|0|Vistor hf|Abbott Scandinavia AB|98|
508952|G03FB0902|Nuvelle|töflur|| |84|stk|1|þpakki||G03FB09|01.08.1997||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2687|4816|lyfalmen|||00|84|0|Icepharma hf|Bayer Schering Pharma AG|84|
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LUN|0|1|0|100|DKK|7816|12131|lyfalmen|||02|10|0|Lundbeck Export A/S|Lundbeck|133,3333|
509091|J01CF0101|Diclocil|hylki|500|mg|100|stk|1|þpakki||J01CF01|01.09.1977||R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|7335|11460|lyfalmen|||10|100|0|Vistor hf|Bristol-Myers Squibb|25|
509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|1054|2254|lyfalmen|||00|15|0|Icepharma hf|N.V. Organon|75|
509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|322|732|lyfalmen|||23|40|0|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|40|
509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|363|817|lyfalmen|||23|40|0|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|40|
509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982||R|A|3|0|0|0|0|STI|0|0|0|100|XEU|266|615|lyfalmen|||23|30|0|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|30|
509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|322|732|lyfalmen|||23|40|0|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|40|
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|39513|51061|lyfsjukr|||00|60|0|GlaxoSmithKline ehf|Glaxo Group Limited||
510248|B03XA0103|NeoRecormon |stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|10291|14680|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|6|
510255|B03XA0103|NeoRecormon |stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|20583|27493|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|12|
510263|B03XA0103|NeoRecormon |stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|30048|39277|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|18|
510271|B03XA0103|NeoRecormon |stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|50753|65055|lyfsjukr|||00|1,8|0|Icepharma hf|Roche|30|
510305|B03XA0103|NeoRecormon |stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|94016|118917|lyfsjukr|||00|3,6|0|Icepharma hf|Roche|60|
510321|B03XA0103|NeoRecormon |stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|192472|241495|lyfsjukr|||00|3,6|0|Icepharma hf|Roche|120|
511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|2232|4125|lyfalmen|||00|28|0|Vistor hf|Boehringer Ingelheim International |14|
511303|G03FB0501|Trisekvens|töflur|| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2108|3936|lyfalmen|V0385|3857|23|84|0|Vistor hf|Novo-Nordisk|84|
511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|17187|23265|lyfsjukr|||00|6000|0|Icepharma hf|Meda AB|6|
511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|10752|15254|lyfsjukr|||00|6000|0|Icepharma hf|Meda AB|6|
512608|B05XA3101|Peditrace|irþ|| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|7447|10662|lyfsjukr|||00|100|0|Icepharma hf|Fresenius Kabi|0,1|
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|SEK|482|1064|lyfalmen|||00|35|0|Vistor hf|AstraZeneca A/S DK||
514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1614|3186|lyfalmen|||23|200|0|Vistor hf|AstraZeneca A/S DK|25|
515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|1644|3232|lyfalmen|||00|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|10|
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|3994|6739|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|30|
516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|E|0|AZD|0|0|0|30|SEK|1265|2656|lyfalmen|||00|14|0|Vistor hf|AstraZeneca A/S DK|7|
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3087|5418|lyfalmen|||00|90|0|Vistor hf|Novo-Nordisk|11,25|
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3623|6199|lyfalmen|||00|90|0|Vistor hf|Novo-Nordisk|22,5|
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4457|7414|lyfalmen|||00|90|0|Vistor hf|Novo-Nordisk|45|
518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|718|1555|lyfalmen|||00|20|0|Actavis Group hf|Actavis Group hf|15|
518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3416|5897|lyfalmen|||00|100|0|Actavis Group hf|Actavis Group hf|75|
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1632|3213|lyfalmen|||23|84|0|Icepharma hf|N.V. Organon|84|
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|814|1755|lyfalmen|||08|125|0|Vistor hf|Recip AB|3,125|
519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|6479|10267|lyfalmen|||02|2|0|Gróco ehf|Nycomed Danmark A/S|5,7222|
520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|3668|6264|lyfalmen|||00|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|2|
520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|4143|6956|lyfalmen|||00|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|4|
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|12907|19119|lyfalmen|||00|12|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|12|
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|4447|7399|lyfalmen|V1300|7269|00|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|8|
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|13667|20066|lyfalmen|||00|12|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|24|
520759|M03BC5101|Norgesic|töflur|| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|DKK|293|671|lyfalmen|||00|30|0|Vistor hf|Meda AB (V)|8,75|
521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|27142|36842|lyfalmen|||00|100|0|Vistor hf|Boehringer Ingelheim International |28|
522003|QJ51RC2302|Streptocillin, vet.|spenalyf|| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|6255|12086|vetalmen|||16|320|0|Vistor hf|Boehringer Ingelheim Danmark||
522599|J07CA0202|Tetravac|bóluefni|| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3,5|0|0|0|0|SPM|0|0|0|100|XEU|2606|4693|lyfalmen|||AC|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|208006|260835|lyfsjukr|||00|1|0|Vistor hf|Novartis Europharm Ltd|0,5|
522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|359|809|lyfalmen|||00|20|0|Vistor hf|Lannacher Heimittel Gmbh|3,33|
522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|1482|2986|lyfalmen|||00|100|0|Vistor hf|Lannacher Heimittel Gmbh|16,67|
522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|7624|11863|lyfalmen|||00|250|0|Vistor hf|Lannacher Heimittel Gmbh|208,3333|
522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|674|1464|lyfalmen|V0732|1464|02|10|0|Vistor hf|Lannacher Heimittel Gmbh|1,6667|
522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|6959|10936|lyfalmen|||00|120|0|Vistor hf|LEO Pharma A/S||
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|968|2075|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|100|
523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|18685|26313|lyfalmen|||00|84|0|Vistor hf|Schering-Plough|28|
524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|326|740|lyfalmen|||22|30|0|Actavis Group hf|Actavis Group hf|3|
524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|304|694|lyfalmen|||22|30|0|Actavis Group hf|Actavis Group hf|6|
525014|M03BC5101|Norgesic|töflur|| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|DKK|805|1736|lyfalmen|||00|100|0|Vistor hf|Meda AB (V)|29,2|
525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|791|1707|lyfalmen|||00|15|0|Vistor hf|Novartis Healthcare A/S-||
525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPF|0|0|0|100|DKK|8647|13250|lyfalmen|||00|30|0|Icepharma hf|Cephalon France|10|
526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|5710|9195|lyfalmen|||00|100|0|Icepharma hf|Roche|33,3333|
526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3605|6173|lyfalmen|||10|100|0|Vistor hf|Desitin Artzneimittel|20|
526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|SPA|0|0|0|100|DKK|5217|10109|vetalmen|||16|187,5|0|Vistor hf|Schering-Plough A/S||
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3198|5580|lyfalmen|||10|100|0|Vistor hf|Desitin Artzneimittel|40|
527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|11894|16676|lyfsjukr|||00|2000|0|Vistor hf|Sanofi-aventis Norge AS|6,6667|
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|805|1736|lyfalmen|||00|5|0|K.Pétursson hf|Alcon||
529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|1501|2149|lyfsjukr|||00|7|0|Vistor hf|Schering-Plough|1,75|
529438|QJ51RC2002|Ampiclox vet.|spenalyf|| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PFV|0|0|0|100|DKK|3348|6549|vetalmen|||16|72|0|Icepharma hf|Pfizer vet.||
529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PFV|0|0|0|100|DKK|2883|5663|vetalmen|||16|100|0|Icepharma hf|Pfizer vet.||
529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|3839|5496|lyfsjukr|||00|7|0|Vistor hf|Schering-Plough|7|
529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|62570|79767|lyfsjukr|||00|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|11,1|
530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|8590|12299|lyfsjukr|||00|1|0|Icepharma hf|CSL Denmark ApS||
530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|23294|30869|lyfsjukr|||00|3|0|Icepharma hf|CSL Denmark ApS||
530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|46588|59870|lyfsjukr|||00|6|0|Icepharma hf|CSL Denmark ApS||
530741|G03FA0105|Activelle|töflur|| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2702|4839|lyfalmen|||23|84|0|Vistor hf|Novo-Nordisk|84|
531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2197|4072|lyfalmen|||43|100|0|Vistor hf|AstraZeneca A/S DK|50|
531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|7092|10154|lyfsjukr|||00|240|0|Vistor hf|Boehringer Ingelheim International |6|
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|279|642|lyfalmen|||01|30|0|Vistor hf|Janssen-Cilag AB|3|
533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1483|2987|lyfalmen|||43|100|0|Vistor hf|AstraZeneca A/S DK|33,3333|
535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|4897|8055|lyfalmen|||00|84|0|Vistor hf|Sanofi-aventis Norge AS|28|
536029|S01EB0105|Isopto Carpine|augndr|10|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|234|549|lyfalmen|||06|10|0|K.Pétursson hf|Alcon|25|
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|284|653|lyfalmen|||06|10|0|K.Pétursson hf|Alcon|25|
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|362|815|lyfalmen|||06|10|0|K.Pétursson hf|Alcon|25|
536938|N04BC0102|Parlodel |hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|DKK|11303|16788|lyfalmen|||52|100|0|Icepharma hf|Meda AS|12,5|
537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PFI|0|0|0|100|DKK|284|491|vetorma|||16|2|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|819|1765|lyfalmen|||05|15|0|Icepharma hf|N.V. Organon|37,5|
538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|110726|139721|lyfsjukr|||00|6|0|Gróco ehf|Serono Nordic|61,3953|
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|8828|13491|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|25|
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|137|347|lyfalmen|||00|25|0|Actavis Group hf|Actavis Group hf|5|
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|299|684|lyfalmen|||00|100|0|Actavis Group hf|Actavis Group hf|20|
539783|D01AC2001|Daktacort|krem|| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||20|15|0|Vistor hf|Janssen-Cilag AB|15|
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|1991|3759|lyfalmen|||23|40|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|8|
540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2182|4049|lyfalmen|||00|250|0|Icepharma hf|Smith & Nephew|250|
540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|6460|10240|lyfalmen|||06|15|0|Icepharma hf|M.S.D.||
541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1540|3074|lyfalmen|V0987|3028|23|200|0|Vistor hf|AstraZeneca A/S DK|50|
541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|7442|11610|lyfalmen|||10|200|0|Swedish Orphan International AB|Sandoz GmbH (S)|60|
541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|12055|18059|lyfalmen|||10|200|0|Swedish Orphan International AB|Sandoz GmbH (S)|100|
542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1171|2497|lyfalmen|||10|28|0|Vistor hf|Abbott Scandinavia AB|28|
543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|3445|5939|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|65,3333|
543686|B02BD0203|ReFacto|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|16964|22988|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe|0,5|
543827|B02BD0203|ReFacto|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|33616|43719|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe|1,43|
543835|B02BD0203|ReFacto|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|66779|85007|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe|2|
543850|B02BD0203|ReFacto|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2004||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|121416|153030|lyfsjukr|||00|1|0|Icepharma hf|Wyeth Europe|4|
543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984||L|A|3|0|0|0|0|CHT|0|0|0|100|DKK|||lyflausa|||01|120|0|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|120|
544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|20490|28560|lyfalmen|||00|10|0|Gróco ehf|Serono Nordic|5|
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|604|1318|lyfalmen|||00|15|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|15|
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LUN|0|1|0|100|DKK|932|2000|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|6,6667|
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LUN|0|1|0|100|DKK|2476|4495|lyfalmen|||00|100|0|Lundbeck Export A/S|Lundbeck|33,3333|
545996|V01AA0507|Alutard SQ, birkifrjo|stl|| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|23655|32501|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S||
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19072|26795|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|23795|32675|lyfalmen|||02|20|0|Vistor hf|ALK-Abello A/S||
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20215|28218|lyfalmen|||02|5|0|Vistor hf|ALK-Abello A/S||
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|30|DKK|1957|3707|lyfalmen|||23|60|0|Vistor hf|Orion Corporation|15|
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|8438|12081|lyfsjukr|||00|100|0|GlaxoSmithKline ehf|Glaxo Group Limited|0,38|
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|2781|3982|lyfsjukr|||00|10|0|GlaxoSmithKline ehf|Glaxo Group Limited|0,1|
547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|6709|10588|lyfalmen|||63|0,5|0|Icepharma hf|N.V. Organon|0,6667|
547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|41711|54980|lyfalmen|||63|2,5|0|Icepharma hf|N.V. Organon|5|
547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|3446|5941|lyfalmen|||63|0,5|0|Icepharma hf|N.V. Organon|0,3333|
547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|16772|23931|lyfalmen|||63|2,5|0|Icepharma hf|N.V. Organon|1,6667|
548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|13455|19802|lyfalmen|||00|98|0|Vistor hf|Abbott Laboratories A/S|98|
548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|13455|19802|lyfalmen|||00|98|0|Vistor hf|Abbott Laboratories A/S|147|
548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|1643|2352|lyfsjukr|||03|10|0|Vistor hf|Bristol-Myers Squibb|2,5|
548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4583|7597|lyfalmen|||00|28|0|Vistor hf|Sanofi-aventis Norge AS|28|
548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|12510|18625|lyfalmen|||00|84|0|Vistor hf|Sanofi-aventis Norge AS|84|
548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|32067|42974|lyfalmen|||00|28|0|Vistor hf|Sanofi-aventis Norge AS|168|
549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|81191|102950|lyfsjukr|||17|1|0|Vistor hf|Abbott Laboratories Ltd||
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6990|10979|lyfalmen|||02|5|0|Vistor hf|Janssen-Cilag AB|151,5152|
549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|135066|170025|lyfsjukr|||17|1|0|Vistor hf|Abbott Laboratories Ltd||
550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1762|3411|lyfalmen|||00|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|24|0|Icepharma hf|GlaxoSmithKline CH A/S|4|
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|60|0|Icepharma hf|GlaxoSmithKline CH A/S|0,48|
550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|10|0|Icepharma hf|GlaxoSmithKline CH A/S|0,4167|
551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|8085|12501|lyfalmen|||00|12|0|Vistor hf|AstraZeneca UK Ltd|12|
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1347|2781|lyfalmen|||03|1|0|Icepharma hf|Meda AB|2,6667|
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3433|5922|lyfalmen|||00|100|0|Icepharma hf|Meda AB|50|
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|2264|4173|lyfalmen|||00|28|0|Vistor hf|Eisai Ltd|14|
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|3681|6283|lyfalmen|||00|56|0|Vistor hf|Eisai Ltd|28|
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|2004|3778|lyfalmen|||00|14|0|Vistor hf|Eisai Ltd|14|
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|3503|6024|lyfalmen|||00|28|0|Vistor hf|Eisai Ltd|28|
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|7010|11007|lyfalmen|||00|56|0|Vistor hf|Eisai Ltd|56|
552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BHC|0|0|0|100|SEK|3167|5535|lyfalmen|||63|100|0|Vistor hf|Bayer HealthCare AG|66,6667|
552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|469|1037|lyfalmen|||00|10|0|Actavis Group hf|Actavis Group hf|7,5|
552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|3932|6649|lyfalmen|||00|500|0|Actavis Group PTC ehf|Merck NM AB|500|
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|2735|4889|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|15|
552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|2715|4858|lyfalmen|||00|50|0|Vistor hf|Novartis Healthcare A/S-|15|
553313|N02CC0601|Relpax|töflur|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|1864|3566|lyfalmen|||00|3|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3|
553339|N02CC0601|Relpax|töflur|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3603|6170|lyfalmen|||00|6|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|6|
554154|QA12CE9902|Selevitan, vet.|stl|| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|5671|10974|vetalmen|||27|500|0|Vistor hf|Boehringer Ingelheim Danmark||
554832|N02BE0101|Panodil|töflur|500|mg|48|stk|1|þpakki||N02BE01|01.07.1994||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|210|499|lyfalmen|||00|48|0|Icepharma hf|GlaxoSmithKline CH A/S|8|
555607|N06AB0601|Zoloft|mixtúra|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001||R|A|3|0|0|B|0|PFI|0|1|0|30|DKK|3821|6487|lyfalmen|||00|60|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|24|
556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2471|3538|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6|
556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|4754|6807|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6|
556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4031|5771|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi||
556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2970|4252|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6|
556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2761|3953|lyfsjukr|||00|6000|0|Icepharma hf|Fresenius Kabi|6|
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|4533|7524|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|30|
556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5265|8574|lyfalmen|||00|50|0|Vistor hf|Novartis Healthcare A/S-|30|
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|9371|14214|lyfalmen|||00|100|0|Vistor hf|Novartis Healthcare A/S-|60|
557546|D10AF0202|Zineryt|áburður|| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1251|2635|lyfalmen|||38|30|0|Vistor hf|Astellas Pharma A/S|30|
558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|134365|169152|lyfsjukr|||02|200|0|Icepharma hf|Schering AG||
559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|766|1655|lyfalmen|||10|28|0|Vistor hf|Abbott Scandinavia AB|14|
559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1838|3526|lyfalmen|||10|98|0|Vistor hf|Abbott Scandinavia AB|49|
559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1109|2368|lyfalmen|V0731|1110|10|100|0|Icepharma hf|Grunenthal|16,6667|
559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|459|1017|lyfalmen|V0730|671|10|20|0|Icepharma hf|Grunenthal|3,3333|
559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1281|2680|lyfalmen|||04|20|0|Icepharma hf|Grunenthal|6,6667|
559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|736|1593|lyfalmen|V0732|1464|02|10|0|Icepharma hf|Grunenthal|1,6667|
559146|J06BA0201|Gammagard S/D|irs|0,5|g/fl|1|fl|1|pakki|+ leysir 10 ml|J06BA02|01.10.1991||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|3059|4380|lyfsjukr|||00|1|0|Icepharma hf|Baxter||
559153|J06BA0201|Gammagard S/D|irs|2,5|g/fl|1|fl|1|pakki|+ leysir 50 ml|J06BA02|01.10.1991||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|15297|20912|lyfsjukr|||00|1|0|Icepharma hf|Baxter||
559161|J06BA0201|Gammagard S/D|irs|5|g/fl|1|fl|1|pakki|+ leysir 96 ml|J06BA02|01.10.1991||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|30599|39963|lyfsjukr|||00|1|0|Icepharma hf|Baxter||
559187|J06BA0201|Gammagard S/D|irs|10|g/fl|1|fl|1|pakki|+ leysir 192 ml|J06BA02|01.10.1991||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|61188|78047|lyfsjukr|||00|1|0|Icepharma hf|Baxter||
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|XEU|||lyfalmen|||00|100|0|Icepharma hf|STADA Arzneimittel AG|100|
559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1900|3620|lyfalmen|||06|5|0|Icepharma hf|Santen Oy||
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|XEU|||lyfalmen|||00|100|0|Icepharma hf|STADA Arzneimittel AG||
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|5551|8973|lyfalmen|||23|1|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|90|
559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|2082|3897|lyfalmen|||23|30|0|Vistor hf|Meda AB (V)|30|
559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|2299|4227|lyfalmen|||23|30|0|Vistor hf|Meda AB (V)|60|
559989|N01AB0701|Suprane|innönd.l|| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|7766|11119|lyfsjukr|||00|240|0|Icepharma hf|Baxter||
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|502|1106|lyfalmen|||07|10|0|Actavis Group hf|Gerhard Mann||
560193|C09AA0101|Capoten|töflur|12,5|mg|100|stk|1|þpakki||C09AA01|01.07.1990||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|1528|3055|lyfalmen|||00|100|0|Vistor hf|Bristol-Myers Squibb|25|
560235|C09AA0101|Capoten|töflur|25|mg|100|stk|1|þpakki||C09AA01|01.04.1995||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|2218|4103|lyfalmen|V0162|2747|00|100|0|Vistor hf|Bristol-Myers Squibb|50|
560250|C09AA0101|Capoten|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.04.1995||R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|3702|6314|lyfalmen|V0166|4187|00|100|0|Vistor hf|Bristol-Myers Squibb|100|
560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|2514|4553|lyfalmen|||00|25|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25|
560334|J05AB0102|Zovir|töflur|200|mg|100|stk|1|þpakki||J05AB01|01.07.1994||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|9898|14916|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5|
560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1434|2913|lyfalmen|||07|4,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|4791|7900|lyfalmen|||00|125|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|1,25|
560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|5195|8476|lyfalmen|||00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|2|
560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|84723|107348|lyfsjukr|||00|5|0|Vistor hf|Abbott Scandinavia AB|1,14|
560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|446547|557819|lyfsjukr|||00|20|0|Vistor hf|Abbott Scandinavia AB|4,55|
561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1904|3627|lyfalmen|||06|5|0|Icepharma hf|Santen Oy||
561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|26066|35502|lyfalmen|||00|250|0|Icepharma hf|N.V. Organon|250|
563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|19479|27302|lyfalmen|||02|6|0|Gróco ehf|Nycomed Danmark A/S|17,1667|
563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|29987|40384|lyfalmen|||02|10|0|Gróco ehf|Nycomed Danmark A/S|28,6111|
563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|559|1224|lyfalmen|||20|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1735|3370|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|559|1224|lyfalmen|||20|30|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|30|
563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1735|3370|lyfalmen|||20|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
563494|N02AA0101|Contalgin|forðatfl|5|mg|25|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|429|954|lyfalmen|||10|25|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|1,25|
563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1268|2661|lyfalmen|||10|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5|
563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|161088|203605|lyfalmen|||02|60|0|Gróco ehf|Nycomed Danmark A/S|171,6667|
563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3719|6339|lyfalmen|||00|15|0|Icepharma hf|Santen Oy||
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3917|6627|lyfalmen|||00|15|0|Icepharma hf|Santen Oy||
563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|6911|10869|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|49|
563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|8750|13387|lyfalmen|||00|98|0|Vistor hf|Novartis Healthcare A/S-|98|
564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|30|DKK|118794|149766|lyfsjukr|||00|168|0|Vistor hf|Schering-Plough|33,6|
565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|9039|13772|lyfalmen|||00|100|0|Vistor hf|U.C.B|50|
566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|3150|5510|lyfalmen|||00|14|0|Vistor hf|Novartis Healthcare A/S-|7|
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|899|1931|lyfalmen|||06|5|0|K.Pétursson hf|Alcon|25|
566661|L04AB0101|Enbrel|sts|| |25|mg|4|hgl|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|72015|91526|lyfsjukr|||00|100|0|Icepharma hf|Wyeth Europe|14,29|
566984|A10BG0201|Avandia|töflur|4|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|3844|6521|lyfalmen|||00|28|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|18,6667|
566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4524|7511|lyfalmen|V0556|4954|10|4|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3|
567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1263|2653|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|4|
567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6565|10387|lyfalmen|V0005|10203|00|56|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|37,3333|
567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|5198|8481|lyfalmen|||00|28|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|37,3333|
567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|5016|8227|lyfalmen|V0791|5103|00|60|0|Vistor hf|Janssen-Cilag AB|12|
567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|11043|16441|lyfalmen|V0793|9441|00|60|0|Vistor hf|Janssen-Cilag AB|24|
567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|18355|25902|lyfalmen|V0794|12730|00|60|0|Vistor hf|Janssen-Cilag AB|36|
567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|24320|33329|lyfalmen|V0795|19696|00|60|0|Vistor hf|Janssen-Cilag AB|48|
567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||24|15|0|Vistor hf|Janssen-Cilag AB|12,5|
567719|C10AA0302|Pravachol|töflur|40|mg|98|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|16411|23482|lyfalmen|||00|98|0|Vistor hf|Bristol-Myers Squibb|196|
568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|14319|20877|lyfalmen|||00|120|0|Vistor hf|Eisai Ltd|120|
568519|N05AB0301|Trilafon|töflur|8|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1576|3128|lyfalmen|||00|100|0|Vistor hf|Schering-Plough|26,6667|
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|899|1931|lyfalmen|||00|3|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|13917|19194|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|18,18|
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|13917|19194|lyfsjukr|||02|20|0|Vistor hf|Novartis Healthcare A/S-|18,18|
569897|J07AJ5204|DiTeKik|bóluefni|| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|1798|3466|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut||
569913|J07CA0203|DiTeKiPol|bóluefni|| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2561|4624|lyfalmen|||51|0,5|0|Icepharma hf|Statens Serum Institut||
572768|B02BC1001|Tisseel Duo Quick|vefjalím|| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|109716|138464|lyfsjukr|||00|5|0|Icepharma hf|Baxter||
572776|B02BC1001|Tisseel Duo Quick|vefjalím|| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|143611|180663|lyfsjukr|||00|10|0|Icepharma hf|Baxter||
572784|B02BC1001|Tisseel Duo Quick|vefjalím|| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|270169|338228|lyfsjukr|||00|20|0|Icepharma hf|Baxter||
573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|2984|5267|lyfalmen|||23|26|0|Vistor hf|Janssen-Cilag AB|45,5|
573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|79935|101387|lyfsjukr|||00|1|0|Icepharma hf|Roche||
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|23255|30820|lyfsjukr|||00|5000|0|Vistor hf|AstraZeneca UK Ltd|2,5|
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|45515|58534|lyfsjukr|||00|10|0|Vistor hf|AstraZeneca UK Ltd|5|
573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|DKK|2764|4933|lyfalmen|V0610|2855|67|100|0|Vistor hf|Novartis Healthcare A/S-|50|
575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|3092|5425|lyfalmen|V0931|2732|00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|28|
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|10390|15572|lyfalmen|V0933|7580|00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|98|
575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|4827|7953|lyfalmen|V0935|4152|00|28|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|56|
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|16723|23870|lyfalmen|V0937|12212|00|98|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|196|
575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|4888|6998|lyfsjukr|||00|12|0|Vistor hf|Sanofi - Aventis||
575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|74589|94731|lyfsjukr|||00|1|0|Vistor hf|Centocor B.V.|26,67|
577494|M05BA0101|Didronate|töflur|200|mg|28|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|4992|8193|lyfalmen|||00|28|0|Sofus Consulting AB|Procter & Gamble-|14|
577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2479|4500|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|28|
579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|965|2069|lyfalmen|||02|10|0|Vistor hf|AstraZeneca A/S DK|0,33|
579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|USD|573|1254|lyfalmen|||00|30|0|Icepharma hf|Wyeth AB|30|
582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PFV|1|0|0|100|DKK|3887|6727|vetorma|||16|50|0|Icepharma hf|Pfizer vet.||
582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PFV|1|0|0|100|DKK|14646|25346|vetorma|||16|200|0|Icepharma hf|Pfizer vet.||
582775|C07AB0205|Seloken|töflur|50|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|435|967|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|9,333|
582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|601|1312|lyfalmen|||00|28|0|Vistor hf|AstraZeneca A/S DK|18,6667|
583443|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|875|1882|lyfalmen|V0272|1882|00|100|0|Actavis Group PTC ehf|Merck NM AB|50|
583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3657|5236|lyfsjukr|||00|5000|0|Icepharma hf|Fresenius Kabi|5|
583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1549|2218|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9|
583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5722|8192|lyfsjukr|||00|1500|0|Icepharma hf|Fresenius Kabi||
583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4694|6721|lyfsjukr|||00|5000|0|Icepharma hf|Fresenius Kabi|5|
583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2280|3264|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9|
584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6517|9331|lyfsjukr|||00|3000|0|Icepharma hf|Fresenius Kabi|3|
584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2579|3692|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9|
584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3073|4400|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi||
584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1738|2488|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9|
584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|ROC|0|1|0|100|DKK|2691|4822|lyfalmen|||64|30|0|Icepharma hf|Roche|30|
585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|7780|11139|lyfsjukr|||02|20|0|Vistor hf|LEO Pharma A/S|50|
585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|2834|4058|lyfsjukr|||02|25|0|Vistor hf|LEO Pharma A/S|12,5|
585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|27885|36584|lyfsjukr|||00|12|0|Icepharma hf|M.S.D.|3|
585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2983|5265|lyfalmen|||02|1|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|26983|36644|lyfalmen|||00|50|0|Vistor hf|Novartis Healthcare A/S-|20|
586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2055|3856|lyfalmen|||20|100|0|Vistor hf|Astellas Pharma A/S|100|
587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2415|3458|lyfsjukr|||00|9000|0|Icepharma hf|Fresenius Kabi|9|
588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1175|2505|lyfalmen|||06|5|0|Vistor hf|Sanofi-aventis Norge AS||
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2747|4907|lyfalmen|V0426|4823|43|20|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|5|
588590|B01AC0501|Ticlid|töflur|250|mg|30|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3292|5717|lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS|15|
588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|10372|15548|lyfalmen|||00|100|0|Vistor hf|Sanofi-aventis Norge AS|50|
588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|6848|10781|lyfalmen|||23|2|0|Vistor hf|Novartis Healthcare A/S-|14|
589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|4756|8230|vetorma|||16|3|0|Icepharma hf|Pfizer Animal Health||
589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|1843|3189|vetorma|||16|0,75|0|Icepharma hf|Pfizer Animal Health||
589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|4588|7940|vetorma|||16|6|0|Icepharma hf|Pfizer Animal Health||
589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2478|4288|vetorma|||16|0,75|0|Icepharma hf|Pfizer Animal Health||
589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2574|4454|vetorma|||16|1,5|0|Icepharma hf|Pfizer Animal Health||
589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|1994|3451|vetorma|||16|2,25|0|Icepharma hf|Pfizer Animal Health||
589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|121159|152710|lyfsjukr|||00|250|0|Icepharma hf|Bayer Schering Pharma AG||
590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|66960|85233|lyfsjukr|||00|336|0|Vistor hf|Abbott Laboratories A/S|28|
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|DKK|||lyfalmen|||00|20|0|Vistor hf|Bayer A/S|20|
590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LUN|0|1|0|100|DKK|20679|28796|lyfalmen|||02|10|0|Lundbeck Export A/S|Lundbeck|250|
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|152497|191726|lyfsjukr|||00|1|0|Vistor hf|Boehringer Ingelheim|1,25|
592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|2537|3632|lyfsjukr|||02|12|0|Vistor hf|Hospira Enterprises B.V.||
592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|4898|8056|lyfalmen|||00|100|0|Icepharma hf|Galderma Nordic AB||
592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|SEK|||lyflausa|||00|500|0|Vistor hf|Regent Medical Overseas Limited|500|
593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|505|1112|lyfalmen|||00|50|0|Icepharma hf|Roche|3,125|
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1030|2204|lyfalmen|||00|150|0|Icepharma hf|Roche|9,375|
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1341|2771|lyfalmen|||00|100|0|Icepharma hf|Roche|25|
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|15792|22711|lyfalmen|||03|12|0|Icepharma hf|Meda AB|32|
594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PFI|0|0|0|100|DKK|264|457|vetorma|||16|10|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PFI|0|0|0|100|DKK|2193|3795|vetorma|||16|100|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||
594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2226|3187|lyfsjukr|||02|9000|0|Icepharma hf|Fresenius Kabi||
594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|799|1577|vetalmen|||27|100|0|Icepharma hf|Intervet International B.V.||
595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|6795|9729|lyfsjukr|||02|5|0|Vistor hf|Novartis Healthcare A/S-|5|
595991|J07BB0201|Fluarix|bóluefni|| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|508|1118|lyfalmen|||02|0,5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf||
596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|SEK|||lyflausa|||00|250|0|Vistor hf|Regent Medical Overseas Limited|250|
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3031|5336|lyfalmen|||43|24|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|3|
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|782|1688|lyfalmen|||00|150|0|Vistor hf|Sanofi-aventis Norge AS|25|
924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|13443|lyfalmen|||00|20|1|Distica|Distica - óskráð lyf|200|
939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|13443|lyfalmen|||00|10|1|Distica|Distica - óskráð lyf|100|
069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|932|2000|lyfalmen|||00|20|0|Icepharma hf|NordMedica A/S|5|
045896|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|Lyfjaver ehf|Lyfjaver ehf|5,6|
370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|336|481|lyfsjukr|||03|1|0|Icepharma hf|NordMedica ApS|0,3333|
081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|1|0|Ísaga ehf|AGA AB||
480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|ELD|0|0|0|100|IKR|3183|5558|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|28|
414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|IKR|1456|2946|lyfalmen|||00|1,5|1|Parlogis hf|Parlogis - óskráð lyf||
045605|N07BA0122|Nicorette (Lyfjaver) |innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|42|0|Lyfjaver ehf|Lyfjaver ehf|7|
443655|L02AB0101|Megace|töflur|160|mg|112|stk|1|glas||L02AB01|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|28479|37324|lyfsjukr|||00|112|1|Distica|Distica - óskráð lyf|112|
066241|C03EA0103|Hydramil |töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|557|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|254|590|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|10|
000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|15128|21885|lyfalmen|V0813|16944|00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|28|
087270|C07AB0309|Atenolol Actavis|töflur|50|mg|100|stk|1|glas||C07AB03|01.10.1985||R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|610|1331|lyfalmen|V0298|1331|00|100|0|Actavis Group hf|Actavis hf|66,6667|
108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1110|lyfalmen|V0731|1110|00|100|0|Actavis Group hf|Actavis hf|16,6667|
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2079|3892|lyfalmen|V0984|3892|00|100|0|Actavis Group hf|Actavis hf|100|
199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|IKR|43060|55477|lyfsjukr|||00|5|0|Icepharma hf|Centocor -|0,4|
166272|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|1,5|0|0|E|0|ACA|0|0|1|100|IKR|327|742|lyfalmen|V0670|742|00|30|0|Actavis Group hf|Actavis hf|10|
037192|M01AB0507|Vostar |sþ-tfl|50|mg|100|stk|1|glas||M01AB05|01.04.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|890|1913|lyfalmen|V0608|1913|10|100|0|Actavis Group hf|Actavis hf|50|
336792|A03AA0701|Dicykloverinklorid |mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3962|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|1,25|
589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1578|3131|lyfalmen|||00|7,5|1|Parlogis hf|Parlogis - óskráð lyf|7,5|
107607|A02BA0201|Asyran |töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|1214|2578|lyfalmen|||00|60|0|Actavis Group hf|Actavis hf|30|
193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|608|1326|lyfalmen|||14|20|0|Vistor hf|Sandoz A/S|21,6|
119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|E|0|POF|0|0|1|100|IKR|327|742|lyfalmen|V0670|742|00|30|0|PortFarma ehf|PortFarma |10|
001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2670|4790|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|100|
428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|436|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|10|
076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|5103|lyfalmen|V0791|5103|00|60|0|PortFarma ehf|PortFarma |12|
071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1576|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|22,1631|
004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|IKR|||lyfalmen|||00|100|0|Vistor hf|Medic Team||
475434|B01AA0301|Kovar |töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|562|1231|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|26,6667|
338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|3,3333|
051732|C08CA0104|Amlódipín PortFarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|1909|3634|lyfalmen|V0308|3634|00|100|0|PortFarma ehf|PortFarma ||
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|IKR|4239|7096|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|28|
406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
045915|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|Lyfjaver ehf|Lyfjaver ehf|11,2|
001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|13370|19696|lyfalmen|V0795|19696|00|60|0|Actavis Group hf|Actavis hf|48|
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|7874|12212|lyfalmen|V0937|12212|00|98|0|Actavis Group hf|Actavis hf|196|
955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|353|796|lyfalmen|||00|25|1|Parlogis hf|Parlogis - óskráð lyf|12,5|
409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1258|lyfalmen|V0290|1258|00|100|0|Actavis Group hf|Actavis hf|33,3333|
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|682|1480|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30|
194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1391|lyfalmen|||00|28|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|0,4667|
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|200|0|Icepharma hf|Fresenius Kabi||
045960|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|Lyfjaver ehf|Lyfjaver ehf|27,2|
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyfalmen|||00|500|0|Icepharma hf|Mundipharma|500|
067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|7764|12059|lyfalmen|V0552|12059|10|30|0|Actavis Group hf|Actavis hf|7,5|
118307|A02BA0201|Asyran |töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|E|0|ACA|0|0|0|30|IKR|981|2102|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|15|
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|7761|12054|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|14|
070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|44276|56991|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS||
016744|N05AH0402|Seroquel (Lyfjaver)|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|11248|16715|lyfalmen|V0726|16715|00|100|0|Lyfjaver ehf|Lyfjaver ehf|25|
107581|N02BE0106|Parasupp |eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|0,4167|
019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4|
020180|C03CC0101|Edecrin|sts|| |50|mg|1|hgl||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|337|482|lyfsjukr|||00|50|1|Parlogis hf|Parlogis - óskráð lyf|1|
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|6605|10443|lyfalmen|V0930|10443|00|100|0|Actavis Group hf|Actavis hf|200|
116244|D11AF01|Verucid|áburður|| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyfalmen|||23|10|0|Icepharma hf|Galderma Nordic AB|10|
005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||00|500|0|Icepharma hf|Napp|500|
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|53298|68224|lyfsjukr|||02|2000|0|Icepharma hf|GE Healthcare AS||
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|777|1678|lyfalmen|V0982|1678|00|30|0|Actavis Group hf|Actavis hf|30|
953449|H02AB0904|Hydrocortone|töflur|20|mg|30|stk|1|glas||H02AB09|01.05.2004||R|A||0|0|E|0|LDR|0|0|1|100|IKR|406|906|lyfalmen|||00|30|1|Parlogis hf|Parlogis - óskráð lyf|20,1|
016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A||
084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1626|3204|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667|
001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|960|2058|lyfalmen|||10|30|0|Actavis Group hf|Actavis hf|30|
575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|S|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyfalmen|||23|40|0|Icepharma hf|Norpharma ||
046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|0|1|VIS|0|0|0|100|IKR|4226|6051|lyfsjukr|||02|20|0|Icepharma hf|Vian SA|2,5|
383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|E|0|SCP|0|0|1|100|IKR|454|1006|lyfalmen|||00|10|0|Vistor hf|Schering-Plough|10|
108183|N02BE0106|Parasupp |eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|0,8333|
535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyfalmen|||00|100|0|Icepharma hf|Bioglan Pharma AB||
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|295|676|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|10|
947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|981|2102|lyfalmen|||00|50|1|Parlogis hf|Parlogis - óskráð lyf|25|
938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|7401|11553|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|2|
008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|1,6|
944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|2969|5244|lyfalmen|||00|100|1|Distica|Distica - óskráð lyf|13,33|
021780|A07EA0602|Entocord (D.A.C.)|forðahlk|3|mg|50|stk|1|glas||A07EA06|01.05.2005||R|A|3|0|0|B|0|DAC|0|0|0|100|IKR|6999|10992|lyfalmen|||00|50|0|D.A.C. ehf|D.A.C. ehf|16,67|
952251|J01CA0101|Ampicillin |sts|| |500|mg|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1374|1967|lyfsjukr|||00|5000|1|Parlogis hf|Parlogis - óskráð lyf|2,5|
488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|1,6667|
078717|N06AB0303|Serol |töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|30|IKR|4110|6908|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|50|
582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|7,5|0|Vistor hf|AstraZeneca A/S DK|1,875|
401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2273|4187|lyfalmen|V0166|4187|00|100|0|Actavis Group hf|Actavis hf|100|
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1381|2832|lyfalmen|V0002|2832|00|90|0|Actavis Group hf|Actavis hf|90|
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||23|60|0|Actavis Group hf|Actavis hf|60|
938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|8233|12698|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|160|
012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|1,6|
055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|36|0|Artasan ehf|Novartis Healthcare A/S-A|1,2|
099184|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|12|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|12|0|Artasan ehf|Novartis Healthcare A/S-A|0,8|
179333|R02AA0304|Strepsils Menthol|sogtfl|| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A||
908048|J07AM5201|Immunoglob. mot tetanus |bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|9865|14872|lyfalmen|||00|1,2|1|Parlogis hf|Parlogis - óskráð lyf||
521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|Distica|Distica - óskráð lyf||
045924|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|Lyfjaver ehf|Lyfjaver ehf|27,2|
475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|0,8333|
045587|N07BA0122|Nicorette (Lyfjaver) |tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|7|
080133|J01MA0203|Siprox |töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2491|lyfalmen|V0526|2491|00|20|0|Actavis Group hf|Actavis hf|10|
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2033|3822|lyfalmen|V1075|3822|00|60|0|Actavis Group hf|Actavis hf|6|
944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|10030|14355|lyfsjukr|||00|100|1|Parlogis hf|Parlogis - óskráð lyf||
923351|S01XA2006|Lacri - Lube|augnsm|| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|306|698|lyfalmen|||00|3,5|1|Distica|Distica - óskráð lyf||
543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|7,5|0|Vistor hf|AstraZeneca A/S DK|9,375|
081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|2|0|Ísaga ehf|AGA AB||
173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5478|8871|lyfalmen|||00|150|1|Parlogis hf|Parlogis - óskráð lyf|50|
000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2590|3708|lyfsjukr|||00|1|1|Parlogis hf|Parlogis - óskráð lyf||
542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|736|1593|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|100|
438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|347|784|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|4|
015301|M01AX0502|Glucosamin Pharma Nord |hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|0|0|lyfalmen|||00|270|0|Icepharma hf|Pharma Nord ApS|72|
003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|15|0|Artasan ehf|Novartis Healthcare A/S-A|15|
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13619|lyfsjukr|||00|4|0|Ísaga ehf|AGA AB||
080106|J01MA0203|Siprox |töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|879|lyfalmen|V0514|879|00|10|0|Actavis Group hf|Actavis hf|2,5|
170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|15052|lyfalmen|V0125|15052|10|30|0|Icepharma hf|NordMedica A/S|1,875|
002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|204|0|Artasan ehf|Novartis Healthcare A/S-A|6,8|
020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|12,8|
001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5887|9441|lyfalmen|V0793|9441|00|60|0|Actavis Group hf|Actavis hf|24|
078709|N06AB0303|Serol |töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|30|IKR|1226|2597|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|15|
014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|IKR|45734|59989|lyfalmen|||AC|3|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|37,5|
010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|3760|6398|lyfalmen|||10|56|0|Actavis Group hf|Actavis hf|56|
568790|N02AA5902|Parkodin forte |eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1079|lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|3,3333|
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|IKR|4622|7654|lyfalmen|||00|4|0|Eli Lilly Danmark A/S|Lilly ICOS Limited|4|
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1315|2732|lyfalmen|V0931|2732|00|28|0|Actavis Group hf|Actavis hf|28|
184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2358|lyfalmen|||00|16|0|Actavis Group hf|LEK Pharmaceuticals d.d.|8|
000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5|
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
952798|A03BA0101|Atropin|stl|1|mg/ml|1|ml|10|lykjur||A03BA01|01.07.2004||R|A||0|0|0|0|LDR|0|0|1|100|IKR|990|2121|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|6,67|
543413|R06AA5201|Koffinatin |töflur|| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|2,5|
045578|N07BA0122|Nicorette (Lyfjaver) |nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|200|0|Lyfjaver ehf|Lyfjaver ehf|3,33|
081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|IKR|2983|5265|lyfalmen|V1350|5265|00|4|0|D.A.C. ehf|D.A.C. ehf|8|
509496|S01XA1202|Bepanthen|augnsm|50|mg/g|5|g|1|túpa||S01XA12|01.10.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|552|1210|lyfalmen|||00|5|1|Parlogis hf|Parlogis - óskráð lyf||
471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|Icepharma hf|GE Healthcare AS||
132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||23|8|0|Icepharma hf|Napp|8|
944886|H02AB0601|Prednisolon |töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|316|lyfalmen|||00|28|1|Parlogis hf|Parlogis - óskráð lyf|2,8|
127696|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|Actavis Group hf|Braun||
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|IKR|4700|7768|lyfalmen|V1350|5265|00|4|0|Eli Lilly Danmark A/S|Lilly ICOS Limited|8|
374504|G01AF0502|Pevaryl Depot|krem/sti|| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyfalmen|||00|15|0|Vistor hf|Janssen-Cilag AB|1,5|
440933|M01AB0507|Vostar |eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1202|lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|5|
081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|4|0|Ísaga ehf|AGA AB||
128306|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|2000|0|Actavis Group hf|Braun||
432971|J01DC0201|Cefuroxim Scand Pharm|sts|750|mg/hgl|750|mg|1|hgl||J01DC02|01.01.1996||R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|230|329|lyfsjukr|||00|750|0|NM Pharma ehf|Generics|0,25|
008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|IKR|649|1412|lyfalmen|||02|5|1|Lyfjaver ehf|Lyfjaver - óskráð lyf|13,3333|
007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|27,2|
003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1220|lyfalmen|||00|0,5|1|Parlogis hf|Parlogis - óskráð lyf||
127647|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|Actavis Group hf|Braun||
018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|922|1979|lyfalmen|||00|30|1|Parlogis hf|Parlogis - óskráð lyf|30|
534537|J01EE0103|Primazol |töflur|480|mg|20|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|476|1052|lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|5|
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61073|lyfsjukr|||00|50|0|Ísaga ehf|AGA AB||
565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|4100|6894|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|33,3333|
087296|C07AB0309|Atenolol Actavis|töflur|100|mg|100|stk|1|glas||C07AB03|01.10.1985||R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|815|1757|lyfalmen|V0306|1757|00|100|0|Actavis Group hf|Actavis hf|133,3333|
085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1454|2943|lyfalmen|||00|3|1|Parlogis hf|Parlogis - óskráð lyf|7,5|
020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4|
113639|A02AD0105|Novaluzid|tuggutfl|500|mg|100|stk|1|þpakki||A02AD01|01.03.1983||L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|100|0|Vistor hf|BioPhausia AB|10|
012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|Artasan ehf|Novartis Healthcare A/S-A|3,5|
589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8874|lyfalmen|||00|7,5|1|Parlogis hf|Parlogis - óskráð lyf|7,5|
003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|IKR|3113|5456|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Takeda Europe -|14|
025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1713|lyfalmen|||00|14|0|Icepharma hf|NordMedica A/S|3,5|
004696|R05DA0901|Dexomet |mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|150|0|Actavis Group hf|Actavis hf|5|
953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|663|lyfalmen|||00|5|1|Parlogis hf|Parlogis - óskráð lyf|1|
300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4152|6969|lyfalmen|||00|60|1|Distica|Distica - óskráð lyf|12|
000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5|
447912|C08DB0107|Korzem |töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1530|lyfalmen|V0352|1530|00|100|0|Actavis Group hf|Actavis hf|25|
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|6940|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|400|
098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|669|1453|lyfalmen|||06|5|1|Distica|Distica - óskráð lyf|25|
944852|A06AX0102|Glycerol infant|eþ-stil|| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|773|lyfalmen|||00|12|1|Parlogis hf|Parlogis - óskráð lyf||
125054|C09AA0201|Daren |töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|1,3|0|0|B|0|ACA|0|0|0|100|IKR|1253|2638|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|Parlogis hf|Parlogis - óskráð lyf||
067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2778|4954|lyfalmen|V0556|4954|10|4|0|Actavis Group hf|Actavis hf|3|
393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6|
129254|V07AB09|Sterilt Vatten Braun|leysir|| |100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|2000|0|Actavis Group hf|Braun||
584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|3000|0|Icepharma hf|Fresenius Kabi||
947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1272|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|1,5625|
005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|IKR|28366|38366|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|56|
000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|IKR|3834|6506|lyfalmen|||00|50|0|Vistor hf|Laboratories Biocodex|12,5|
181289|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|glas||M01AE01|01.01.1988||L|A|5|0|0|E|0|ACA|0|0|1|100|IKR|327|742|lyfalmen|V0670|742|00|30|0|Actavis Group hf|Actavis hf|10|
066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|Artasan ehf|Novartis Healthcare A/S-A|31,5|
940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3132|5484|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|166,67|
005576|R05CA1002|Tussol |mixtúra|| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|Actavis Group hf|Actavis hf||
394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|27,2|
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4|
081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|11420|16944|lyfalmen|V0813|16944|00|28|0|D.A.C. ehf|D.A.C. ehf|28|
045933|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|Lyfjaver ehf|Lyfjaver ehf|5,6|
037176|M01AB0507|Vostar |sþ-tfl|50|mg|30|stk|1|glas||M01AB05|01.04.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|361|813|lyfalmen|||10|30|0|Actavis Group hf|Actavis hf|15|
012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|1,6|
019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|IKR|13040|19285|lyfalmen|||00|140|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -||
065540|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|27,2|
005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6|
107532|N02BE0106|Parasupp |eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|0,2|
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|IKR|||lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|30|
099746|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|Lyfjaver ehf|Lyfjaver ehf|12,8|
075305|N02BE0108|Paratabs Retard |forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|3068|lyfalmen|||10|300|0|Actavis Group hf|Actavis hf|50|
448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|4138|6949|lyfalmen|||02|100|1|Parlogis hf|Parlogis - óskráð lyf|5|
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4521|7507|lyfalmen|V0197|7507|00|98|0|Actavis Group hf|Actavis hf|98|
551739|N02AA0102|Morfin |töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|1944|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|2|
475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|IKR|4537|7530|lyfalmen|||00|15|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|37,5|
497313|C09AA0201|Daren |töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|1,5|0|0|B|0|ACA|0|0|0|100|IKR|3028|5332|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|200|
191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|7,5|0|Vistor hf|AstraZeneca A/S DK|4,6875|
067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|29063|39234|lyfalmen|V0557|39234|10|30|0|Actavis Group hf|Actavis hf|30|
457192|N05BA1202|Paxal |töflur|0,5|mg|50|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|440|977|lyfalmen|V0860|977|00|50|0|Actavis Group hf|Actavis hf|25|
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3847|lyfalmen|V0703|3847|00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|9,3333|
019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6|
184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|971|lyfalmen|||08|100|0|Actavis Group hf|LEK Pharmaceuticals d.d.|2,5|
927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3420|lyfalmen|||00|180|1|Parlogis hf|Parlogis - óskráð lyf|15,03|
081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|10|0|Ísaga ehf|AGA AB||
475533|N02AA5902|Parkodin forte |töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|188|453|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|10|
543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyfalmen|||42|250|0|Vistor hf|Recip AB|21,7857|
131995|J01AA0203|Doxytab |töflur|100|mg|30|stk|1|glas||J01AA02|01.04.1987||R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|1192|2541|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30|
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2519|4561|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|200|
022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1766|3417|lyfalmen|V0918|3417|00|60|0|Actavis Group hf|Actavis hf|60|
049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|954|2046|lyfalmen|V0358|2046|00|98|0|PortFarma ehf|PortFarma |65,3333|
046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|0|1|VIS|0|0|0|100|IKR|2113|3025|lyfsjukr|||02|10|0|Icepharma hf|Vian SA|1,25|
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS||
045951|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|Lyfjaver ehf|Lyfjaver ehf|11,2|
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|492|1085|lyfalmen|V0609|1085|00|30|0|Actavis Group hf|Actavis hf|15|
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|9553|14457|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|6,3|
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1843|3534|lyfalmen|V0003|3534|00|90|0|Actavis Group hf|Actavis hf|135|
007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|583|1274|lyfalmen|||00|30|1|Lyfjaver ehf|Lyfjaver - óskráð lyf|10|
001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1154|2462|lyfalmen|V0365|2462|00|98|0|Actavis Group hf|Actavis hf|130,6667|
007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|IKR|120706|152146|lyfsjukr|||00|1|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|0,5|
537720|L01CB0101|Vepesid|hylki|100|mg|10|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13691|18913|lyfsjukr|||00|10|1|Distica|Distica - óskráð lyf||
011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|992|2125|lyfalmen|V0195|2125|00|28|0|Actavis Group hf|Actavis hf|7|
001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyfalmen|||00|20|0|Vistor hf|Bayer A/S|2,16|
546143|N02BE0108|Paratabs Retard |forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|30|0|Actavis Group hf|Actavis hf|5|
568055|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS||
052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|2|0|D.A.C. ehf|D.A.C. ehf|2|
051067|N03AX0902|Lamictal (D.A.C.)|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.2007||R|A|3|0|0|E|0|DAC|0|0|0|100|IKR|2510|4547|lyfalmen|V0703|3847|00|56|0|D.A.C. ehf|D.A.C. ehf|9,33|
017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1709|lyfalmen|||00|20|0|Actavis Group hf|LEK Pharmaceuticals d.d.|5|
942468|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|3163|5529|lyfalmen|||00|20|1|Distica|Distica - óskráð lyf|20|
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|3011|lyfalmen|||00|42|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|3,5|
087445|A02BX1301|Gaviscon|mixtúra|| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|30|IKR|||lyfalmen|||01|500|0|Vistor hf|Nordic Drugs AB||
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|725|1570|lyfalmen|||00|30|1|Distica|Distica - óskráð lyf|45|
534552|J01EE0103|Primazol |töflur|480|mg|100|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|2062|3867|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|25|
153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|Parlogis hf|Parlogis - óskráð lyf||
937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1461|2092|lyfsjukr|||02|10|1|Parlogis hf|Parlogis - óskráð lyf|2|
945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1548|3086|lyfalmen|||00|10|1|Distica|Distica - óskráð lyf|10|
008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|3,2|
123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|IKR|1275|2671|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|40|
128769|V07AB09|Sterilt Vatten Braun|leysir|| |10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|200|0|Actavis Group hf|Braun||
076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1597|lyfalmen|V1070|1597|00|20|0|PortFarma ehf|PortFarma |2|
004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1912|3639|lyfalmen|V0925|3639|00|56|0|Actavis Group hf|Actavis hf|56|
388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|5240|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
037861|C03AA0301|Aquazið|töflur|25|mg|100|stk|1|glas||C03AA03|01.05.1983||R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|582|1272|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|6,25|
565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6153|9812|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|66,6667|
021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|20|0|Artasan ehf|Novartis Healthcare A/S-A|2,5|
024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|3359|4809|lyfsjukr|||03|10|0|Icepharma hf|NordMedica ApS|3,3333|
476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|IKR|3656|6247|lyfalmen|||51|15|0|Icepharma hf|Eli Lilly Danmark A/S|37,5|
335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9646|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf||
444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|30|IKR|1500|3013|lyfalmen|V0914|2383|00|30|0|Icepharma hf|Eli Lilly Danmark A/S|30|
015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|2642|4747|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30|
944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|0|0|LDR|0|0|0|100|IKR|755|1632|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|8,333|
169524|J01AA0203|Doxytab |töflur|100|mg|14|stk|1|glas||J01AA02|01.07.1993||R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|720|1559|lyfalmen|||00|14|0|Actavis Group hf|Actavis hf|14|
087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|28|
163709|V03AE0101|Resonium|duft|| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5041|8262|lyfalmen|||00|454|1|Parlogis hf|Parlogis - óskráð lyf||
045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|210|0|Lyfjaver ehf|Lyfjaver ehf|28|
188532|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|50|sk|1|stauk||R03BA02|01.10.1993||R|A|2|0|0|0|1|AZD|0|0|0|100|IKR|2824|4043|lyfsjukr|||23|50|0|Vistor hf|AstraZeneca A/S DK|25|
077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|478|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|5|
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|23081|31786|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|42|
432989|J01DC0201|Cefuroxim Scand Pharm|sts/irs|1,5|g/hgl|1,5|g|1|hgl||J01DC02|01.01.1996||R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|459|657|lyfsjukr|||00|1,5|0|NM Pharma ehf|Generics|0,5|
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|9553|14457|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|3,5|
160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|Icepharma hf|GE Healthcare AS||
055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|96|0|Artasan ehf|Novartis Healthcare A/S-A|3,2|
108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|671|lyfalmen|V0730|671|00|20|0|Actavis Group hf|Actavis hf|3,3333|
471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|7625|10917|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS||
019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A||
180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|12,5|
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|2667|4785|lyfalmen|V0919|4785|00|100|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|100|
457127|N05BA1202|Paxal |töflur|0,25|mg|20|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|117|306|lyfalmen|V0844|306|00|20|0|Actavis Group hf|Actavis hf|5|
049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1154|2462|lyfalmen|V0365|2462|00|98|0|PortFarma ehf|PortFarma |130,667|
183319|D08AG0201|Betadine|smyrsli|100|mg/g|80|g|1|túpa||D08AG02|01.07.1988||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||00|80|0|Icepharma hf|Napp|80|
958829|A06AD0002|Miralax|lausnduf|| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3914|lyfalmen|||00|238|1|Parlogis hf|Parlogis - óskráð lyf||
042669|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|4000|0|Icepharma hf|Fresenius Kabi||
067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|820|1767|lyfalmen|V0554|1767|10|1|0|Actavis Group hf|Actavis hf|0,75|
045905|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|Lyfjaver ehf|Lyfjaver ehf|13,6|
001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|1992|lyfalmen|||00|28|0|Actavis Group hf|Actavis hf|37,3333|
075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|3013|lyfalmen|||00|300|0|Actavis Group hf|Actavis hf|50|
091360|C08DB0108|Korzem-R |forðatfl|120|mg|60|stk|1|þpakki||C08DB01|01.04.2008||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2449|4454|lyfalmen|V0351|4454|10|60|0|Actavis Group hf|Actavis hf|30|
568022|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS||
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1481|2984|lyfalmen|||67|30|0|Actavis Group hf|Actavis hf|10|
087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|14|
045406|N07BA0127|Nicorette Mint (Lyfjaver) |tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|28|
007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|E|0|GSK|0|0|0|30|IKR|545|1195|lyfalmen|||00|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10|
081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|20|0|Ísaga ehf|AGA AB||
433722|J01EE0104|Primazol sterkar |töflur|960|mg|10|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|486|1073|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|5|
087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|14|
035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2049|3847|lyfalmen|V0703|3847|00|56|0|Actavis Group hf|Actavis hf|9,33|
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|IKR|||lyfalmen|||00|500|0|Vistor hf|Medic Team|49,7761|
471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9600|13745|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS||
590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1510|3028|lyfalmen|V0139|3028|10|98|0|Actavis Group hf|Actavis hf|147|
080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyfalmen|||05|1|0|Vistor hf|Janssen-Cilag AB|1,5|
013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2580|lyfalmen|V0465|2580|00|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|10|
040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|289|663|lyfalmen|||06|15|0|K.Pétursson hf|Alcon||
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1555|lyfalmen|||08|80|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|4|
099755|N07BA0124|Nicotinell Mint (Lyfjaver) |tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|Lyfjaver ehf|Lyfjaver ehf|12,8|
095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|3130|lyfalmen|||00|100|1|Distica|Distica - óskráð lyf|50|
035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|6434|10204|lyfalmen|V0706|10204|00|56|0|Actavis Group hf|Actavis hf|37,34|
947690|C01CA2403|Adrenalin|stl|1|mg/ml|1|ml|10|lykjur||C01CA24|01.07.2000||R|A||0|0|0|0|LDR|0|0|1|100|IKR|659|1432|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|20|
005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|454|1006|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
165019|C05AA0102|Proctosedyl|eþ-smyr|| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyfalmen|||00|30|0|Vistor hf|Sanofi-aventis Norge AS||
012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|Artasan ehf|Novartis Healthcare A/S-A|10,5|
109678|N02BE0107|Paratabs |töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|3,3333|
019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|IKR|4643|6648|lyfsjukr|||00|1|0|Icepharma hf|Eli Lilly Danmark A/S||
015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|IKR|684|1484|lyfalmen|||00|10|0|Icepharma hf|Meda AB|17,8571|
123166|M01AE5101|Ibukod|töflur|| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|655|1424|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,67|
194076|N02CA5201|Cafergot|töflur|| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|1099|2347|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|5|
062711|J01EE0103|Primazol |töflur|480|mg|30|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|694|1505|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|7,5|
565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1088|2324|lyfalmen|||00|28|1|Parlogis hf|Parlogis - óskráð lyf|4,6667|
045942|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|Lyfjaver ehf|Lyfjaver ehf|13,6|
012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|3,2|
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1909|3634|lyfalmen|V0308|3634|00|100|0|Actavis Group hf|Actavis hf|100|
110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|3|0|Ísaga ehf|AGA AB||
568865|C08CA0201|Feldil |forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2575|4646|lyfalmen|V0324|4646|10|100|0|Actavis Group hf|Actavis hf|200|
940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1607|3175|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|83,33|
066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|Icepharma hf|GE Healthcare AS||
007758|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.09.2005||L|A|2|0|0|0|0|MET|0|0|0|100|IKR|||lyfalmen|||00|500|0|Vistor hf|Medic Team|49,7761|
081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|2|0|Ísaga ehf|AGA AB||
034066|V07AB09|Sterilt Vatten Braun|leysir|| |5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|100|0|Actavis Group hf|Braun||
081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|4|0|Ísaga ehf|AGA AB||
393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|27,2|
471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9018|12912|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS||
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|4960|8146|lyfalmen|V0411|8146|00|98|0|Actavis Group hf|Actavis hf|98|
525170|M01AB0504|Klofen-L |forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|8351|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|100|
019470|G03XC0102|Evista (Lyfjaver)|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.04.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|IKR|7818|12134|lyfalmen|V0377|12134|00|84|0|Lyfjaver ehf|Lyfjaver ehf|84|
371658|A02BA0201|Asyran |töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|E|0|ACA|0|0|0|30|IKR|339|767|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|5|
938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2510|4547|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|50|
045596|N07BA0122|Nicorette (Lyfjaver) |innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|18|0|Lyfjaver ehf|Lyfjaver ehf|3|
470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6223|8910|lyfsjukr|||02|150|0|Icepharma hf|GE Healthcare AS||
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|9255|14060|lyfalmen|V0339|14060|00|100|0|Actavis Group hf|Actavis hf|400|
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyfalmen|||00|125|0|Vistor hf|McNeil Denmark ApS|0,875|
073860|A10BG0302|Actos (D.A.C.)|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|IKR|10901|16252|lyfalmen|V0010|16252|00|98|0|D.A.C. ehf|D.A.C. ehf|98|
597575|D01AC0301|Pevaryl|húðduft|10|mg/g|30|g|1|stauk||D01AC03|01.07.1991||L|A|5|0|0|0|0|JAS|0|0|1|100|IKR|||lyfalmen|||00|30|0|Vistor hf|Janssen-Cilag AB|30|
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|960|2058|lyfalmen|V0355|2058|23|120|0|Actavis Group hf|Actavis hf|120|
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||20|2|0|Icepharma hf|GlaxoSmithKline CH A/S|2|
066142|N05BA0204|Klordiazepoxið Actavis|töflur|10|mg|50|stk|1|glas||N05BA02|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|345|780|lyfalmen|||00|50|0|Actavis Group hf|Actavis hf|16,6667|
582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|IKR|23972|31713|lyfsjukr|||02|1|0|Icepharma hf|Eli Lilly Danmark A/S|9|
439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|12,5|
005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|36|0|Artasan ehf|Novartis Healthcare A/S-A|2,4|
099598|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|12|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|12|0|Artasan ehf|Novartis Healthcare A/S-A|0,8|
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|Vistor hf|AstraZeneca A/S DK|2,5|
922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1605|2298|lyfsjukr|||00|4|1|Parlogis hf|Parlogis - óskráð lyf||
016755|N05AH0402|Seroquel (Lyfjaver)|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|5037|8256|lyfalmen|V0725|8256|00|100|0|Lyfjaver ehf|Lyfjaver ehf|6,25|
019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|IKR|22972|30468|lyfsjukr|||00|1|0|Icepharma hf|Eli Lilly Danmark A/S||
187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|3130|5481|lyfalmen|||00|100|1|Distica|Distica - óskráð lyf|20|
115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyfalmen|||23|55|0|Icepharma hf|Norpharma ||
523274|S01XA2008|Artelac|augndr|| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|264|611|lyfalmen|||00|10|0|Actavis Group hf|Gerhard Mann||
081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|50|0|Ísaga ehf|AGA AB||
951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|405|904|lyfalmen|||00|21|1|Parlogis hf|Parlogis - óskráð lyf|21|
022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|200|0|Actavis Group hf|Actavis Group hf|45,45|
140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyfalmen|||23|10|0|Vistor hf|McNeil Denmark ApS|3,33|
019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|3,2|
953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007||R|A||0|0|*|0|LDR|0|0|0|100|IKR|1890|3605|lyfalmen|||00|112|1|Parlogis hf|Parlogis - óskráð lyf|5,6|
001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2876|5103|lyfalmen|V0791|5103|00|60|0|Actavis Group hf|Actavis hf|12|
055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3734|6360|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|33,3333|
045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|21|0|Lyfjaver ehf|Lyfjaver ehf|31,5|
388272|N01BB2001|Emla|plástur|| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|Vistor hf|AstraZeneca A/S DK||
143413|S01JX|Methocel 2% |lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|710|1538|lyfalmen|||00|30|1|Distica|Distica - óskráð lyf||
000018|G01AF0501|Pevaryl|krem/sti|| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyfalmen|||00|15|0|Vistor hf|Janssen-Cilag AB|4,5|
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|5128|8383|lyfalmen|V0337|8383|00|100|0|Actavis Group hf|Actavis hf|100|
529289|R02AA0301|Strepsils|sogtfl|| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A||
945602|A11EA08|Vitamin B-komplex|stl|| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1202|2560|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf||
007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||00|2500|0|Icepharma hf|Baxter Medical AB||
153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2214|4097|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
544049|C01DA1402|Monit-L |forðahlk|60|mg|100|stk|1|glas||C01DA14|01.10.1992||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2489|4515|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|150|
406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|734|1588|lyfalmen|||00|12|0|D.A.C. ehf|D.A.C. ehf|7,5|
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|IKR|14316|20874|lyfalmen|V1955|20874|00|98|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|98|
128819|V07AB09|Sterilt Vatten Braun|leysir|| |20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|400|0|Actavis Group hf|Braun||
071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|391|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyfalmen|||23|210|0|Vistor hf|McNeil Denmark ApS|14|
383075|N02AA5904|Ibukod sterkar|töflur|| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|253|588|lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|6,6667|
124727|C09AA0201|Daren |töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|1,3|0|0|B|0|ACA|0|0|0|100|IKR|680|1476|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30|
591131|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|31979|41681|lyfsjukr|||00|1200|0|Icepharma hf|GE Healthcare AS||
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|82356|104401|lyfsjukr|||02|3000|0|Icepharma hf|GE Healthcare AS||
124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|562|1231|lyfalmen|||00|20|1|Parlogis hf|Parlogis - óskráð lyf|10|
062935|G03AA1005|Harmonet|töflur|| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|IKR|1232|2606|lyfalmen|||23|63|0|Icepharma hf|Wyeth Medica|63|
170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|12,5|
087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|7|
591149|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|36833|47725|lyfsjukr|||00|1200|0|Icepharma hf|GE Healthcare AS||
160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|Icepharma hf|GE Healthcare AS||
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|5352|lyfalmen|V0831|5352|00|12|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|12|
956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|476|1052|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|2,5|
005178|J01CF0102|Staklox |hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1630|lyfalmen|V0452|1630|10|30|0|Actavis Group hf|Actavis hf|3,75|
165928|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|IKR|4725|7804|lyfalmen|||17|15|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|37,5|
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|IKR|2441|4442|lyfalmen|||17|10|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|25|
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|Vistor hf|AstraZeneca A/S DK|1,25|
035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2914|lyfalmen|||00|56|0|Actavis Group hf|Actavis hf|4,67|
015037|M01AX0502|Glucosamin Pharma Nord |hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|0|0|lyfalmen|||00|90|0|Icepharma hf|Pharma Nord ApS|24|
947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5636|9091|lyfalmen|||00|50|1|Parlogis hf|Parlogis - óskráð lyf|133,33|
371583|A06AG1001|Klyx|innhl|| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||23|240|0|Vistor hf|Ferring Lægemidler A/S|1|
045397|N07BA0127|Nicorette Mint (Lyfjaver) |tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|14|
022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|664|1443|lyfalmen|V0917|1443|00|20|0|Actavis Group hf|Actavis hf|20|
080124|J01MA0203|Siprox |töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1407|lyfalmen|V0522|1407|00|10|0|Actavis Group hf|Actavis hf|5|
065094|V08AB0901|Visipaque|stl|150|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5486|7855|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|17114|23174|lyfsjukr|||00|50|1|Distica|Distica - óskráð lyf||
177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|50|0|Artasan ehf|Novartis Healthcare A/S-A||
592469|N02BE0107|Paratabs |lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||09|30|0|Actavis Group hf|Actavis hf|1,6|
568840|C08CA0201|Feldil |forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1662|3259|lyfalmen|V0316|3259|10|100|0|Actavis Group hf|Actavis hf|100|
118406|A02BA0201|Asyran |töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|1154|2462|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|30|
149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|IKR|1212|2575|lyfalmen|||00|75|1|Distica|Distica - óskráð lyf|18,75|
082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|36|0|Ísaga ehf|AGA AB||
950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1307|1871|lyfsjukr|||55|10|1|Parlogis hf|Parlogis - óskráð lyf||
171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|IKR|398|890|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|33,3333|
128280|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|Actavis Group hf|Braun||
012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|Artasan ehf|Novartis Healthcare A/S-A|7|
497297|C09AA0201|Daren |töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|872|1875|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|50|
501734|M01AB0508|Vostar-R |forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5581|lyfalmen|||67|100|0|Actavis Group hf|Actavis hf|75|
951287|J01CA0101|Ampicillin |sts|| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1554|2225|lyfsjukr|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|5|
066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|Artasan ehf|Novartis Healthcare A/S-A|10,5|
590539|A01AD1101|Bonjela|hlaup|| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyfalmen|||00|15|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.||
041996|A06AG1101|Microlax|innhl|| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyfalmen|||56|20|0|Vistor hf|McNeil Denmark ApS|4|
461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|464|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|1,6667|
036541|A03AX1301|Minifom|dropar|| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|30|0|Vistor hf|AstraZeneca A/S DK|6|
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18536|lyfsjukr|||00|10|0|Ísaga ehf|AGA AB||
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|IKR|5221|8513|lyfalmen|||00|56|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -||
487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis Group hf|0,4167|
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|92841|117455|lyfsjukr|||02|3000|0|Icepharma hf|GE Healthcare AS||
003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|IKR|15989|22957|lyfalmen|V0010|16252|00|98|0|Eli Lilly Danmark A/S|Takeda Europe -|98|
003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|IKR|10690|15971|lyfalmen|||00|98|0|Eli Lilly Danmark A/S|Takeda Europe -|49|
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|9553|14457|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|21|
464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|30|0|Icepharma hf|GlaxoSmithKline CH A/S|5|
097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|3042|5352|lyfalmen|V0831|5352|00|12|0|Actavis Group hf|Actavis Group PTC ehf|12|
451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|59672|lyfalmen|||00|100|0|Icepharma hf|GE Healthcare AS||
128926|V07AB09|Sterilt Vatten Braun|leysir|| |50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|1000|0|Actavis Group hf|Braun||
938954|A04AD0501|Vogalene|stl|10|mg/ml|1|ml|10|lykjur||A04AD05|01.05.1998||R|A||0|0|0|1|PCO|0|0|0|100|IKR|3072|4398|lyfsjukr|||00|10|1|Distica|Distica - óskráð lyf|6,6667|
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|862|1854|lyfalmen|||00|1|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|1|
088015|N07BA0125|Nicotinell Fruit (Lyfjaver) |tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|Lyfjaver ehf|Lyfjaver ehf|6,4|
473348|A03AA0402|Spasmerin |töflur|135|mg|50|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|742|1605|lyfalmen|||00|50|0|Actavis Group hf|Actavis hf|22,5|
916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2074|3885|lyfalmen|||00|100|1|Distica|Distica - óskráð lyf|33,3333|
105023|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5432|7777|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS||
473371|A03AA0402|Spasmerin |töflur|135|mg|100|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|1302|2712|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|45|
949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1181|2518|lyfalmen|||00|30|1|Parlogis hf|Parlogis - óskráð lyf|10|
010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|1983|3747|lyfalmen|||10|28|0|Actavis Group hf|Actavis hf|28|
076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3822|lyfalmen|V1075|3822|00|60|0|PortFarma ehf|PortFarma |6|
006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|10|0|Icepharma hf|GlaxoSmithKline CH A/S|1,67|
523043|N02AA5902|Parkodin forte |töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|220|520|lyfalmen|||00|40|0|Actavis Group hf|Actavis hf|13,3333|
944985|A06AX0103|Glycerol adult|eþ-stil|| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|773|lyfalmen|||00|12|1|Parlogis hf|Parlogis - óskráð lyf||
417030|A02AD0104|Balancid Novum|tuggutfl|| |30|stk|1|þpakki||A02AD01|01.10.1992||L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|30|0|Vistor hf|BioPhausia AB|3|
038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|1766|3417|lyfalmen|V0918|3417|00|60|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|60|
567990|V08AB0901|Visipaque|stl|150|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|14023|19326|lyfsjukr|||02|1200|0|Icepharma hf|GE Healthcare AS||
006172|S01XA2007|Simplex|augnsm|| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|456|1010|lyfalmen|||00|4|1|Parlogis hf|Parlogis - óskráð lyf||
019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|IKR|167186|210014|lyfsjukr|||00|1|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -||
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2667|4785|lyfalmen|V0919|4785|00|100|0|Actavis Group hf|Actavis hf|100|
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|5|0|Ísaga ehf|AGA AB||
475491|N02AA5902|Parkodin forte |töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|111|293|lyfalmen|V0775|293|00|20|0|Actavis Group hf|Actavis hf|6,6667|
582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|IKR|47638|61177|lyfsjukr|||02|1|0|Icepharma hf|Eli Lilly Danmark A/S|18|
480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|ELD|0|0|0|100|IKR|9486|14367|lyfalmen|V0377|12134|00|84|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|84|
069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|1849|3543|lyfalmen|||00|40|0|Icepharma hf|NordMedica A/S|10|
002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007||R|A||0|0|B|0|PCO|0|0|0|100|IKR|510|1123|lyfalmen|||00|50|1|Distica|Distica - óskráð lyf|12,5|
457150|N05BA1202|Paxal |töflur|0,5|mg|20|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|199|476|lyfalmen|V0856|476|00|20|0|Actavis Group hf|Actavis hf|10|
327817|A03AA0701|Dicykloverinklorid |mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2944|5206|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|1,25|
012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|3,2|
452896|A06AD1701|Phosphoral|mixtúra|| |45|ml|2|fl||A06AD17|01.03.1999||L|A|3|0|0|0|0|LCF|0|0|0|100|IKR|||lyfalmen|||00|90|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.||
019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4|
424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006||R|A||0|0|E|0|PCO|0|0|0|100|IKR|248|578|lyfalmen|||00|100|1|Distica|Distica - óskráð lyf|25|
181404|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|462|1023|lyfalmen|V0678|1023|00|100|0|Actavis Group hf|Actavis hf|50|
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|IKR|5087|8326|lyfalmen|||00|56|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -||
426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|Vistor hf|AstraZeneca A/S DK|0,5|
371609|A06AG1001|Klyx|innhl|| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||23|120|0|Vistor hf|Ferring Lægemidler A/S|1|
109751|N02BE0107|Paratabs |töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|204|486|lyfalmen|V0772|486|00|100|0|Actavis Group hf|Actavis hf|16,6667|
025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|Distica|Distica - óskráð lyf||
001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|2861|lyfalmen|||00|28|0|Actavis Group hf|Actavis hf|18,6667|
045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|210|0|Lyfjaver ehf|Lyfjaver ehf|14|
568030|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5568|7972|lyfsjukr|||02|200|0|Icepharma hf|GE Healthcare AS||
938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|1770|3423|lyfalmen|||00|11|1|Parlogis hf|Parlogis - óskráð lyf|4,4|
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|3180|5553|lyfalmen|V0922|5553|00|100|0|Actavis Group hf|Actavis hf|50|
011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1471|2969|lyfalmen|||00|28|0|Actavis Group hf|Actavis hf|28|
170845|A07AA0901|Vancocin|hylki|250|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|20000|27950|lyfalmen|V0126|27950|10|30|0|Icepharma hf|NordMedica A/S|3,75|
165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|Icepharma hf|GE Healthcare AS||
938665|A12CX0001|K-Phos Neutral|töflur|| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2993|5281|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf||
912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2816|5012|lyfalmen|||00|50|1|Distica|Distica - óskráð lyf|25|
005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|Artasan ehf|Novartis Healthcare A/S-A|6,25|
005189|J01CF0102|Staklox |hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1649|lyfalmen|||10|20|0|Actavis Group hf|Actavis hf|5|
947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3266|5679|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|66,6667|
546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6004|9605|lyfalmen|||00|56|1|Parlogis hf|Parlogis - óskráð lyf|37,3333|
049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1827|3510|lyfalmen|V0367|3510|00|100|0|PortFarma ehf|PortFarma |266,67|
371617|A06AG1001|Klyx|innhl|| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|4232|7086|lyfalmen|||23|1200|0|Vistor hf|Ferring Lægemidler A/S|10|
108209|N02BE0106|Parasupp |eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|1,6667|
051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|60|0|D.A.C. ehf|D.A.C. ehf||
000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|30097|40521|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|56|
081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|600|0|Ísaga ehf|AGA AB||
948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|850|1830|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf|33,33|
013593|A01AA3001|Xerodent|munnstfl|| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|388|869|lyfalmen|||00|90|0|Actavis Group hf|Actavis Group hf||
054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|4|0|Artasan ehf|Novartis Healthcare A/S-A||
457143|N05BA1202|Paxal |töflur|0,25|mg|100|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|461|1021|lyfalmen|V0852|1021|00|100|0|Actavis Group hf|Actavis hf|25|
952855|N02AA0102|Morfin |eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|1761|3409|lyfalmen|||00|12|1|Parlogis hf|Parlogis - óskráð lyf|4|
001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4836|lyfalmen|||00|28|0|Actavis Group hf|Actavis hf|74,6667|
198432|N02BE5102|Parkodin|eþ-stil|510|mg|10|stk|1|pakki|10+500 mg|N02BE51|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|498|1098|lyfalmen|||04|10|0|Actavis Group hf|Actavis hf|1,6667|
463778|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|glas||M01AE01|01.01.1989||L|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|3,3333|
004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|862|1854|lyfalmen|V0921|1854|00|28|0|Actavis Group hf|Actavis hf|14|
066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|Artasan ehf|Novartis Healthcare A/S-A|21|
007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6|
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|3111|5453|lyfalmen|V0310|5453|00|100|0|Actavis Group hf|Actavis hf|200|
400101|R05DB2002|Pektolin |mixtúra|| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|150|0|Actavis Group hf|Actavis hf||
538207|A02AD0106|Rennie|sog/tugg|| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|96|0|Icepharma hf|Bayer AB|9,6|
017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2580|lyfalmen|V0465|2580|00|20|0|Actavis Group hf|LEK Pharmaceuticals d.d.|12,5|
434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|30|IKR|5966|9552|lyfalmen|||00|100|0|Icepharma hf|Eli Lilly Danmark A/S|100|
087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|14|
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|4571|7580|lyfalmen|V0933|7580|00|98|0|Actavis Group hf|Actavis hf|98|
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|61388|78296|lyfsjukr|||02|2000|0|Icepharma hf|GE Healthcare AS||
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1396|2855|lyfalmen|V0610|2855|00|100|0|Actavis Group hf|Actavis hf|50|
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|874|1879|lyfalmen|V0001|1879|00|90|0|Actavis Group hf|Actavis hf|45|
081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|2,5|0|Ísaga ehf|AGA AB||
007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyfalmen|||00|5000|0|Icepharma hf|Baxter||
025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|722|1563|lyfalmen|||08|100|0|Icepharma hf|NordMedica A/S|2,5|
157768|S01AA3001|Terramycin Polymyxin B|augnsm|| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|IKR|290|665|lyfalmen|||07|3,5|1|Distica|Distica - óskráð lyf||
075096|N02AA5902|Parkodin forte |töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1829|3513|lyfalmen|||00|300|0|Actavis Group hf|Actavis hf|300|
003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|IKR|4728|7808|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Takeda Europe -|28|
002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|15|0|Artasan ehf|Novartis Healthcare A/S-A|15|
532739|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997||L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|100|0|Actavis Group hf|Braun||
538181|A02AD0106|Rennie|sog/tugg|| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|24|0|Icepharma hf|Bayer AB|2,4|
907024|A04AD0501|Vogalene|eþ-stil|5|mg|10|stk|1|pakki||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|1597|3160|lyfalmen|||00|10|1|Distica|Distica - óskráð lyf|3,3333|
019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|Artasan ehf|Novartis Healthcare A/S-A|1,6|
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|5429|8803|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1681|3288|lyfalmen|||00|250|1|Parlogis hf|Parlogis - óskráð lyf|13,8889|
104372|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|100|stk|1|glas||N05BA02|01.10.1995||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|475|1050|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667|
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7277|11380|lyfalmen|V0338|11380|00|100|0|Actavis Group hf|Actavis hf|200|
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
497289|C09AA0201|Daren |töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|455|1008|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|15|
109728|N02BE0107|Paratabs |töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|5|
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3686|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|Lyfjaver ehf|Lyfjaver ehf|6,4|
087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|14|
801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|IKR|711|1541|lyfalmen|||00|20|1|Distica|Distica - óskráð lyf||
038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|664|1443|lyfalmen|V0917|1443|00|20|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|20|
087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|Lyfjaver ehf|Lyfjaver ehf|7|
080115|J01MA0203|Siprox |töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1389|lyfalmen|V0518|1389|00|20|0|Actavis Group hf|Actavis hf|5|
451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|116293|lyfalmen|||00|200|0|Icepharma hf|GE Healthcare AS||
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|39554|51112|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS||
399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|6434|10204|lyfalmen|V0706|10204|00|56|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|37,3333|
010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|6708|10586|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|100|
099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyfalmen|||00|500|0|Icepharma hf|Mundipharma|500|
923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|7418|lyfalmen|||00|100|1|Distica|Distica - óskráð lyf|100|
077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1112|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667|
104034|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|Icepharma hf|GE Healthcare AS||
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|IKR|9254|14058|lyfalmen|V1351|9812|00|8|0|Eli Lilly Danmark A/S|Lilly ICOS Limited|16|
940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1313|2729|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|1,39|
440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2279|lyfalmen|||00|70|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|5,6|
938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|29029|39191|lyfalmen|||00|100|1|Parlogis hf|Parlogis - óskráð lyf||
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|3007|5301|lyfalmen|V0926|5301|00|100|0|Actavis Group hf|Actavis hf|100|
497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2216|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|10|
001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|954|2046|lyfalmen|V0358|2046|00|98|0|Actavis Group hf|Actavis hf|65,3333|
178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|426|948|lyfalmen|||03|1|1|Distica|Distica - óskráð lyf|5,333|
081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|1|0|Ísaga ehf|AGA AB||
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2579|4652|lyfalmen|||67|30|0|Actavis Group hf|Actavis hf|20|
123596|N02AA5904|Ibukod sterkar|töflur|| |100|stk|1|glas|30+200 mg|N02AA59|01.10.1998||R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|920|1975|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|33,3333|
582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|IKR|95482|120743|lyfsjukr|||02|1|0|Icepharma hf|Eli Lilly Danmark A/S|36|
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|Icepharma hf|GE Healthcare AS||
019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|12,8|
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|9553|14457|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|8,75|
048452|M01AE5101|Ibukod|töflur|| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|464|1027|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|5,01|
160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|Icepharma hf|GE Healthcare AS||
081539|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|357|805|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|33,3333|
087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|Lyfjaver ehf|Lyfjaver ehf|28|
938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|5294|lyfalmen|||00|10|1|Parlogis hf|Parlogis - óskráð lyf|4|
145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|IKR|15569|22434|lyfalmen|||00|28|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|28|
051750|C08CA0104|Amlódipín PortFarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|3111|5453|lyfalmen|V0310|5453|00|100|0|PortFarma ehf|PortFarma ||
438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|E|0|SCP|0|0|1|100|IKR|380|852|lyfalmen|||00|10|0|Vistor hf|Schering-Plough|10|
015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|1787|3449|lyfalmen|||00|100|1|Lyfjaver ehf|Lyfjaver - óskráð lyf|33,3333|
181131|J01EE0103|Primazol |mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|370|832|lyfalmen|||01|100|0|Actavis Group hf|Actavis hf|2,5|
008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|IKR|30408|39725|lyfsjukr|||00|1|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|0,13|
393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|Artasan ehf|Novartis Healthcare A/S-A|13,6|
081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|0|0|lyfalmen|||00|4|0|Ísaga ehf|AGA AB||
433730|J01EE0104|Primazol sterkar |töflur|960|mg|20|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|929|1994|lyfalmen|||00|20|0|Actavis Group hf|Actavis hf|10|
169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|597|1304|lyfalmen|||00|100|1|Distica|Distica - óskráð lyf|50|
416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|30|IKR|3849|6528|lyfalmen|||00|300|1|Parlogis hf|Parlogis - óskráð lyf|15|
030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|0|0|lyfalmen|||00|60|0|Icepharma hf|Navamedic ASA|25|
097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2084|3900|lyfalmen|V0832|3900|00|6|0|Actavis Group hf|Actavis Group PTC ehf|12|
051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|2|0|Icepharma hf|GlaxoSmithKline CH A/S|2|
432880|N02BE0107|Paratabs |töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|519|1141|lyfalmen|||00|300|0|Actavis Group hf|Actavis hf|50|
184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1216|lyfalmen|||00|15|0|Actavis Group hf|LEK Pharmaceuticals d.d.|3,75|
049015|A02BA0201|Asyran |töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|3553|6097|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|100|
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|70812|90028|lyfsjukr|||02|3000|0|Icepharma hf|GE Healthcare AS||
081513|M01AE0102|Ibufen|töflur|200|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|336|761|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667|
546168|N02BE0108|Paratabs Retard |forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1145|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|16,6667|
541169|R02AA0302|Strepsils med honning og citron|sogtfl|| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A||
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|IKR|9553|14457|lyfalmen|||00|28|0|Icepharma hf|Eli Lilly Danmark A/S|14|
005200|J01CF0102|Staklox |hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2299|lyfalmen|V0460|2299|10|30|0|Actavis Group hf|Actavis hf|7,5|
525147|M01AB0504|Klofen-L |forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|3062|lyfalmen|||10|30|0|Actavis Group hf|Actavis hf|30|
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyfalmen|||00|100|0|Vistor hf|Abigo Medical AB|3|
074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|Icepharma hf|GE Healthcare AS||
019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|12,8|
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|4521|7507|lyfalmen|V0197|7507|00|98|0|PortFarma ehf|PortFarma |98|
020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|0|0|lyfalmen|||23|1|0|Icepharma hf|Medimpex UK Limited||
111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|IKR|6153|9812|lyfalmen|V1351|9812|00|8|0|D.A.C. ehf|D.A.C. ehf|16|
074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|IKR|1251|2635|lyfalmen|||23|3,5|0|Icepharma hf|Galderma Nordic AB|3,5|
451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87982|lyfalmen|||00|150|0|Icepharma hf|GE Healthcare AS||
000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|IKR|1662|3259|lyfalmen|||00|20|0|Vistor hf|Laboratories Biocodex|5|
477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|500|0|Icepharma hf|Fresenius Kabi||
184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1715|lyfalmen|||08|100|0|Actavis Group hf|LEK Pharmaceuticals d.d.|5|
381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|IKR|4556|7558|lyfalmen|||00|15|0|Eli Lilly Danmark A/S|Eli Lilly Nederland -|37,5|
538199|A02AD0106|Rennie|sog/tugg|| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|48|0|Icepharma hf|Bayer AB|4,8|
475715|N02AA5902|Parkodin forte |töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|425|946|lyfalmen|V0780|946|00|100|0|Actavis Group hf|Actavis hf|33,3333|
484832|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|1|fl||B05BB01|01.05.2004||R|A||0|0|0|1|LDR|0|0|0|100|IKR|543|777|lyfsjukr|||00|100|1|Parlogis hf|Parlogis - óskráð lyf||
431205|C08DB0107|Korzem |töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1694|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|12,5|
052944|C01DA1402|Monit-L |forðahlk|30|mg|100|stk|1|glas||C01DA14|01.01.1994||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1770|3423|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|75|
401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1325|2747|lyfalmen|V0162|2747|00|100|0|Actavis Group hf|Actavis hf|50|
084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|758|1638|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|6,6667|
326991|V03AB1502|Naloxonhydroklorid|stl|| |1|ml|10|lykjur||V03AB15|01.12.2007||R|A||0|0|0|1|PCO|0|0|0|100|IKR|12994|18045|lyfsjukr|||00|10|1|Distica|Distica - óskráð lyf||
019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|Artasan ehf|Novartis Healthcare A/S-A|6,4|
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3900|lyfalmen|V0832|3900|00|6|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|12|
061762|N02BA0106|Magnyl |töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|50|0|Actavis Group hf|Actavis hf|8,3333|
067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1601|3166|lyfalmen|V0555|3166|10|2|0|Actavis Group hf|Actavis hf|1,5|
012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|IKR|1343|2774|lyfalmen|||00|20|0|Icepharma hf|Meda AB|35,7143|
070623|C03AA0301|Aquazið|töflur|12,5|mg|100|stk|1|glas||C03AA03|01.03.1984||R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|530|1164|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|50|
457135|N05BA1202|Paxal |töflur|0,25|mg|50|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|246|574|lyfalmen|V0848|574|00|50|0|Actavis Group hf|Actavis hf|12,5|
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1116|2383|lyfalmen|V0914|2383|10|30|0|Actavis Group hf|Actavis hf|30|
001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8257|12730|lyfalmen|V0794|12730|00|60|0|Actavis Group hf|Actavis hf|36|
940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|5374|8726|lyfalmen|||00|1|1|Parlogis hf|Parlogis - óskráð lyf|333,33|
104356|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|30|stk|1|glas||N05BA02|01.10.1995||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|193|464|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|5|
016677|N05AH0402|Seroquel (Lyfjaver)|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2003||R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|17805|25217|lyfalmen|V0727|25217|00|100|0|Lyfjaver ehf|Lyfjaver ehf|50|
093625|B03AA0702|Ferlen-R |forðatfl|100|mg|100|stk|1|glas||B03AA07|01.04.1993|30.06.2008|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|50|
588723|B03AA0702|Ferlen-R |forðatfl|100|mg|60|stk|1|glas||B03AA07|01.01.1994|30.06.2008|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|60|0|Actavis Group hf|Actavis hf|30|
080598|N06AA0901|Amilin|töflur|25|mg|100|stk|1|glas||N06AA09|01.04.1987|30.06.2008|R|A|4|0|0|B|0|ACA|0|1|0|100|IKR|369|829|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|33,3333|
080572|N06AA0901|Amilin|töflur|10|mg|100|stk|1|glas||N06AA09|01.04.1987|30.06.2008|R|A|4|0|0|B|0|ACA|0|1|0|100|IKR|218|516|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|13,3333|
466797|N06AG0201|Aurorix|töflur|150|mg|30|stk|1|þpakki||N06AG02|01.10.1990|30.06.2008|R|A|5|0|0|B|0|ROC|0|1|0|100|IKR|1217|2583|lyfalmen|||64|30|0|Icepharma hf|Roche|15|
068023|QJ51CF0201|Latocillin, vet.|spenalyf|500|mg/dælu|1|stk|1|stk|spenadæla|QJ51CF02|01.01.1991|30.06.2008|R|A|2|0|0|0|0|VEQ|0|0|0|100|CHF|256|505|vetalmen|||16|1|0|Icepharma hf|Vétoquinol AG||
417220|N01AX1001|Diprivan|stl|10|mg/ml|100|ml|1|hgl||N01AX10|01.01.1994|30.06.2008|R|A|3|0|0|0|1|ASZ|0|0|0|100|IKR|2240|3207|lyfsjukr|||02|100|0|Vistor hf|AstraZeneca UK Ltd||
169334|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003|30.06.2008|R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1865|3567|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK||
169367|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003|30.06.2008|R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2031|3819|lyfalmen|||02|100|0|Vistor hf|AstraZeneca A/S DK||
063560|J07AH0301|Meningovax A+C|bóluefni|| |0,5|ml|10|hgl||J07AH03|01.01.1996|30.06.2008|R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15647|22531|lyfalmen|||02|5|0|Icepharma hf|Sanofi Pasteur MSD||
155580|J07AH0301|Meningovax A+C|bóluefni|| |0,5|ml|1|hgl||J07AH03|01.01.1996|30.06.2008|R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|1646|3235|lyfalmen|||02|0,5|0|Icepharma hf|Sanofi Pasteur MSD||
004481|J01MA0203|Siprox |töflur|500|mg|10|stk|1|glas||J01MA02|01.01.1994|30.06.2008|R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1407|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|5|
131987|J01AA0203|Doxytab |töflur|100|mg|10|stk|1|glas||J01AA02|01.04.1987|30.06.2008|R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|404|902|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|10|
135368|J01CA0405|Flemoxin|mixtúrud|25|mg/ml|100|ml|1|glas||J01CA04|01.11.1979|30.06.2008|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|622|1355|lyfalmen|||08|100|0|Vistor hf|Astellas Pharma A/S|2,5|
557603|C08DB0108|Korzem-R |forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.07.1990|30.06.2008|R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2295|4220|lyfalmen|||10|100|0|Actavis Group hf|Actavis hf|50|
497305|C09AA0201|Daren |töflur|20|mg|30|stk|1|glas||C09AA02|01.07.1990|30.06.2008|R|A|1,5|0|0|B|0|ACA|0|0|0|100|IKR|1157|2468|lyfalmen|||00|30|0|Actavis Group hf|Actavis hf|60|
090076|C03EA0109|Sparkal|töflur|55|mg|30|stk|1|glas|5+50 mg|C03EA01|01.10.1995|30.06.2008|R|A|2|0|0|E|0|HEX|0|0|0|100|DKK|281|646|lyfalmen|||00|30|0|Vistor hf|Hexal A/S|30|
090084|C03EA0109|Sparkal|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.10.1995|30.06.2008|R|A|2|0|0|E|0|HEX|0|0|0|100|DKK|624|1360|lyfalmen|||00|100|0|Vistor hf|Hexal A/S|100|
478438|C08CA0101|Norvasc|töflur|5|mg|200|stk|1|glas||C08CA01|01.03.2004|30.06.2008|R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|13114|19377|lyfalmen|||00|200|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|200|
082370|C08DA0101|Geangin|töflur|80|mg|30|stk|1|glas||C08DA01|01.04.1985|30.06.2008|R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|502|1106|lyfalmen|||00|30|0|Vistor hf|Gea|10|
066068|C08DA0101|Geangin|töflur|80|mg|100|stk|1|glas||C08DA01|01.04.1985|30.06.2008|R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|1310|2724|lyfalmen|||00|100|0|Vistor hf|Gea|33,3333|
066050|C08DA0101|Geangin|töflur|120|mg|100|stk|1|glas||C08DA01|01.04.1985|30.06.2008|R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|1706|3326|lyfalmen|||00|100|0|Vistor hf|Gea|50|
066076|C08DA0101|Geangin|töflur|40|mg|100|stk|1|glas||C08DA01|01.04.1985|30.06.2008|R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|671|1457|lyfalmen|||00|100|0|Vistor hf|Gea|16,6667|
082354|C08DA0101|Geangin|töflur|40|mg|30|stk|1|glas||C08DA01|01.04.1985|30.06.2008|R|A|5|0|0|B|0|GEA|0|0|0|100|DKK|285|655|lyfalmen|||00|30|0|Vistor hf|Gea|5|
104158|A02AD0101|Alminox|tuggutfl|600|mg|20|stk|1|glas|500+100mg|A02AD01|01.01.1986|30.06.2008|L|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||11|20|0|Actavis Group hf|Actavis hf|2|
104174|A02AD0101|Alminox|tuggutfl|600|mg|100|stk|1|glas|500+100mg|A02AD01|01.01.1986|30.06.2008|L|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||11|100|0|Actavis Group hf|Actavis hf|10|
011270|A10BB0101|Daonil|töflur|1,75|mg|100|stk|1|þpakki||A10BB01|01.12.1983|30.06.2008|R|A|5|0|0|*|0|SNO|0|0|0|100|NOK|1043|2231|lyfalmen|||44|100|0|Vistor hf|Sanofi-aventis Norge AS|25|
011528|A10BB0101|Daonil|töflur|3,5|mg|100|stk|1|þpakki||A10BB01|01.12.1983|30.06.2008|R|A|5|0|0|*|0|SNO|0|0|0|100|NOK|1697|3312|lyfalmen|||44|100|0|Vistor hf|Sanofi-aventis Norge AS|50|
058024|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|50|ml|10|fl|30+30+60+6|QI04AB01|01.05.1997|30.06.2008|R|K|3|0|0|0|0|INI|0|0|0|100|DKK|14186|24550|vetorma|||AA|500|0|Icepharma hf|Intervet International B.V.||
065896|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|100|fl|30+30+60+6|QI04AB01|01.05.1998|30.06.2008|R|K|3|0|0|0|0|INI|0|0|0|100|DKK|237086|410289|vetorma|||AA|10000|0|Icepharma hf|Intervet International B.V.||
065888|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|50|ml|100|fl|30+30+60+6|QI04AB01|01.05.1997|30.06.2008|R|K|3|0|0|0|0|INI|0|0|0|100|DKK|127721|221028|vetorma|||AA|5000|0|Icepharma hf|Intervet International B.V.||
041806|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|10|fl|30+30+60+6|QI04AB01|01.05.1998|30.06.2008|R|K|3|0|0|0|0|INI|0|0|0|100|DKK|26281|45481|vetorma|||AA|1000|0|Icepharma hf|Intervet International B.V.||
001895|B05AA0704|Voluven|irl|60|mg/ml|500|ml|15|pokar|Freeflex umbúðir|B05AA07|01.04.2005|30.06.2008|R|A|5|0|0|0|1|REP|0|0|0|100|DKK|20345|27197|lyfsjukr|||00|7500|0|Vistor hf|Recip AB|7,5|
111229|G02BA0301|Levonova|lykkja|20|mcg/sólh|1|stk|1|pakki|í leg|G02BA03|01.04.1994|30.06.2008|R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|12962|19188|lyfalmen|||23|1|0|Icepharma hf|Schering Oy|1825|
042994|N01BB0902|Naropin|stl|10|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998|30.06.2008|R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4387|6281|lyfsjukr|||00|100|0|Vistor hf|AstraZeneca A/S DK||
133413|N01BB0902|Naropin|stl/irl|2|mg/ml|10|ml|5|plastl||N01BB09|01.05.1998|30.06.2008|R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|1193|1708|lyfsjukr|||00|50|0|Vistor hf|AstraZeneca A/S DK||
008990|J07AH0702|Menjugate|sts|10|mcg/hgl|0,5|ml|1|hgl|+leysir|J07AH07|01.07.2002|30.06.2008|R|K|3|0|0|0|0|NVD|0|0|0|100|XEU|3807|6467|lyfalmen|||00|0,5|0|Novartis Vaccines and Diagnostics S.r.l.|Novartis Vaccines and Diagnostics S.r.l.||
462606|N05BA0204|Klordiazepoxið Actavis|töflur|25|mg|25|stk|1|glas||N05BA02|01.10.1995|30.06.2008|R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|440|977|lyfalmen|||00|25|0|Actavis Group hf|Actavis hf|20,8333|
370254|N05BA0204|Klordiazepoxið Actavis|töflur|10|mg|25|stk|1|glas||N05BA02|01.10.1995|30.06.2008|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|254|590|lyfalmen|||00|25|0|Actavis Group hf|Actavis hf|8,3333|
049570|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|28|stk|1|þpakki||C10AA01|01.07.2006|30.06.2008|R|A|2|0|0|0|0|POF|0|0|0|100|IKR|928|1992|lyfalmen|||00|28|0|PortFarma ehf|PortFarma |37,3333|
049588|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|30|stk|1|þpakki||C10AA01|01.07.2006|30.06.2008|R|A|2|0|0|0|0|POF|0|0|0|100|IKR|2815|5010|lyfalmen|||00|30|0|PortFarma ehf|PortFarma |30|
049552|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|28|stk|1|þpakki||C10AA01|01.07.2006|30.06.2008|R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1400|2861|lyfalmen|||00|28|0|PortFarma ehf|PortFarma |18,6667|
518894|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|örglas||J01CA04|01.10.1998|31.07.2008|R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1442|2925|lyfalmen|||00|20|0|Actavis Group PTC ehf|Merck NM AB|15|
013307|B02BD0402|BeneFIX|sts|| |1000|ae|1|hgl|+leysir|B02BD04|01.02.2004|31.07.2008|R|K|3|0|0|0|1|WTE|0|0|0|100|USD|87319|110580|lyfsjukr|||00|1000|0|Icepharma hf|Wyeth Europe|2,86|
016250|A10BD0301|Avandamet|filmhtfl|502|mg|56|stk|1|þpakki|500+2mg|A10BD03|01.03.2004|30.06.2008|R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|3172|5542|lyfalmen|||00|56|0|GlaxoSmithKline ehf|SmithKline Beecham PLC|28|
413252|N05BE0106|Buspiron Actavis|töflur|10|mg|100|stk|1|glas||N05BE01|01.04.1995|30.06.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|DKK|6164|9828|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|33,3333|
067835|A02BC0303|Lanser|sh-hylki|30|mg|14|stk|1|glas||A02BC03|01.01.1997|30.06.2008|R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|1123|2397|lyfalmen|||00|14|0|Actavis Group hf|Actavis hf|14|
067868|A02BC0303|Lanser|sh-hylki|30|mg|56|stk|1|glas||A02BC03|01.01.1997|30.06.2008|R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|3688|6293|lyfalmen|||00|56|0|Actavis Group hf|Actavis hf|56|
067850|A02BC0303|Lanser|sh-hylki|30|mg|28|stk|1|glas||A02BC03|01.01.1997|30.06.2008|R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|1763|3412|lyfalmen|||00|28|0|Actavis Group hf|Actavis hf|28|
505867|D07XB0202|Kenalog med Salicylsyre|áburður|| |30|ml|1|glas|í hárssvörð|D07XB02|01.12.1972|30.06.2008|R|A|2|0|0|B|0|BRS|0|0|1|100|DKK|727|1574|lyfalmen|||33|30|0|Vistor hf|Bristol-Myers Squibb|30|
047548|R03DC0101|Accolate|töflur|20|mg|28|stk|1|þpakki||R03DC01|01.04.1998|30.06.2008|R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|1753|3397|lyfalmen|||00|28|0|Vistor hf|AstraZeneca UK Ltd|14|
122606|M01AE5101|Ibukod|töflur|| |10|stk|1|glas|10+200 mg|M01AE51|01.10.1998|30.06.2008|R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|232|545|lyfalmen|||00|10|0|Actavis Group hf|Actavis hf|1,67|
090118|C03EA0110|Sparkal mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.10.1995|30.06.2008|R|A|2|0|0|E|0|HEX|0|0|0|100|DKK|540|1185|lyfalmen|||00|100|0|Vistor hf|Hexal A/S|100|
090100|C03EA0110|Sparkal mite|töflur|27,5|mg|30|stk|1|glas|2.5+25 mg|C03EA01|01.10.1995|30.06.2008|R|A|2|0|0|E|0|HEX|0|0|0|100|DKK|243|567|lyfalmen|||00|30|0|Vistor hf|Hexal A/S|30|
413898|N05BE0104|Buspirone OF|töflur|5|mg|100|stk|1|glas||N05BE01|01.04.1995|30.06.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|DKK|4296|7179|lyfalmen|||00|100|0|Actavis Group hf|Actavis hf|16,6667|
022207|A10AB0603|Apidra [optiset]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.04.2007|30.06.2008|R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|4240|7097|lyfalmen|||02|15|0|Vistor hf|Sanofi - Aventis|37,5|